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THE AORTIC VALVE-SPARING OPERATIONS: AN OVERVIEW 
 
The definition “aortic-valve sparing operations” was coined in the early ‘90s to describe 
procedures developed to preserve the native aortic valve in patients with aortic root 
aneurysm with or without aortic incompetence (AI).  Until then the main procedure to 
treat this pathology was the Bentall operation consisting in the replacement of the aortic 
root by means of a valve conduit  (1). In very selected cases, the Ross procedure 
(pulmonary autograft in aortic position) was considered an alternative  (2). Although 
the Bentall operation has been shown excellent short and long-term results, why to 
replace, in the setting of an aortic root aneurysm, an anatomically normal or nearly 
normal aortic valve? This is the question that Magdi Yacoub and Tirone David asked 
themselves about 25 years ago when they developed “the aortic root remodelling” and 
“the aortic valve reimplantation”, respectively  (3,4). The aortic root remodelling 
consists, basically, in the excision of the aortic wall to within 2 to 3 mm of leaflet 
attachment, detachment of the coronary ostia, reconstruction of the aortic root with the 
aid of a tailored Dacron graft and reimplantation of the coronary ostia.  The aortic valve 
reimplantation differs from the latter because after the excision of the aortic root 
aneurysm, the native aortic valve is entirely reimplanted within a Dacron graft (figure 
1). 
 
 
 
Fig 1. After the excision of the aortic root, the native valve is entirely reimplanted within the Dacron graft  
(reimplantation of the aortic valve) or, sutured to a tailored graft (remodelling of the aortic root). Reprint with 
permission form Elsevier. 
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 Remodelling of the aortic root is considered physiologically superior to reimplantation 
of the aortic valve mainly because the aortic annulus and the neo-aortic root seem to 
maintain their compliance during the cardiac cycle, thereby mimicking the native 
sinuses of Valsalva  (5). The principal criticism to this operation is that it doesn’t 
stabilize the ventriculo-aortic junction, with possible further dilatation and risk for 
recurrent AI, particularly in patients with connective tissue disorders  (6) or in patients 
with dilated annulus. However, it has provided excellent results in patients with 
preserved aortic annulus  (7). Conversely, the reimplantation of the aortic valve 
stabilizes the annulus, which is entirely contained within the Dacron graft thus 
preventing from further dilatation but, however, it doesn’t permit the physiological 
systo-diastolic movement of the annulus and the neo-aortic root.  Several modifications 
have been made over the years to overcome the limitations of both techniques. To 
address the issue of annular dilatation during remodelling of the aortic root several 
types of internal and external annuloplasty were designed, including the use of strip of 
Dacron  (8), polytetra-fluoroethylene (PTFE) suture  (9), and more recently, a 
commercially available flexible ring  (10). On the opposite side, to overcome the lack of 
compliance at the level of the neo-root during aortic valve reimplantation, in 2000 
Ruggero De Paulis introduced the Valsalva graft that, upon implantation and 
pressurization generates 3 independent pseudo-sinuses without the need for any 
substantial variation in the original reimplantation technique  (11). The peculiar design 
of the Valsalva graft allows for proper root reconstruction by re-establishing the main 
root characteristics: 2 rings (annulus and ST junction), joined by 3 pillars (the 
commissures), separating 3 independent bulging sinuses (figure 2).  
 
 
Fig 2: Graft drawing of the Valsalva conduit in 
a reimplantation type of valve-sparing 
procedure. Dotted lines represent suturing of 
the patient’s own valve to the skirted section 
of the graft. Note that the top of the 
commissures reach the new sinotubular 
junction. After suturing of the valve is 
completed, the conduit can bulge only at the 
site of the sinuses whereas it will remain 
straight behind the commissural posts. 
Coronary artery is attached at the center of 
the corresponding sinus. 
Reprint with permission form Elsevier. 
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Similarly, a few other attempts to reproduce the sinuses of Valsalva by placating a 
tubular Dacron graft have been carried out in recent years  (12,13). 
In 2003 Craig Miller proposed a classification of the different techniques as follows  
(14): 
• David I: original reimplantation technique using a cylindrical tubular graft 
• David II: classic Yacoub remodelling 
• David III: remodelling with an external synthetic strip added between the left 
and right mitral fibrous trigones 
• David IV: reimplantation using a 4-mm larger graft size with plication of the 
graft circumferentially at the sino-tubular junction above the top of the 
commissures 
• David V: reimplantation using even a larger graft which is necked down at 
both the bottom and top ends to create pseudo-sinuses. 
 
Nowadays, in literature this group of operations is also identified with the definition  
“valve-sparing aortic root replacement”.  
The main advantages of the reimplantation technique performed with the Valsalva graft, 
being ventriculo-aortic junction fixation and recreation of the sinuses of Valsalva, made 
it the preferred method of aortic-valve sparing operation at Isituto Clinico Humanitas in 
Milan.  
 
 
THE ANATOMICAL BASES OF THE VALVE-SPARING AORTIC ROOT SURGERY 
 
In considering the prospect of an aortic valve-sparing procedure a deep knowledge of 
the surgical anatomy of the aortic root is mandatory. The aortic valve needs to be 
considered a functional unit composed by three structures: (I) the functional aortic 
annulus, comprising the ventriculo-aortic junction and the sino-tubular junction, (II) the 
aortic cusps and (III) the three sinuses of Valsalva. Although the “anatomic” ventriculo-
aortic junction seems to be positioned at about a third of height the aortic root, the 
“surgical” intraluminal ventriculo-aortic junction is a virtual ring formed by joining basal 
attachment of the aortic cusps (Figure 3) (15,16). On the extraluminal side of the aortic 
root, the limit of the surgical dissection during valve-sparing aortic root replacement (V-
SARR) corresponds to the roof of the left atrium on the side of the non - and left-
coronary sinus and to the myocardium coming from the ventricular septum and 
continuing laterally to the right ventricular outflow tract, on the side of right-coronary 
  16 
sinus  (17). To achieve a proper positioning of the graft during aortic valve 
reimplantation, the dissection outside the aorta must be at the level just described 
above, so that the prosthesis can incorporate the entire functional aortic annulus, thus 
preventing further dilatation. Conversely, during remodelling of the aortic root, a deep 
dissection outside the aorta is not required as the graft doesn’t incorporate the valve but 
is sutured just above. 
 
 
 
 
PATIENTS’ SELECTION FOR THE AORTIC VALVE-SPARING OPERATIONS 
The valve-sparing operations were originally designed for young patients with aortic 
root aneurysm and normal aortic valve cusps.  Over the years, the encouraging mid- and 
long-term results in terms of mortality, morbidity and valve durability, have convinced 
many surgeons to expand the indication to older subjects  (18) and to subjects with 
more compromised aortic valve, including patients with Marfan syndrome  (6), 
bicuspidity  (19), and aortic valve affected by severe incompetence  (20). This evolution 
has resulted in the need to develop a technique that, in addition to the root graft 
implantation, could correct residual aortic insufficiency due to abnormalities of the 
aortic valve. Several techniques to correct the residual valve prolapse or to minimize the 
valve-restricted motion have been introduced. Although the results of valve-sparing 
Fig 3: A, Three-
dimensional 
arrangement of the 
aortic root, which 
contains 3 circular 
“rings,” but with the 
leaflets sus-pended 
within the root in 
crown-like fashion. B, 
The leaflets have been 
removed from this 
specimen of the aortic 
root, show-ing the 
location of the 3 rings 
relative to the crown-
like hinges of the 
leaflets. VA indicates 
ventriculoarterial; A-M, 
aortic-mitral. 
Reprint with permission 
form Wolters Kluwer 
Health, Inc. 
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operations in patients with connective tissue disorders and in selective cases of elderly 
patients seems to be extremely encouraging, especially with the reimplantation 
technique  (21,22), the impact of the additional aortic cusp repair on the recurrent AI is 
still controversial, particularly in patients with bicuspid aortic valve requiring complex 
repair  (23-25).  
Trans-esophageal echocardiography remains the best diagnostic tool to select patients 
for these operations. All the components of the aortic root need to be investigated, 
particularly the cusps. Diffusely calcified, sclerotic and stiff cusps are usually considered 
not suitable for repair. In the setting of significant aortic incompetence, identification of 
the prolapsing cusp and regurgitant jet direction are of paramount importance.  
Angio-CT scan of the chest is also required to precisely measure the root and the 
ascending aorta and to rule out an involvement of the aortic arch in the aneurysmal 
pathology. 
 
AORTIC VALVE-SPARING REIMPLANTATION OPERATIVE TECHNIQUE 
A median sternotomy is performed and hypothermic cardiopulmonary bypass (32 °C) is 
instituted with aortic arch, femoral artery or right axillary artery and right atrium 
cannulation. Myocardial protection is achieved by antegrade or a combination of 
antegrade and retrograde crystalloid cardioplegic solution. The sinuses and the 
ascending aorta are excised so that only 3 to 4 mm of the aortic wall is left attached to 
the annulus. The coronary ostia are prepared for a button reimplantation as for a 
conventional root-replacement procedure. Then, Ethibond 2/0 with pledgets or 
alternatively, 4-0 polypropylene sutures are placed from the inside to the outside 
around the ventriculo-aortic junction along a horizontal plane (basal ring) 2-mm below 
the valve leaflets level. Prosthesis diameters are calculated from the diameter of the left 
ventricular outflow tract and/or the height of the aortic cusps. In all the reimplantation 
procedures the Gelweave Valsalva prosthesis (Sulzer Vascutek, Renfrewshire, Scotland) 
was implanted. At this point of the operation, it is of crucial importance to make sure 
that the cusps are coapting at the same level and well above the nadir of the aortic 
annulus (8–11mm) and the cusps have no ‘restricted’ motion.  If one or both of these 
conditions are not met, additional cusp repair is needed. The coronary arteries are then 
implanted and the graft is anastomosed to the distal aorta in a conventional way. In case 
the aortic arch is involved in the aneurysmal disease, total or partial arch replacement is 
performed according to dr. Kazui protocol  (26). 
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AIM OF THE THESIS 
The aortic valve-sparing reimplantation is a challenging procedure even for experienced 
aortic surgeons. Preservation of the native valve permits the maintenance of a proper 
hemodynamic and avoids the lifelong anticoagulation but the risk of recurrent aortic 
regurgitation remains its Achilles heel.  
The aim of this study is to evaluate the results of the aortic-valve sparing reimplantation 
technique presented both as single and multi -center experience. The impact of several 
variables on mortality and morbidity has been investigated, focusing particularly on the 
residual aortic incompetence. Moreover, the outcome of alternative techniques to treat 
the aortic root aneurysmal pathology, such as the Bentall and the Ross operation, has 
been explored. 
 The centers involved in the clinical study are as follows: 
- Humanitas Research Hospital, Humanitas University, Milan, Italy 
- S. Orsola Hospital, University of Bologna, Bologna, Italy 
- Tor Vergata Hospital, Tor Vergata University, Rome, Italy 
- Hospital of the University of Pennsylvania, Philadelphia, USA 
- St. Antonius Hospital, Nieuwegein, The Netherlands 
 
The following issues have been explored in details in the corresponding chapters: 
- Early and mid-term results of the aortic valve reimplantation technique with 
reconstruction of the sinuses of Valsalva and compliance of the Valsalva graft 
pseudo-sinus at mid-term follow-up (Chapter 2-5). 
- Results of valve-sparing aortic root replacement in different settings including 
Marfan patients, bicuspid aortic valve and older patients (Chapter 6-8). 
- Impact of additional aortic cusp repair in patients with bicuspid and tricuspid 
aortic valve including long-term results (Chapter 9,10). 
- Outcome of the aortic root replacement with composite valve graft (Chapter 
11,12). 
- Results of the Ross operation for the aortic root replacement (Chapter 13). 
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Abstract 
 
 
 
Objective: Aortic valve-sparing operations were developed to preserve the native aortic 
valve in patients with aneurysms of the aortic root or ascending aorta and normal aortic 
valve leaflets. This paper describes our initial experience with valve-sparing operations 
and earlyclinical and echocardiographic results obtained. 
 
 
Methods: From October 2002 to March 2004, 32 consecutive patients underwent aortic 
valve-sparing operations at the Istituto Clinico Humanitas, Rozzano, Italy. Preoperative 
transesophageal echocardiography showed moderate or severe aortic incompetence 
(AI) in 15 patients (47%). Twenty-nine patients underwent reimplantation of the aortic 
valve and 3 patients remodeling of one sinus. In 2 cases prolapsing cusp repair was 
carried out. 
 
Results: There were no intraoperative deaths. At discharge, two-dimensional 
echocardiogram showed no or trivial aortic incompetence (AI) in 17 (52%) patients and 
mild AI in 13 (42%); 2 (6%) patients had severe AI requiring reoperation, respectively 4 
and 6 weeks later. 
 
Conclusions: The valve-sparing procedures showed good preliminary results, thus 
encouraging further use of this type of repair. However, further larger studies and long-
term results are needed in order to define the durability of these techniques. 
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Introduction 
 
Aortic valve-sparing operations were developed to preserve the native aortic valve in 
patients with aneurysms of the aortic root or ascending aorta and normal aortic valve 
leaflets [1]; in recent years indications have been extended also to valves having cusps 
without gross structural defects [2,3]. These kind of aneurysms are frequently 
associated with aortic incompetence (AI) which is caused by loss of the sino-tubular 
junction, dilatation or distortion of one or more sinuses of Valsalva, annuloaortic ectasia 
or a combination of these problems [4]. The conventional treatment consists of 
composite replacement of the aortic valve and the ascending aorta [5]; though it’s 
considered ‘safe’, it is not free from complications including thromboembolism, 
endocarditis, and long-term anticoagulation related problems [6]. Then, from October 
2002, we have adopted valve-sparing operations to treat patients with root dilatation 
and aortic cusps without gross structural defects. This paper describes our initial 
experience with valves-paring operations and early clinical and echocardiographic 
results obtained. 
 
 
Material and methods 
 
From October 2002 to March 2004, 32 consecutive patients underwent aortic valve-
sparing operations at the Istituto Clinico Humanitas, Rozzano, Italy. Our standard 
indications have been aneurysms of the aortic root and/or ascending aorta and aortic 
cusps without gross structural defects. The final decision to preserve the valve was 
made intraoperatively by the surgeon after inspection of valve cusps and root geometry. 
When the structural defects of the cusps were considered unsuitable for repair the 
Bentall procedure was performed. Demographic data are listed in Table 1. Patients were 
predominantly male and mean age was 58 ±13 (range 28–83). The mean ascending 
aorta diameter was 5.1±1.1 cm. Among the patients with no, trivial or mild AI the mean 
ascending aorta diameter was 5.0±1.0 cm and of these 33.3% had a bicuspid aortic 
valve. 
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Table 1: Preoperative patients characteristics 
Characteristics  n=32 
Age (years) 58±13 
Sex (male) 25 (78) 
NYHA functional class 
• I 
• II 
• III 
• IV 
 
22 (69) 
8 (25) 
2 (6) 
- 
Left ventricular ejection fraction 
• >60% 
• 40-59 
• <39 
 
22 (78) 
5 (18) 
1 (4) 
Aortic incompetence 
• None/trivial 
• Mild 
• Moderate 
• Severe 
 
 
10 (31) 
7 (22) 
7 (22) 
8 (25) 
Marfan syndrome 1 (3) 
Aortic Valve Morphology 
• Bicuspid (congenital) 
• Tricuspid 
 
7 (22) 
25 (78) 
Coronary artery disease 4 (13) 
Mitral regurgitation 3 (9) 
Diameter of aneurysm (cm) 
1. Aortic root 
2. Ascending aorta 
 
4.6±0.6 
5.1±1.1 
Values are mean ±1 S.D. 
Numbers in parentheses are percent. 
 
 
Operative techniques 
 
A median sternotomy was performed and hypothermic cardiopulmonary bypass (32 °C) 
was instituted with femoral artery and right atrium cannulation. Femoral artery 
cannulation was preferred in order to achieve a more distal cross-clamping site on the 
ascending aorta. Myocardial protection was achieved by combination of antegrade and 
retrograde Custodiol® cardioplegic solution and topical cooling with 4 °C saline solution. 
All patients but three, underwent the reimplantation of the aortic valve according to the 
technique described by David [1]. The sinuses and the ascending aorta were excised so 
that only 3 to 4 mm of the aortic wall were left attached to the annulus. The coronary 
ostia were prepared for a button reimplantation as for a conventional root-replacement 
procedure [5]. In the presence of a bicuspid valve, radial tension was placed on the 2 
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commissures by means of two sutures in order to assess leaflet prolapse. The free 
margin of congenital fusion of the left and right coronary leaflets was found to be 
elongated in 2 cases. Shortening of the free margin was achieved by a plication of the 
margin itself with a Gore-Tex® 6-0 running suture. Shortening of the leaflet margin was 
considered adequate if both leaflets were at identical heights after applying radial 
tension on the two commissures. Then, 4-0 polypropylene sutures were placed from the 
inside to the outside around the aortic annulus along a horizontal plane below the valve 
leaflets level. Prosthesis diameters were calculated from the diameter of the left 
ventricular outflow tract and the height of the aortic cusps. In all the 29 reimplantation 
procedures the Gelweave Valsalva™ prosthesis (Sulzer Vascutek, Renfrewshire, 
Scotland) [7,8] was implanted. The diameter of the graft was equal or slightly smaller 
than the average length of the free margins of the aortic cusps [1]. The coronary arteries 
were then implanted and the graft was anastomosed to the distal aorta in a conventional 
way.  
Three patients with ascending aorta aneurysms and isolated non-coronary aortic sinus 
dilatation underwent the remodeling procedure [4]. The non-coronary sinus and the 
ascending aorta were replaced by a scalloped shape dacron tubular graft (Sulzer 
Vascutek, Renfrewshire, Scotland). 
The graft size was 28 millimetres (mm) in 4 (13%) patients, 30 mm in 13 (40%) and 32 
mm in 15 (47%). A transesophageal echocardiogram (TEE) was carried out 
intraoperatively in all the patients after the cardiopulmonary bypass weaning in order 
to evaluate the competence of the aortic valve. None of the patients showed AI grater 
than mild. 
Table 2 shows the operative data. 
Table 2: Operative data 
Characteristic n=32 
Cardiopulmonary bypass time (min) 126±21 
Cross clamping time (min) 109±16 
Root procedure 
• Reimplantation 
• Remodeling of noncoronary sinus 
 
29 (91) 
3 (9) 
Prolapsing cusp repair 2 (6) 
Coronary artery bypass grafting 4 (13) 
Mitral valve plasty 2 (6) 
Mitral valve replacement 1 (3) 
Stay in the intensive care unit (days) 1.4±0.9 
Intubation time (hours) 15.5±5.5 
Values are mean ±1 S.D. Numbers in parentheses are percent 
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Results 
 
All patients underwent the operation during a recent 18- month period. There were no 
intraoperative deaths. One patient showed ischemia at the electrocardiogram soon after 
the cardiopulmonary bypass weaning; an intraoperative TEE showed a hypokinetic left 
ventricular posterior wall. A kinking at the right coronary ostium site was noted. After a 
venous graft on the right coronary was performed, the patient recovered completely and 
did not develop myocardial infarction (creatinine phosphokinase<300 IU/l, myocardial 
band < 5%). Three patients required early reoperation (<24 h) for bleeding. Two 
patients underwent pacemaker implantation because of permanent atrioventricular 
block. 
 
 
Aortic valve function 
 
All the patients underwent two-dimensional echocardiogram at discharge. Colour flow 
Doppler was used to detect AI, and severity was subjectively graded as trivial (1+), mild 
(2+), moderate (3+) and severe (4+). There was no or trivial (1+) AI in 17 (52%) 
patients; 13 (42%) had a mild (2+) AI and 2 (6%) had severe (4+) AI requiring 
mechanical aortic valve replacement respectively 4 and 6 weeks after the aortic valve 
reimplantation procedure. The first patient was a 28-year-old man with Marfan 
syndrome, the second, with a bicuspid aortic valve, had during the first operation a 
prolapsing cusp repair by shortening of the free margin. Two more patients required 
reoperation for non-valve related complications. One patient developed a 
pseudoaneurysm for a leak at the left coronary anastomosis 1 month after the first 
operation; the second developed a constrictive pericarditis three months after the first 
procedure. Both of them recovered completely after the reoperation. 
 
Discussion 
 
The mechanisms that lead to AI in patients with aortic root and/or ascending aorta 
aneurysms are nowadays well known [9–11]. The conventional treatment of these 
patients consists of aortic root replacement with a composite graft. Many series [12,13] 
showed that this operation is safe and has a low mortality and morbidity rate. However, 
most of these patients arrive for the operation with intact or minimally stretched aortic 
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cusps. Why should one remove an anatomically normal aortic valve? This is the question 
that Sarsam, Yacoub and David asked themselves approximately a decade ago. Sarsam 
and Yacoub [14] proposed the remodeling technique of the aortic root to achieve cusps 
coaptation by reduction of the sinotubular junction. This approach preserves the 
anatomy and the function of the sinuses of Valsalva; this step is considered essential in 
order to avoid cusps trauma and degeneration, but does not provide stabilization of the 
annulus with a tendency towards progressive AI [15]. We did not use this technique in 
our series. This aspect was addressed by David and Feindel [1]; they found that in many 
patients with sinotubular dilatation, it also co-exists annulus dilatation. This is 
particularly evident in patients with connective tissues disorders, such as the Marfan 
syndrome [16]. They proposed the reimplantation technique to provide stabilization of 
the aortic annulus, better support of the aortic wall and less chance of suture bleeding. 
Nevertheless, we have to admit that one of the two patients of our series, a young man 
with Marfan syndrome, who underwent reoperation for severe AI, had originally a 
reimplantation procedure and did not benefit from it. This technique, however, does not 
preserve the anatomy and the function of the sinuses of Valsalva. This issue was 
addressed by De Paulis [7,8], introducing modified Dacron conduit (Gelweave Valsalva™, 
Sulzer Vascutek, Renfrewshire, Scotland) that on implantation recreates sinuses of 
Valsalva of normal shape and dimension, providing a sufficient gap that should avoid 
any contact between the open leaflet and the Dacron wall. Longer follow-up is needed in 
order to assess the cusps preservation. We used this prosthesis in all the patients who 
underwent aortic valve reimplantation in our series. 
Langer and colleagues [17] showed that the addition of leaflet prolapse repair to root 
replacement does not result in increased morbidity or hospital mortality. Our 
experience in cusp repair is very limited; we used the free margin shortening technique 
just in two patients, but one of them, with a bicuspid aortic valve, rapidly developed 
severe AI and underwent reoperation. The TEE carried out before reoperation showed a 
central jet through the valve. The valve, in fact, turned out to have a central gap caused 
by the retraction of the cusp presenting a raphe. Was the raphe fibrosis the cause of the 
cusp retraction? Was our approach in shortening the free margin too aggressive? We are 
still not able to answer these questions, but since our approach consists of triangular 
resection of the raphe [18] in case of prolapsing bicuspid aortic valve. It has been shown 
that reconstruction of the regurgitant bicuspid valve by means of triangular resection of 
a median raphe, in combination with proximal aortic replacement provides good 
midterm results [2]. Although the current results are promising, further follow-up will 
  32 
be required in order to determine the reliability of this technique in the long term. In our 
series there were no deaths and the freedom from moderate or severe AI at discharge 
was 94%; we thus conclude that the valve-sparing operations have, in our short 
experience, a low morbidity rate especially in patients with tricuspid aortic valve. We 
moreover think that the optimal technique of leaflet repair is still open to controversy. 
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Abstract 
 
 
Background: This study evaluates the midterm clinical results of valve-preserving 
aortic root reconstruction by means of a modified conduit incorporating sinuses of 
Valsalva. 
 
Methods: During a 5-year period, 151 patients with aneurysm of the aortic root 
underwent a reimplantation type of valve-sparing procedure using the Gelweave 
Valsalva™ prosthesis that incorporates sinuses of Valsalva. There were 121 males 
(80.1%), and the mean age was 56.4 ± 14.4 years (range, 14 to 83). Fourteen percent of 
the patients had Marfan syndrome and 8.6% had bicuspid aortic valve. Seven patients 
(4.6%) suffered from acute aortic dissection. Aortic replacement was extended to the 
arch in 14 patients (9.3%). Sixteen patients (10.6%) had associated cusp repair.  
 
Results: In-hospital mortality was 3.3%, and it was significantly higher among patients 
operated on for acute dissection (p = 0.001) and in symptomatic patients (III–IV New 
York Heart Association class; p = 0.021). Follow-up (mean, 18 months; range, 1 to 60) 
was 100% complete. There were 2 late deaths. Ten patients (6.8%) had 3 to 4+ aortic 
regurgitation, and 8 of these required late aortic valve replacement. Cusp repair was 
associated with a high incidence of late aortic valve replacement (p = 0.005). At 5 years, 
freedom from aortic valve replacement and freedom from grade 3 to 4 aortic 
insufficiency was 90.8% ± 3.3% and 88.7% ± 3.6%, respectively. 
 
Conclusions: The reimplantation valve-sparing procedure with the Gelweave Valsalva 
prosthesis provides satisfactory results for patients with aortic root aneurysm. Aortic 
cusp repair may lead to late aortic insufficiency. Proper leaflet evaluation is of 
paramount importance in preventing residual valve regurgitation. 
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The use of aortic valve-sparing operations has increased in the last years owing to a 
better understanding of anatomy, function and pathology of the aortic root. The two 
main surgical procedures adopted are the remodeling and the reimplantation 
techniques. While the remodeling technique allows a certain reconstruction of the 
sinuses, it does not stabilize the annulus and carries an higher incidence of residual 
aortic insufficiency. Conversely, the classical reimplantation prevents progressive 
annular dilatation but completely abolishes the sinuses. In fact, the cylindrical shape of 
the tube has been demonstrated to be a cause of increased stress motion of the valve 
leaflets, and it might lead to sudden cusps deterioration [1–3]. As it is well known that 
the sinuses of Valsalva are important in assuring normal function of the aortic valve, 
many technical changes in the original reimplantation procedures have been suggested 
to create a sort of pseudosinuses [4, 5]. In 2000, it became available as a modified 
Dacron (C. R. Bard, Haverhill, Pennsylvania) tube, the Gelweave Valsalva graft (Vaskutek; 
Renfrewshire, Scotland), designed to recreate sinuses of Valsalva of normal shape and 
dimensions [6]. The advantages of this conduit have been already reported [7–9], not 
only for valve-sparing procedures but also in cases of Bentall procedures [10]. In the 
current paper, we describe the combined experience of three cardiac surgery 
departments in the reimplantation type of valve-sparing procedure using this conduit 
and analyse the clinical results of the first 151 patients. 
 
 
Patients and Methods 
 
Between May 2000 and August 2005, 151 patients with aneurysm of the aortic root 
underwent a valve-sparing operation according to reimplantation procedure using the 
Gelweave Valsalva prosthesis at S. Orsola Hospital (University of Bologna, Italy), at 
Istituto Clinico Humanitas (Rozzano, Italy), and at the Tor Vergata University of Rome 
(Rome, Italy). The study was approved by the Institutional Review Board of each 
institute, and informed consent was obtained from all patients. 
Patients’ age ranged from 14 to 83 years (mean, 56.4 ± 14.4). There were 121 male 
(80.1%) and 30 female (29.9%) patients. All patients were preoperatively evaluated 
with transthoracic or transesophageal echocardiography. Angiography was performed 
in patients older than 50 years of age or with a history of coronary artery disease. The 
clinical and demographic profile of patients is described in Table 1. 
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Table 1: Clinical Data 
Characteristic Value 
Number of patients 151 
Sex, male (%) 121 (80.1) 
Age, years (range) 56.4 ±14.4 (14–83) 
Hypertension (%) 74 (49) 
Coronary artery disease (%) 25 (16.6) 
Renal insufficiency (%) 5 (3.3) 
Marfan syndrome (%) 21 (13.9) 
Bicuspid aortic valve (%) 13 (8.6) 
Acute type A dissection (%) 7 (4.6) 
Reoperation (%) 3 (2) 
NYHA (%) 
• I 
• II 
• III 
• IV 
 
48 (31.8) 
60 (39.7) 
37 (24.5) 
6 (4) 
NYHA = New York Heart Association. 
 
 
 
The Valsalva Graft 
 
The peculiarity of the Valsalva graft is the possibility of reconstructing the sinuses of 
Valsalva upon graft implantation and pressurization. The graft design has been 
described in detail elsewhere [6]. Briefly, it is a standard Dacron conduit that 
incorporates a short segment of the same material with corrugation at a 90-degree angle 
with respect to the rest of the graft. This segment, called the skirt, has a length equal to 
the graft diameter, and it is resilient in the horizontal plane so that upon implantation 
and pressurization, it will generate pseudosinuses of Valsalva. The suture joining these 
two sections of Dacron acts as a new sinotubular junction. 
 
Operative Procedures 
 
Cardiopulmonary bypass was instituted through cannulation of the right atrium and the 
ascending aorta. The systemic temperature was lowered to 32°C. In patients who had an 
aneurysm of the aortic arch or acute type A dissection, a peripheral cannulation, right 
femoral or axillary artery was preferred. In these cases, a systemic body temperature of 
26°C was used, and antegrade selective cerebral perfusion was utilized during the 
period of circulatory arrest. Myocardial protection was achieved by antegrade infusion 
of cold (5°C to 10°C) crystalloid HTK solution (Custodiol; Koehler Chemie, Alsbach-
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Haenlein, Germany) or by intermittent blood antegrade cardioplegia depending on the 
surgeon preferences. The left ventricle was vented by inserting a cannula through the 
superior right pulmonary vein. 
The surgical procedure followed the steps described by David and Feindel [11] in their 
original article. After the aortic wall is excised, U stitches of Ethibond 3-0 (Ethicon Inc, 
Johnson and Johnson Co, Somerville, NJ) are passed below the aortic valve, at the level of 
the ventriculoarterial junction, in a circular fashion. The aortic annulus is then measured 
with a standard valve sizer, and a 5-mm larger prosthetic tube is chosen (ie, if the aortic 
annulus measures 25 mm, a 30-mm Valsalva conduit is used). In case of dilated annulus, 
the sinotubular junction is sized instead. In detail, once a proper leaflet coaptation is 
obtained by pulling and aligning on the three commissures, the sinotubular junction can 
be easily measured and the proper size (+5 mm) of the Valsalva graft can be chosen. In 
case of an overdilated annulus, a subcommissural annuloplasty is performed using 
pledgeted Ethibond 2-0 at the level of the interleaflet triangles. 
Once the Valsalva graft size has been selected, one important step is to adapt the height 
of the skirt to the height of the patients commissures (Fig 1). The key point of the 
surgical technique when using a Valsalva conduit is the correct placement of the top of 
the commissures at the level of the union of the skirted section and the standard graft, 
which represents the new ST junction. This is achieved by sizing the height of the 
commissures from the annulus to the top of the commissure. The three commissures are 
usually of different heights, and the one in between the right and the left cusp is shorter. 
Therefore, the base of the skirt can be scalloped accordingly to compensate for this 
length difference. This can also prevent the impingement of the “annular to sinus 
junction.” 
After the annular stitches have been passed through the graft and tied, the commissures 
are retrieved from inside and are pulled at the level of the neo-sinotubular junction. 
Next, the valve remnants are secured to the Dacron wall and the coronary buttons 
reattached to the corresponding sinus. 
Sixteen patients (10.6%) had associated cusp repair consisting of one or more of the 
following procedures: shortening of the free margin either by central plication or by 
weaving a double layer of 6-0 polytetrafluoroethylene suture in 11 patients; raphe 
resection with annular plication in 7 patients (in 2 of these, shortening of the free 
margin by a double layer suture was also performed, and in another 1, an autologous 
pericardium patch was utilized to reconstruct the leaflet where the raphe was present); 
suturing of a cusp fenestration with 6-0 polypropylene suture in 3 patients. 
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Fig 1. Techniques description: adjustment of the Valsalva graft to the patient’s valve remnants to obtain the 
correct placement of the commissures at the level of the prosthesis sinotubular junction. See text for details.  
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Aortic arch or hemiarch replacement was performed in 14 patients (9.3%), and in 1 
case, an elephant trunk technique was utilized. Antegrade selective cerebral perfusion 
was used for cerebral protection in all cases. Twenty-one patients (13.9%) underwent 
coronary artery bypass, 10 patients (6.6%) underwent mitral valve repair or 
replacement, 3 patients had atrial septal defect repair, and 4 patients underwent 
radiofrequency ablation for atrial fibrillation. Table 2 summarizes the operative data. 
 
 
Table 2: Operative Data 
Characteristic Value 
Cusp repair (%) 16 (10.6) 
Aortic arch replacement (%) 
• Hemiarch 
• Total arch 
• Elephant trunk 
14 (9.3) 
9 (6) 
3 (2.6) 
1 (0.7) 
CABG (%) 21 (13.9) 
MVR/MVP (%) 10 (6.6) 
ASD repair 3 (2) 
Radiofrequency ablation 4 (2.6) 
CPB time, minutes (range) 143 ± 35.4 (99–373) 
CC time, minutes (range) 119 ± 24.1 (67–229) 
ASD = atrial septal defect; CABG _ coronary artery bypass graft; CC = cross clamp; CPB _ cardiopulmonary bypass; MVP = mitral valve 
plasty; MVR = mitral valve replacement. 
 
 
 
 
Follow-Up 
 
All hospital survivors were available for follow-up at intervals ranging from 1 to 60 
months (mean, 18). Follow- up information was obtained by direct examination or by 
correspondence with the patient. The date of the last inquiry was between May and 
August 2005. Every patient had an echocardiogram at 3 and 9 months after the 
operation and then every year. The degree of residual valve regurgitation was assessed 
semiquantitatively as follows: 0, none; 1, minimal; 2, mild; 3, moderate; 4, severe. In case 
of valve insufficiency of grade 3 or greater, echocardiography was repeated at shorter 
intervals. Echocardiographic data are summarized in Table 3. 
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Table 3: Echocardiographic Data 
 Early 
Postoperative 
Last Visita 
Grade of aortic 
regurgitation (%) 
• 0-1+ 
• 2+ 
• 3+ 
• 4+ 
 
 
104 (71.2) 
35 (24) 
5 (3.4) 
2 (1.4) 
 
 
95 (69.8) 
39 (28.7) 
2 (1.5) 
0  
a Eight patients reoperated on during follow-up were excluded; 2 patients died during follow-up and were 
excluded. 
 
 
 
Statistical Analysis 
 
Statistical analysis was performed with SPSS 11.0 statistical software (SPSS, Chicago, 
Illinois). Continuous variable were expressed as the mean ± SD and were compared with 
an unpaired two-tailed t test. Categorical variables were analyzed with a Χ2 test or 
Fisher’s exact test where appropriate. Survival analyses were calculated using the 
Kaplan-Meier actuarial technique; in addition, freedom from grade 3 or 4 aortic 
insufficiency and freedom from aortic valve replacement were calculated. Subgroup 
comparisons were made by means of the log-rank test. 
 
 
Results 
 
Early Outcomes 
There were 5 in-hospital deaths (3.3%): 2 due to multiple organ failure, 2 due to low 
cardiac output, and 1 due to intestinal ischemia. Three of these patients were operated 
on because of acute type A aortic dissection and 2 because of annuloaortic ectasia. In-
hospital mortality was significantly higher among patients operated on for acute 
dissection (42.9% versus 1.4%; p = 0.001) and among symptomatic patients (New York 
Heart Association class III to IV; 9.5% versus 0.9%; p = 0.021). One patient operated on 
for acute dissection had an acute severe aortic insufficiency on the second postoperative 
day. At reoperation, a commissural detachment causing prolapse of the left and the 
noncoronary cusps was found. The patient underwent aortic valve replacement with a 
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mechanical valve, leaving the reimplanted aortic tissue inside the graft. Three days later, 
a transesophageal echocardiogram showed a malfunction of the valve due to a 
mechanical leaflet blockage. This had been caused by some aortic wall tissue becoming 
detached from the graft. The patient underwent a third operation for total root 
replacement with a composite valved graft. Weaning from cardiopulmonary bypass was 
impossible, and a biventricular assist device was implanted. The patient died 2 days 
later. Two other deaths occurred in patients operated on for acute dissection with 
peripheral malperfusion and tamponade. They died of multiple organ failure during the 
postoperative period. The fourth patient was operated on for annuloaortic ectasia, but 
the postoperative course was complicated by aortic dissection originating from the 
distal anastomosis; renal insufficiency developed and the patient died of multiple organ 
failure on the 12th postoperative day. The last patient underwent successful 
reimplantation procedure associated with CABG but died of intestinal ischemia after 12 
days.  
Four patients required rethoracotomy for bleeding. At discharge, 5 patients had grade 3 
and 2 patients had grade 4 residual aortic regurgitation. 
 
Late Outcomes 
 
There were 2 late deaths (1.4%). The causes of death were gastric hemorrhage and 
multiple organ failure. Both patients had only trivial aortic regurgitation. The 5-year 
survival for all patients was 91.2% ± 3.4% (Fig 2). Eight patients were reoperated on 
during follow-up and required aortic valve replacement because of residual aortic 
regurgitation. Five of these patients had already a significant valve regurgitation at the 
time of discharge and were reoperated on within a period between 1 month and 20 
months. Two patients had a rapid appearance of aortic valve regurgitation because of 
endocarditis in 1 case and leaflet elongation (probably due to extreme growth spur in a 
Marfan child) in another case. The last patient (who had a grade 2 residual valve 
regurgitation at the time of discharge because of untreated leaflet prolapse) had a 
progressive worsening of valve regurgitation with initial ventricular enlargement. Two 
patients with grade 3 residual aortic regurgitation since hospital discharge are 
asymptomatic with normal left ventricular size and function and are being followed 
closely by serial echocardiograms. The incidence of reoperation was significantly higher 
among patients who had undergone cusp valve repair (25% versus 3%; p = 0.005). In 
fact, 4 of the reoperated patients with grade 3 to 4 aortic insufficiency had a cusp repair 
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procedure. 
At 5 years, freedom from late aortic valve replacement and freedom from combined 
grade 3/4 aortic insufficiency and aortic valve replacement was 90.8% ± 3.3% and 
88.9% ± 3.3%, respectively (Fig 3A, B). The sinuses of Valsalva were well reproduced, as 
shown by echocardiography, in all patients (Fig 4). Some patients also underwent other 
imaging modality such as computed tomography scan, magnetic resonance imaging, or 
angiography that confirmed the echocardiographic findings (Figs 5, 6). 
 
 
 
Fig 2: Overall actuarial survival for all patients.                     Fig 3: (A) Actuarial freedom from late aortic valve  
Survival was 93.5% at 1 year and 91.2% at 5 years.           replacement.  Freedom from aortic valve replacement  
  was 95.7% at 1 year and 90.8% at 5 year.  
 (B)  Actuarial    freedom from residual grade 3-4 aortic      
regurgitation and aortic valve replacement. Freedom 
from combined residual grade 3-4 aortic regurgitation 
and aortic valve replacement was 94.7% at 1 year and 
88.7% at 5 years.                        
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Fig 4: Postoperative echocardiographic 
aspect of the aortic root in a patient after a 
reimplantation procedure with the 
Valsalva graft. 
Fig 5: Postoperative magnetic resonance 
image of a Marfan syndrome patient 3 years 
after aortic reimplantation procedure with 
the Valsalva graft. 
Fig 6: Postoperative multislice computed 
tomography scan reconstruction of the entire aorta 
after a reimplantation procedure with the Valsalva 
graft: the left and the noncoronary sinuses are clearly 
detectable. 
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Comment 
 
Aortic valve-sparing procedures are particularly appealing for patients with aortic root 
dilatation because these procedures avoid the problems of prosthetic heart valves, but 
pose the problem of the long-term durability of the spared aortic valve. Residual aortic 
valve regurgitation is the Achille’s heel of this type of surgical procedure. Among the two 
major techniques of valve-sparing procedures, remodeling [12] or reimplantation [11], 
the latest has gained popularity in the past years because it provides a better annulus 
stabilization, which has been shown as an important variable in the long-term durability 
of the result. The drawbacks of the reimplantation technique is that it completely 
abolishes the sinuses of Valsalva that have been demonstrated of paramount importance 
in assuring a physiologic movement of the aortic leaflets and at the same time reducing 
leaflet stress. For these reasons, several variations in the original David I technique have 
been introduced by various authors [4, 5, 13]. Nonetheless, the classic David I technique 
has demonstrated encouraging medium-term results in an adult [14, 15] as well as in a 
Marfan [16, 17] population in various reports. Our preference goes to the use of the 
Valsalva graft (Gelweave Valsalva) because it has all the advantages of the 
reimplantation procedure while allowing a proper reconstruction of the sinuses without 
significant modification in the surgical technique. It is hoped that the anatomical 
reconstruction that is possible using the Valsalva graft could contribute to a better and 
longer preservation of valve integrity. It has been proved that the absence of sinuses, 
among other factors, causes an alteration in the opening and closing characteristics of 
the valve leaflets that could induce, with time, thickening and rolling of the cusps’ free 
margins [1, 2]. 
It goes without saying that a perfect postoperative result with absence of residual aortic 
regurgitation is required if we want to compare, in terms of long-term benefit, the 
positive effect of the presence of sinuses of Valsalva. Presence of more than trivial 
residual valve regurgitation is the sign of cusp malalignment, torsion, altered coaptation, 
and cusp prolapse among others; all these different anatomical factors will invariably 
tend to a progressive worsening with time, with the consequent increase of valve 
insufficiency. 
Imperfect results, independently from the technical or anatomical reasons that have 
caused them, should not be considered if the scope of the study is to ascertain whether 
the presence of physiologic eddy currents inside the reconstructed sinuses are 
important in preserving valve integrity in the long term. In any case, imperfect results 
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with more than trivial residual valve regurgitation should not be accepted because the 
patient will face a second operation within a short time. 
The initial results of this multicenter study clearly show that an imperfect result in the 
immediate postoperative period should be strongly avoided. In fact, excluding one case 
of endocarditis and a pediatric case with a significant growth spur, all reoperated 
patients had already evidence of grade 2 or higher aortic regurgitation at time of 
discharge. Furthermore, all patients were reoperated on in a period ranging from 1 to 20 
months. This clearly indicates that residual aortic valve regurgitation has a tendency to 
worsen at a rapid pace. If the postoperative transesophageal echocardiogram shows a 
more than trivial valve regurgitation, it is advisable reopen the graft and either fix the 
problem if possible or, better, immediately proceed for valve replacement. Most of the 
failures reported are obviously the consequence of our learning curve. All centers did 
not have a previous direct experience with the reimplantation type of valve-sparing 
procedure, which started only after the Valsalva graft became available. Therefore, we 
must consider not only a learning curve for the correct use of the graft but also for the 
surgical procedure itself. 
If other procedures are added on the valve cusps, such as triangular resection or 
plication, free-edge reinforcement to correct an intrinsic leaflet prolapse, or a cusp 
prolapse that has been induced by a suboptimal orientation of the valve, the chances of 
ending up with an imperfect result are much higher. As a matter of fact, among all 
patients who required an aortic valve replacement, half of them had received some sort 
of cusp plasty. 
On the other hand, it appears evident from this initial experience that a proper root and 
sinuses reconstruction remains stable at least for the time considered. It is therefore 
evident that only these patients should be considered in a long-term evaluation to 
ascertain whether the use of the Valsalva graft, with optimal sinuses reconstruction, is 
superior for preserving valve integrity. 
In conclusion, this initial experience from three different centers has shown satisfactory 
midterm results. Proper patient selection and correct surgical technique will contribute 
to better root reconstruction. Patients with satisfactory reconstruction show, for the 
time being, stable results over time. 
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Abstract 
Objectives: Reimplantation valve-sparing aortic root replacement has been increasingly 
performed with improving perioperative and midterm results. The success of this 
operation primarily depends on preserving the highly sophisticated dynamic function of 
the aortic valve by recreating an anatomical three-dimensional configuration similar to 
the normal aortic root, thus minimizing the mechanical stress and strain on the cusps. 
Over the years several techniques have been proposed to reproduce the sinuses of 
Valsalva. We reviewed our experience with aortic valve reimplantation by means of a 
modified Dacron graft that incorporates sinuses of Valsalva, in a series of 100 
consecutive patients.  
 
Methods: During a 60-month period, 100 patients with aortic root aneurysm underwent 
aortic valve reimplantation using the Gelweave Valsalva™ prosthesis. There were 74 
males and the mean age was 60±12 years (range 28–83 years). Five patients had the 
Marfan’s syndrome, 15 had a bicuspid aortic valve. Cusp repair was performed in five 
patients. The mean follow-up time was 28.6 months (range 1–60). Transesophageal 
echocardiogram was performed at the end of each procedure to assess the aortic valve 
in terms of competence, dynamic motion and level of coaptation within the graft.  
 
Results: There was one hospital death and two late deaths. Overall survival at 60 
months was 91.7±5.1%. Five patients developed severe aortic incompetence (AI) during 
follow-up requiring aortic valve replacement (AVR). The 60 months freedom from re-
operation due to AI was 90.9±4.4%. One patient had moderate AI at latest 
echocardiographic study. The 60 months freedom from AI>2+ was 91.6±7.9%. Cox 
regression identified cusp’s repair as independent risk factor (P=0.001) for late 
reimplantation failure (AVR or AI>2+). There were no episodes of endocarditis and the 
majority of the patients (88%) were in New York Heart Association functional class I.  
 
Conclusions: The aortic valve reimplantation with the Gelweave Valsalva™ prosthesis 
provided satisfactory mid-term results. An accurate assessment of the level of 
coaptation of the aortic cusps in respect to the lower rim of the Dacron graft by means of 
intraoperative transesophageal echocardiogram at the end of each procedure is 
mandatory in order to avoid early reimplantation failure. Cusp’s repair may play an 
important role in the development of late AI. However, long-term results are needed in 
order to define the durability of this technique. 
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Introduction 
 
Aortic valve reimplantation procedure introduced by David in 1995 [1], is now 
considered a safe operation with satisfactory mid- and long-term results. To overcome 
the main limit of this technique, the lack of the sinuses of Valsalva, in 2000 De Paulis 
introduced the Valsalva graft [2], a modified Dacron conduit that on implantation 
recreates the sinuses of Valsalva of normal shape and dimension [3]. Since then, an 
increasing number of surgeons have been using this prosthesis. The aim of this 
retrospective single institution study is to review our experience with aortic valve 
reimplantation using the Valsalva graft, in a series of 100 consecutive patients during a 
5-year period. 
 
Materials and methods 
 
From October 2002 to November 2007, 100 consecutive patients underwent aortic root 
reimplantation using the Valsalva graft. Patients’ demographic profile is reported in 
Table 1. Our technique has been previously described in detail [4]. The Maselli technique 
to reposition the ‘Valsalva graft sinotubular junction’ [5] was used in three cases. The 
graft sizes used were 28 mm in two patients, 30 mm in 28 patients and 32 mm in 70 
patients.  
The mean cardiopulmonary bypass (CPB) time was 125± 22 min (range 90–201) with a 
mean aortic cross-clamp time of 107±17 min (range 67–170). Hemiarch reconstruction 
using moderate hypothermic circulatory arrest (24 °C nasopharyngeal) and antegrade 
selective cerebral perfusion (ASPC) was performed in the only patient operated on for 
acute type A aortic dissection, with ASCP time of 27 min and HCA time of 29 min. 
Cusp’s repair was performed in five patients and all of them had a bicuspid aortic valve. 
Repair consisted of free margin shortening in two cases and triangular resection in 
three. 
Concomitant procedures included mitral valve repair in nine patients (9%), scheduled 
coronary artery bypass in 12 patients (12%), non-scheduled coronary artery bypass in 
two patients (2%), atrial septal defect repair in one patient (1%), and radio frequency 
ablation for atrial fibrillation in two patients (2%). 
Transesophageal echocardiogram was performed at the end of each procedure to assess 
the reimplanted valve’s dynamic motion and incompetence grade. In all patients, the 
reconstruction of the ‘pseudo-sinuses’ assured a sufficient gap to avoid any contact 
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between the open leaflet and the Dacron wall. None of the patients left the operating 
room with an AI greater than mild. From 2004 onwards, the level of coaptation of the 
aortic cusps within the Dacron graft was also evaluated. Since then, a level of coaptation 
>2 mm below the lower border of the Dacron graft was not considered acceptable. All 
the patients underwent a further transthoracic echocardiogram before discharge. 
 
Table 1: Patient demographic profile 
Characteristic n=100 
Age (years) 60±12 
NYHA functional class 
• I 
• II 
• III 
• IV 
 
41 
35 
22 
2 
Pathology 
• Aortic root aneurysm 
• Chronic dissection 
• Acute type A dissection 
 
94 
5 
1 
Left ventricular ejection fraction 
1. >60% 
2. 40-59% 
3. <39% 
 
68 
27 
5 
Aortic incompetence 
• None/trivial 
• Mild 
• Moderate 
• Severe 
 
19 
17 
27 
37 
Marfan syndrome 5 
Bicuspid aortic valve 15 
Coronary disease 14 
Mitral regurgitation greater than mild 8 
Diameter of aneurysm (mm) 
• Annulus 
• Sinus segment 
• Ascending aorta 
 
26.9±6.3 
48±8.8 
51.2±9.1 
Values are mean±1 S.D. 
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Follow-up 
 
Follow-up was conducted by one investigator in December 2007 and was 100% 
complete. Transthoracic echocardiogram was used for AI evaluation. AI was scored as 
none, trivial, mild, moderate, or severe (0–4+). The mean follow-up time was 28.6 
months, ranging from 1 to 60 months. 
 
Statistical analysis 
 
Continuous variables were expressed as the mean±S.D. and were analyzed by using the 
unpaired two-tailed t-test. Categorical variables were presented as percentage and were 
analyzed with the χ2-test or Fisher exact test when appropriate. All preoperative, 
intraoperative and postoperative variables were first analyzed by using univariate 
analysis to determine whether any single factor influenced AI during follow-up. 
Variables that achieved a P-value of <0.2 in the univariate analysis were examined by 
using multivariate analysis with forward stepwise logistic regression to evaluate 
independent risk factors for the AI during follow-up. Estimates for long-term survival 
and freedom from morbid events were made by the Kaplan–Meier method. Differences 
between survival curves were evaluated with the log-rank statistic. 
 
Results 
 
There was one hospital death and two late deaths. The cause of the hospital death was 
sepsis at four months after reimplantation in a patient that had a cardiac arrest on 
postoperative day 4. Although resuscitation was successful, the patient had a 
devastating neurological injury due to anoxia. Coronary angiography demonstrated no 
evidence of coronary button occlusion, and the cause of the cardiac arrest remains 
unclear. The causes of late death were cardiac (sudden death) in one patient at 37 
months and non-cardiac (hepatocellular carcinoma) in the other patient at 48 months. 
At the time of surgery, there was no evidence of hepatic neoplasm. Liver function test, 
hepatitis B and C markers were negative. Both patients had trivial AI at latest follow-up. 
Overall survival at 60 months was 91.7±5.1% (Fig. 1). 
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Eight patients required early re-exploration (<24 h) for bleeding and tamponade. Three 
patients developed postoperative myocardial infarction (creatinine phosphokinase >300 
IU/myocardial band >5%) without hemodynamic deterioration and with no significant 
ejection fraction reduction. Intubation time longer than 48 h occurred in four cases. 
Postoperative renal failure requiring dialysis occurred in one patient. Two patients 
developed bacterial mediastinitis and were treated successfully with the vacuum- 
assisted closure device (VAC). Two patients underwent pacemaker implantation 
because of permanent atrio-ventricular block. 
 
Re-operations and aortic valve function 
 
During follow-up five patients developed significant AI requiring aortic valve 
replacement (AVR), respectively 1, 7, 8, 33, 42 months after the first procedure. Re-
operated patients’ details are shown in Table 2. The 60 months freedom from re-
operation due to AI was 90.9±4.4% (Fig. 2).  
At the closure of the study, the grade of AI among the 92 survived, non-re operated 
patients was as follows: none or trivial (0–1+) 47 patients, mild (2+) 44 patients, 
moderate (3+) 1 patient, severe (4+) none. 
The 60 months freedom from AI greater than mild was 91.6±7.9%. Cusp’s repair turned 
out to be a significant risk factor for reimplantation failure (AVR or AI>2+) both to 
univariate analysis (P=0.002) and Cox regression (P=0.001). 
 
  
Fig 1: overall survival   
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Table 2: Re-operated patient characteristics 
 Age 
(years) 
Valve 
morphology 
Cusp’s 
repair 
Level of cusps 
coaptation>2mm 
below the graft 
Aortic 
incompetence 
at discharge 
Months 
between 
first 
procedure 
and re-
operation 
Patient  
1 
28 Tricuspid No Yes Moderate 1 
Patient 
2 
33 Bicuspid Free 
margin 
shortening 
No Mild 7 
Patient 
3 
36 Bicuspid Triangular 
resection 
No Mild 8 
Patient 
4 
51 Tricuspid No No Mild 33 
Patient 
5 
65 Tricuspid NO No No 
incompetence 
42 
 
  
 
 
Discussion 
 
Since its introduction in 1995, the original aortic valve reimplantation technique 
underwent several modifications, mostly devised to reproduce the sinuses of Valsalva 
[6–8]. When we began our experience with this procedure in October 2002, we chose 
the Valsalva graft for two main reasons. Firstly, we thought it was based on a very 
simple and effective idea to reproduce an anatomical configuration very similar to the 
normal aortic root. Furthermore, over the years this graft has proven to be reliable and 
has shown encouraging mid-term results [9]. Although the radial compliance of this 
graft at the skirt (the prosthetic aortic root) has not been shown to be maintained over 
the years, its curvature is supposed to reduce the stress and strain of the aortic cusps 
Fig. 2. Freedom from re-operation. 
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during systole and diastole, perhaps providing a long durability of the native valve [10]. 
The second reason that led us to adopt the Valsalva graft is the simplicity of the 
implantation technique, as it is the same as the original one described by David [11] 
except for the need to measure the heights of the interleaflet triangles, tailoring the graft 
according to it. Indeed, the precise placement of the top of the commissures at the 
junction between the skirt and the tubular part of the graft (the prosthetic sinotubular 
junction) is crucial to obtain good cusps’ coaptation. Because the heights of the three 
commissures are often unequal (the height of the interleaflet triangle between the non-
coronary and the left coronary cusps is usually shorter than the other two), heights of all 
three interleaflet triangles are carefully measured. According to it, the Maselli 
modification [12] may be useful when an imperfect alignment between the prosthetic 
STJ and the top of the commissures is noted. We actually used this tip in three patients 
with good results in terms of cusps’ coaptation. 
The importance of intraoperative TEE at the end of each procedure in order to assess 
the competence and the dynamic motion of the valve is nowadays well known. 
Specifically, as previously suggested by the Hannover group [13], from 2004 onwards 
we pay particular attention to the level of coaptation of the cusps in respect to the lower 
rim of the graft. It has been shown that a level of coaptation within the tube graft is 
essential to achieve valve competence. Looking at it retrospectively, the intraoperative 
TEE of the patient re-operated on for severe AI one month after the first procedure 
(November 2002), showed a level of coaptation frankly below the lower rim of the 
Dacron graft. A second interesting element detected by TEE is the lack of contact 
between the open aortic leaflet and the Dacron wall that, as previously noted [3], could 
be an important characteristic for valve’s durability in the long-term. 
In our series, two out of five patients who underwent cusp’s repair were re-operated on 
for severe AI with a strong statistical significance. It must be stressed that both had a 
bicuspid aortic valve with asymmetric cusps. The other three patients who underwent 
cusp’s repair also had a bicuspid aortic valve but the asymmetry was less evident and 
required a less extensive cusp’s repair. Therefore, according to our experience, we have 
recently adopted the policy to spare bicuspid aortic valves only in case of symmetric 
cusps with no need for extensive additional repair. However, other authors have 
described excellent results with bicuspid valve-sparing operations regardless of the 
valve’s morphology. In particular, Aicher et al. in a clinical study comparing the results of 
valve-sparing root replacement in bicuspid and tricuspid aortic valve, failed to show any 
significant difference between the two groups in terms of valve durability [12]. Similarly, 
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El Khoury et al. described encouraging results after cusp’s prolapse correction during 
valve-sparing operation [13]. 
The results of our study, in terms of freedom from aortic valve re-operation, are 
consistent with the outcomes of others. Pacini et al. [14], in a similar mid-term study on 
aortic valve-sparing reimplantation, including 57 patients treated with the Valsalva 
graft, reported a three-year freedom from AVR of 92%. Kallenbach et al. reported, in a 
large series of aortic valve-sparing operations using a tubular graft, an actuarial freedom 
from re-operation of 95%, 91% and 87%, respectively, at 3, 5 and 10 years [15]. 
During follow-up none of the patients developed endocarditis. This must be regarded as 
a considerable advantage of valve-sparing procedure over the Bentall operation that has 
invariably a certain incidence of valve related complications including endocarditis 
either with mechanical or tissue valve [16–18]. 
The main limitations of this study are to be retrospective and the length of follow-up 
(maximum 60 months), but to our knowledge is one of the largest single-center 
experience with a valve-sparing operation using the Valsalva graft. 
In conclusion, the aortic valve reimplantation with the Gelweave Valsalva™ prosthesis 
provided satisfactory midterm results. An accurate assessment of the valve’s dynamic 
motion and of the level of cusps’ coaptation within the graft by means of TEE at the end 
of each procedure is mandatory in order to avoid early reimplantation failure. Cusp’s 
repair may play an important role in the development of late AI and should be 
performed with caution in cases of asymmetric bicuspid aortic valve. The radial 
extension of the skirt portion of the Valsalva graft over the years has not yet been 
demonstrated and should be investigated. Long-term results are needed in order to 
define the durability of this technique. 
 
 
 
 
 
 
  
  60 
References 
 
1. David TE, Feindel CM, Bos J. Repair of the aortic valve in patients with aortic 
insufficiency and aortic root aneurysm. J Thorac Cardiovasc Surg 
1995;109:345–351. 
2. De Paulis R, De Matteis GM, Nardi P, Scaffa R, Colella DF, Chiariello L. A new 
aortic Dacron conduit for surgical treatment of aortic root pathology. Ital Heart 
J 2000;1:457–463. 
3. De Paulis R, De Matteis GM, Nardi P, Scaffa R, Buratta MM, Chiariello L. Opening 
and closing characteristics of the aortic valve after valvesparing procedures 
using a new aortic root conduit. Ann Thorac Surg 2001;72:487–494. 
4. Settepani F, Ornaghi D, Barbone A, Citterio E, Eusebio A, Manasse E, Gallotti R. 
Aortic valve-sparing operations in patients with aneurysms of the aortic root 
or ascending aorta: preliminary results. Interact CardioVasc Thorac Surg 
2005;4:137–139. 
5. Maselli D, Minzioni G. A technique to reposition sinotubular junction in aortic 
valve reimplantation procedures with the De Paulis Valsalva graft. Eur J 
Cardiothorac Surg 2006;29:107–109. 
6. David TE. Aortic valve sparing operations. Ann Thorac Surg 2002; 73:1029–
1030. 
7. Demers P, Miller DC. Simple modification of ‘T. David-V’ valve-sparing aortic 
root replacement to create graft pseudosinuses. Ann Thorac Surg 
2004;78:1479. 
8. Thubrikar MJ, Robicsek F, Gong GG, Fowler BL. A new aortic root prosthesis 
with compliant sinuses for valve-sparing operations. Ann Thorac Surg 
2001;71(5 Suppl):S318–S322. 
9. Settepani F, Szeto WY, Pacini D, De Paulis R, Chiariello R, Di Bartolomeo R, 
Gallotti R, Bavaria JE. Reimplantation valve-sparing aortic root replacement in 
Marfan syndrome using the Valsalva conduit: an intercontinental multicenter 
study. Ann Thorac Surg 2007;83:S769–S773; discussion S785–S790. 
10. De Paulis R, De Matteis GM, Nardi P, Scaffa R, Colella DF, Bassano C, Chiariello 
L. One-year appraisal of a new aortic root conduit with sinuses of Valsalva. J 
Thorac Cardiovasc Surg 2002;123:33–39. 
  61 
11. Pethig K, Milz A, Hagl C, Harringer W, Haverich A. Aortic valve reimplantation 
in ascending aortic aneurysm: risk factors for early valve failure. Ann Thorac 
Surg 2002;73:29–33. 
12. Aicher D, Langer F, Kissinger A, Lausberg H, Fries R, Schafers HJ. Valvesparing 
aortic root replacement in bicuspid aortic valves: a reasonable option? J Thorac 
Cardiovasc Surg 2004;128:662–668. 
13. El Khoury G, Vanoverschelde JL, Glineur D, Poncelet A, Verhelst R, Astarci P, 
Underwood MJ, Noirhomme P. Repair of aortic valve prolapse: experience with 
44 patients. Eur J Cardiothorac Surg 2004 Sep; 26:628– 633. 
14. Pacini D, Di Marco L, Suarez SM, Botta L, Bracchetti G, Cattabriga I, Di 
Bartolomeo R. Aortic valve sparing operations: early and mid-term results. 
Heart Surg Forum 2006;9:E650–E656. 
15. Kallenbach K, Karck M, Pak D, Salcher R, Khaladj N, Leyh R, Hagl C, Haverich A. 
Decade of aortic valve sparing reimplantation: are we pushing the limits too 
far? Circulation 2005;112(9 Suppl):I253–I259. 
16. Dossche KM, Schepens MA, Morshuis WJ, de la Riviere AB, Knaepen PJ, 
Vermeulen FE. A 23-year experience with composite valve graft replacement of 
the aortic root. Ann Thorac Surg 1999;67:1070–1077. 
17. Gott VL, Cameron DE, Alejo DE, Greene PS, Shake JC, Caparelli DJ, Dietz HC. 
Aortic root replacement in 271 Marfan patients: a 24-year experience. Ann 
Thorac Surg 2002;73:438–443. 
18. Ehrlich MP, Ergin MA, McCollough JN, Lansman SL, Galla JD, Bodian CA, Griepp 
RB. Favorable outcome after composite valve-graft replacement in patients 
older than 65 years old. Ann Thorac Surg 2001;71:1454– 1459. 
 
 
 
 
 
 
 
 
 
 
 
  62 
 
  
  63 
CHAPTER 5 
 
 
 
 
 
 
 
 
 
Compliance of the Valsalva graft’s pseudosinuses at midterm follow-
up with cardiovascular magnetic resonance 
 
 
 Lorenzo Monti, Giovanni Mauri, Luca Balzarini, Giuseppe Tarelli, Giorgio Brambilla,  
Ettore Vitali, Diego Ornaghi, Enrico Citterio,  
and FabrizioSettepani 
 
Department of Cardiac Surgery, Istituto Clinico Humanitas,  
Rozzano, Italy 
 
 
 
Ann Thorac  Surg. 2011; 91(1): 92-6. 
 
 
 
 
  
  64 
 
Abstract 
 
 
 
Background. In previous studies, the Valsalva graft’s compliance at the level of the 
Dacron pseudosinuses was found similar to that of normal sinuses shortly (2 ± 1 
months) after the operation. We sought to investigate with cardiac magnetic resonance 
the compliance of the Valsalva graft pseudosinuses at midterm follow-up. 
 
Methods. Seven patients (group A) and 7 age-matched controls (group B) were studied 
with steady-state free precession and phase-contrast cardiac magnetic resonance for 
aortic root and ascending aorta evaluation. Blood pressure was measured during phase-
contrast acquisition to derive the following mechanical properties of the vascular 
prosthesis: pulsatility, compliance, distensibility, and elastic modulus. 
 
Results. Mean postoperative follow-up was 55 ± 9.84 months. Mean age was 69.2 ± 4.98 
years in group A, and 65.7 ± 7.16 years in group B. All the studied variables were 
coherent in showing a significant difference between the two groups, and between 
aortic root (skirt portion of the graft) and ascending aorta (tubular part of the graft) in 
group A. The presence of periaortic fibrosis did not show any correlation with the 
ascending aorta’s mechanical properties. 
 
Conclusions. At midterm follow-up, the pseudosinuses compliance of the Valsalva graft 
is still appreciable and significantly greater than the tubular portion. 
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The original technique of reimplantation of the aortic valve using a standard Dacron 
(C.R. Bard, Haverhill, PA) conduit, described by David and Feindel [1] in 1992, does not 
allow a proper reconstruction of the sinuses of Valsalva. To overcome this limit, in 2000, 
De Paulis and associates [2] introduced a new Dacron conduit, the Valsalva graft, that 
incorporates sinuses of Valsalva (the skirt portion of the graft), recreating sinuses of 
normal shape and dimensions (pseudosinuses). Reconstruction of the sinuses of 
Valsalva is aimed to assure a normal valve motion, decreasing mechanical stress and 
thereby increasing valve durability [3]. It has been shown that a loss of sinus compliance 
may play a role in both the natural process of aortic valve degeneration as it occurs in 
aortas stiffened by old age fibrosis or by atherosclerosis, as well as in the degeneration 
of aortic bioprostheses [4]. 
Previous studies demonstrated that the distensibility of the Valsalva graft at the level of 
the Dacron pseudosinuses in the very short term (2 ± 1 months after the operation) is 
similar to the sinuses distensibility of control healthy subjects [5]. However, it is 
unknown whether the compliance of the Valsalva graft at the pseudosinuses is 
maintained over the years. Because cardiac magnetic resonance (CMR) allows an 
accurate a reproducible assessment of great vessel anatomy and deformation over time, 
we sought to use this technology to investigate the Valsalva graft’s skirt compliance at 
midterm follow-up. 
 
 
Material and Methods 
 
Patient Population 
 
From October 2002, all patients admitted to our department with aortic root aneurysm 
and normal or nearly normal aortic cusps underwent aortic valve reimplantation using 
the Valsalva graft. Surgical technique has been previously reported in detail [6]. Among 
them, 7 nonselected patients with a similar follow-up duration agreed to undergo a CMR 
study aimed at aortic root compliance assessment, and were selected to form the study 
group (group A). Patients with atrial fibrillation, potentially hampering an accurate CMR 
evaluation of aortic distensibility, were excluded from the study. Seven agematched 
subjects without any evidence of heart disease and with normal aortic root anatomy, 
after a CMR study performed for various clinical reasons,, underwent an aortic root and 
ascending aorta assessment, and served as a control group (group B). Our Institutional 
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Review Board approved the study. All subjects gave written informed consent. Patient 
characteristics are reported in Table 1. 
Table 1. Patient Characteristics 
Characteristic Surgical 
Group 
Control 
Group 
p Value 
Male/Female 6/1 7/0  
Age at surgery, years 64.5 ± 5.1 −  
Age at follow-up, years 69.2 ± 4.9 65.7 ± 7.1 0.07 
Follow-up after surgery, 
months 
55.2 ± 9.8 −  
Weight, kg 79 ± 15.25 82 ± 9.72 0.715 
Height, cm 170 ± 7.48 177.5 ± 4.76 0.095 
SBP, mm Hg 127.85 ± 9.94 126.14 ± 9.55 0.817 
DBP, mm Hg 76.42 ± 4.75 75.86 ± 6.09 0.982 
Pulse pressure, mm Hg 51.42 ± 10.69 50.29 ± 10.50 0.933 
Data are expressed as mean ±SD.  
DBP = diastolic blood pressure; SBP = systolic blood pressure. 
 
 
 
Magnetic Resonance Study and Measurements 
 
All studies were performed on a 1.5-T magnetic resonance imaging system (Philips 
Achieva, release 1.6; Philips Medical Systems, Best, Netherlands) equipped with a five-
elements phased array surface coil. Vectorcardiographic gating was used, with images 
acquired during midexpiratory breath-holds. After acquisition of standard cardiac 
planes according to the Society of Cardiovascular Magnetic Resonance 
recommendations [7], an additional steady-state free precession (SSFP) plane, 
perpendicular to the left ventricular outflow tract, was prescribed to depict two 
orthogonal planes dissecting the aortic root (Fig 1).  
 
Fig 1. (A) Original horizontal long-axis three-chamber view image. (B) Derived three-chamber image. Scan plane 
perpendicular to the dash line in (A). (C) Derived image on aortic root. Scan plane indicated by solid line in (A) 
and (B). 
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Thereafter, an SSFP image (slice thickness 5 mm, temporal resolution 30 ms or less) was 
acquired at the aortic root level. This latter was then repeated on the ascending aorta, 3 
cm above the aortic valve plane, perpendicular to the vessel. Finally, for the quantitative 
flow measurements, a retrospectively gated phase-contrast sequence was used during 
expiratory breath-holds, velocity encoded through-plane in the slice select gradient 
direction. The following imaging parameters were used: 40 frames per heartbeat; field 
of view 320 mm; repetition time 7 ms; echo time 3.5 ms; flip angle (α) 15 degrees; 
matrix 256 × 128. 
Typically, the velocity encoding range was set at 135 cm/s. Flow images were 
reacquired with a higher velocity encoding range if velocity aliasing occurred. During 
the acquisition of velocity encoded data, noninvasive blood pressure was measured with 
a MR-safe monitor (Veris MR Vital Signs Monitor; Medrad, Indianola, PA). For the 
quantitative flow measurements and contour tracing of the vessels, data were 
transmitted to offline image analysis software (CMR42; Circle Cardiovascular Imaging 
Inc, Calgary, AB, Canada). 
The contours of the aortic root and ascending aorta cross sections were traced in each 
phase, and the maximal and minimal areas were recorded. Tracings were performed on 
the magnitude images, using the velocity images as reference. Moreover, we measured 
the area of periaortic fibrosis from a still frame of SSFP images, both at root and 
ascending aorta level. Various indexes descriptive of the mechanical stiffness of the 
vessel were calculated from CMR and noninvasive blood pressure measurement, as 
shown in Table 2. 
Table 2. Indexes of Aortic Stiffness 
Variable Units Formula Definition 
Pulsatility % maxA − minA / minA 
× 100 
Relative change in 
lumen area 
during the cardiac 
cycle 
Compliance mm2/mm Hg [(maxA − minA) / 
PP] 
Absolute change in 
lumen area 
for a given change in 
pressure 
Distensibility %/mm Hg [(maxA − minA) / PP 
× minA] × 100 
Pressure change 
driving a 
relative increase in 
lumen area 
Elastic modulus mm Hg PP × minA / (maxA − 
minA) 
Pressure change 
driving a 
relative increase in 
lumen area 
maxA = maximal area; minA = minimal area; PP = pulse pressure. 
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Statistical Analysis 
 
Data are expressed as number or percentage, or median and range, where appropriate. 
Differences between groups were evaluated with Mann-Whitney U test for discrete and 
continuous variables. A p value less than 0.05 was considered as significant. All the 
analyses were performed using Stata version 10 software (StataCorps, College Station, 
TX). 
 
 
Results 
 
Mean follow-up after surgery was 55.2 ± 9.8 months. The systolic blood pressure was 
similar between patients of the same group, reducing the possible effect of blood 
pressure on the observed vessel’s area changes.  
The main results are listed in Table 3. In normal control subjects, we observed no 
substantial difference between aortic root and ascending aorta mechanical properties: 
vessel mechanical properties were very similar at the two observed levels, with a 
constant nonsignificant difference between aortic root and ascending aorta, the latter 
showing greater stiffness, with reduced pulsatility, distensibility, and compliance, and a 
higher elastic modulus. When compared with normal control subjects, patients with the 
Valsalva graft showed a clear and constant reduction in aortic root elastic properties, 
but a near total loss of the elastic properties of the ascending aorta. However, while 
distensibility and pulsatility at the level of the tubular portion of the graft were virtually 
absent, at the level of pseudosinuses they were only about half of the normal values as 
measured in the control group. In fact, a significant difference in all measured variables 
was evident between the pseudosinuses and the tubular portion of the graft. 
Furthermore, we sought to measure the amount of periaortic fibrosis, nearly always 
present in variable fashion among operated patients, to assess the possible relationship 
with the ascending aorta stiffness. The amount of periaortic fibrosis showed high 
variability: mean observed value at aortic root level was 9.35 ± 5.63 cm2 (range, 4 to 19 
cm2; median value 8 cm2). The amount of fibrosis, however, did not show any 
relationship with the mechanical properties of the vessel (Fig 2). 
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Table 3. Mechanical Proprieties of Native Aorta (Control Group) and Valsalva Prosthesis 
(Surgical Group) 
 Surgical Group 
n=7 
Control Group 
n=7 
p value 
Pulsatility, % 
• Aortic root 
• Ascending aorta 
• p value 
 
10.42 ± 4.51a 
3.54 ± 3.17b 
0.002 
 
23.55 ± 8.94 
21.14 ± 8.55 
0.916 
 
0.007 
0.001 
Compliance, mm2/mm Hg 
1. Aortic root 
2. Ascending aorta 
3. p value 
 
 
1.81 ± 0.69a 
0.68 ± 0.83b 
0.001 
 
 
4.06 ± 2.23 
2.85 ± 1.10 
0.254 
 
0.003 
0.001 
Distensibility, %/mm Hg 
1. Aortic root 
2. Ascending aorta 
3. p value 
 
17.41 ± 9.98a 
6.33 ± 8.00b 
0.002 
 
36.88 ± 27.02 
19.49 ± 7.35 
0.118 
 
0.037 
0.005 
Elastic modulus, mm Hg 
• Aortic root 
• Ascending aorta 
• p value 
 
6.03 ± 3.47a 
31.859 ± 31.129b 
0.039 
 
2.42 ± 0.74 
3.02 ± 1.87 
0.7 
 
0.015 
0.02 
 
a Skirt portion of the prosthesis. 
b Tubular portion of the prosthesis. 
 
 
 
 
 
Fig 2. (A, B) The amount 
of periaortic fibrosis 
showed high variability 
among patients: mean 
observed value at aortic 
root level was 9.35± 
5.63 cm2 (range, 4 to 19; 
median value 8). The 
amount of fibrosis, 
however, did not show 
any relationship with 
the mechanical 
properties of the vessel, 
as shown in (C). 
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Comment 
 
Aortic root dynamics are functional to optimized transvalvular hemodynamics and to 
minimized cusp stress and strain by creating optimal cusp loading conditions and by 
lowering transvalvular turbulence; hence, cusp fatigue throughout the complex opening 
and closing mechanics of the cusps 30 to 40 million times a year [8] (and the likelihood 
of structural valve deterioration), may be minimized by the dynamics of the aortic root. 
The importance of the sinuses of Valsalva, firstly investigated by Leonardo da Vinci 
about 4 centuries ago, has been confirmed by recent observations. Robicsek and 
Thubrikar [5] have demonstrated that in vitro under normal hemodynamic conditions, 
although stiffening of the exterior of the aortic root does not change pressure flow 
relations, it does lead to severe dysfunction and increased stress loading of the aortic 
valve cusps. Based on this concept, several authors have introduced in recent years 
some changes in aortic valve-sparing surgery to make this operation more physiologic 
[9, 10]. 
In 2002, De Paulis and colleagues [5] published an echocardiographic analysis of valve 
motion after aortic valve reimplantation with the Valsalva graft and found that shortly 
after the operation (mean follow-up was 2 months), the anatomic reconstruction of the 
aortic root allowed leaflet motion similar to that of normal subjects. In particular, graft 
distensibility was found to be maintained at the pseudosinuses, whereas it was reduced 
both at the annulus and at the sinotubular junction [5]. 
Schoenhoff and colleagues [11], by means of CMR, have recently confirmed the 
compliance of the Valsalva graft’s skirt during the postoperative course. Nevertheless, 
they utilized the peak velocity above the aortic valve as an indirect marker of 
compliance [11]. 
According to our knowledge, until now, no data were available in literature about the 
mechanical proprieties of this graft in the midterm follow-up. Our results show that the 
mechanical proprieties of the aorta are significantly different between the surgical 
group and the control group. In details, the aortic root of the surgical patients (the skirt 
portion of the graft) seems to have distensibility, pulsatility, and compliance 
approximately halved compared with controls. However, surprisingly enough, our data 
show that the elastic proprieties of the pseudosinuses are still appreciable over the 
years. Indeed, the pulsatility, compliance, distensibility, and elastic modulus of the skirt 
are significantly different than those of the tubular portion of the prosthesis. This finding 
seems to confirm that, over the years, the Valsalva graft continues to behave like the 
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native aortic root not only from a static point of view (curvature of the sinuses) but also 
from a dynamic point of view, somehow responding to the systodiastolic changes in 
pressure. Moreover, it is not surprising that in the surgical group, contrary to the control 
group, elastic changes in the tubular portion of the graft are minimal. In fact, the tubular 
portion of the graft behaves like a conventional vascular Dacron prosthesis, which, as is 
known, is not able to guarantee the Windkessel effect [12]. 
A further interesting point is the lack of relationship between the periaortic fibrosis and 
the mechanical proprieties of the prosthesis, indicating that the inflammatory 
postoperative reaction generated by the graft does not affect in any way its dynamic 
function. Based on these results, it is therefore reasonable to assume that the root 
portion of the prosthesis maintains its compliance even in the long term. 
In conclusion, our study shows that the mechanical proprieties of the Valsalva graft are, 
to a certain extent, maintained during the midterm follow-up. That could play an 
important role in the durability of the native aortic valve by reducing the stress and 
strain on the cusps. Nevertheless, long-term results are still needed to draw definitive 
conclusions. 
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INVITED COMMENTARY 
 
Replacing any part of the human aorta by a standard vascular graft results in an increase 
of characteristic impedance leading to decreased compliance and a decreased ability to 
maintain the “Windkessel” function of the aorta. These effects may be most pronounced, 
if the sinus of Valsalva is to be replaced, because the dynamic characteristics in this 
part—aiming at reducing stress to the cusps of the aortic valve and optimizing 
ventriculoarterial coupling— are crucial to maintain physiologic flow in the coronary 
arteries and physiologic instantaneous movement patterns of the valve leaflets and the 
aortic wall.  
Especially the latter subject attracted clinical notice when the original Bentall operation 
for repair of aortic root pathologies was more and more replaced by valvesparing 
techniques during the last 15 years. The remodelling procedure was considered to 
maintain the function of the sinus, but redilatation of the aortic root frequently occurred. 
This problem was avoided by the reimplantation technique, which, however, completely 
abolished the function of the sinus of Valsalva, with the risk of increased stress on the 
native valve leaflets probably resulting in poor durability of the repair. 
Although the controversies concerning the pros and cons of these techniques were going 
on and technical refinements of both procedures were proposed, the Valsalva graft with 
a distensible proximal part (the “skirt”) was introduced into clinical practice. Initial 
short-term results were encouraging, but scepticism widely persisted concerning the 
maintenance of the elastic properties over time. The formation of adhesions and 
pseudoneointimal ingrowth was considered to diminish these favorable effects in the 
long run. 
The article presented here [1] addresses this crucial question. Even if the cohort of 
patients was small, this nicely performed magnetic resonance imaging study 
demonstrated that there still was compliance of the “skirt” of the graft compared with 
the tubular part after a follow-up of roughly 5 years. Even if the distensibility was lower 
compared with the native aorta of control subjects, these findings give hope that the best 
of the two worlds of valve-sparing surgery of the aortic root may be combined by the use 
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of this graft. Larger, comparative studies are now warranted to demonstrate the 
superiority and clinical benefit of the Valsalva graft over a simple tubular prosthesis. 
 
Robert Bauernschmitt, MD, PhD 
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Department of Cardiovascular Surgery 
Lazarettstr. 36 
80636 Munich, Germany 
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PART 2 
 
 
 
 
 
 
 
 
 
 
THE VALVE-SPARING AORTIC ROOT REPLACEMENT 
IN DIFFERENT SETTINGS: 
MARFAN SYNDROME, BICUSPID AORTIC VALVE AND OLDER 
PATIENTS 
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CHAPTER 6 
 
 
 
 
 
 
 
 
 
Reimplantation valve-sparing aortic root replacement in Marfan 
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Abstract 
 
 
Background. Introduced by DePaulis in 2000, the Gelweave Valsalva graft (Sulzer 
Vascutek, Refrewshire, Scotland) is a modified Dacron conduit (DuPont, Wilmington, 
DE), with prefashioned sinuses of Valsalva. The aim of this study was to evaluate the 
mid-term results of the reimplantation valve-sparing aortic root replacement using the 
Gelweave Valsalva prosthesis in Marfan syndrome patients. 
 
Methods. A retrospective review was performed of 35 patients with Marfan syndrome 
in four centers who underwent the reimplantation valve-sparing aortic root 
replacement using the Gelweave Valsalva prosthesis. 
 
Results. The patients were predominantly men, with a mean age of 36.5 ± 12.6 years 
(range, 14 to 62 years). Two patients presented with acute type A dissections and 
underwent emergent operations. Elective hemiarch reconstruction using hypothermic 
circulatory arrest was required in 11 patients. Aortic valve cusp repair was performed in 
2 patients. There were no operative or hospital deaths, and no patients died during 
follow-up. The mean follow-up was 19 months (range, 1 to 60 months). Significant (>2+) 
aortic insufficiency (AI), requiring aortic valve replacement, developed in 3 patients 
during follow-up that requiring aortic valve replacement. The 5-year freedom from 
reoperation owing to structural valve deterioration was 88.9% ± 8.1%. There were no 
episodes of clinically significant thromboembolism. 
 
Conclusions. Reimplantation valve-sparing aortic root replacement with the Gelweave 
Valsalva prosthesis in Marfan patients provides satisfactory mid-term results, thus 
encouraging further use of this type of repair. However, long-term results are needed in 
order to define the durability of this technique. 
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Marfan syndrome is an autosomal-dominant connective tissue disorder characterized by 
manifestation in different organ systems involving the ocular, skeletal, and 
cardiovascular system [1]. Cardiovascular complications such as rupture of aortic root 
aneurysm and aortic dissection are the primary causes of premature death [2]. Until 
recently, the standard treatment of aortic root aneurysms in patients with Marfan 
syndrome has been replacement of the aortic root and ascending aorta [3]. Although the 
results of this technique have been satisfactory, the patients must undergo the 
placement of mechanical valve prostheses and anticoagulation-related complications 
may occur [4]. 
Despite the presence of aortic insufficiency (AI) with aortic root and ascending aortic 
aneurysm, the aortic valve leaflets are often normal in Marfan patients. Valve-sparing 
aortic root replacement, first described by Yacoub and colleagues (remodelling) [5] and 
David and Feindel (reimplantation) [6] in the early 1990s, is increasingly gaining 
acceptance, particularly for patients with Marfan syndrome [7–9]. Although the 
remodelling technique achieves reconstruction of the sinuses, recent data suggest that 
its failure to stabilize the annulus has resulted in higher incidence of recurrent AI [8, 10]. 
Conversely, the standard reimplantation technique has been criticized for the absence of 
sinuses of Valsalva, and thus, a potential deleterious effect on leaflet stress and 
questionable durability. This has led to multiple modifications of the standard 
reimplantation technique to incorporate sinuses of Valsalva [10 –12]. In 2000, De Paulis 
and colleagues [13] introduced a Dacron (DuPont, Wilmington, DE) conduit (Gelweave 
Valsalva, Sulzer Vascutek, Renfrewshire, Scotland) modified with prefashioned sinuses 
of Valsalva. 
Reimplantation valve-sparing root replacement using this Valsalva graft has 
demonstrated satisfactory short-term results [13]. In this study, we have examined the 
mid-term results of reimplantation valve-sparing aortic root replacement in Marfan 
patients using the Valsalva graft in four cardiac surgical facilities. 
 
 
Material and Methods 
 
From October 2000 to February 2006, 35 patients diagnosed with Marfan syndrome 
according to the Gent criteria [14] underwent reimplantation valve-sparing aortic root 
replacement using the Gelweave Valsalva prosthesis at the Istituto Clinico Humanitas 
(Rozzano, Italy), at the Sant Orsola Hospital (University of Bologna, Italy), at the Tor 
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Vergata University Hospital (Rome, Italy), and at the University of Pennsylvania Medical 
Center (Philadelphia, PA). A retrospective review was performed. The study and all 
research protocols were conducted in compliance with the Institutional Review Boards 
at their respective institutions. 
 
 
Operative Techniques 
 
Median sternotomy was performed and cardiopulmonary bypass was instituted with 
arterial cannulation through the ascending aorta or femoral artery and venous 
cannulation through bicaval or right atrial cannulation. In patients for elective hemiarch 
reconstruction, deep hypothermic circulatory arrest and retrograde cerebral perfusion 
were used during the open distal anastomosis [15]. In patients with acute type A 
dissection, a systemic body temperature of 26°C was applied, and antegrade selective 
cerebral perfusion was used during the period of circulatory arrest. Depending on the 
surgeon’s preferences, myocardial protection was achieved by combination of antegrade 
and retrograde Custodiol (Kohler Chemie, Alsbach-Haenlein, Germany) cardioplegic 
solution and topical cooling with 4°C saline solution or by intermittent antegrade and 
retrograde blood perfusion. 
All patients underwent the reimplantation valve-sparing aortic root replacement 
according to the technique described by David and colleagues [16]. At the beginning of 
our experience, the diameter of the prosthesis was calculated from the average height of 
the three aortic cusps using David’s original formula [16]. More recently, some surgeons 
have modified their calculation of the size of the prosthesis based on direct 
measurement of the aortic annulus with a standard valve sizer and adding 5 mm to the 
calculation. In cases of dilated annulus (>28 mm), some surgeons prefer sizing the 
prosthesis based on the sinotubular junction measurement, once proper leaflet 
coaptation is obtained by pulling and aligning the three commissures. 
To reconstruct the commissures precisely at the level of the “neo-sinotubular junction” 
of the graft, which is the connection between the skirt and the standard tubular section, 
the length of the commissural posts are matched against the length of the skirted section 
of the graft. The annular collar is then trimmed to customize the prosthesis to the 
patient’s anatomy. Because of the right ventricular outflow tract, the base of the skirt at 
the commissure between the right and left coronary sinuses needs to be fashioned to 
facilitate reimplantation of the conduit at the subannular level. When relative prolapse 
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owing to unequal cusp length was noted (2 cases), plication of the free margin with a 6-0 
Gore-Tex (W.L. Gore & Assoc, Flagstaff, AZ) running suture was performed. 
Concomitant procedures included mitral valve repair in 3 patients and patent foramen 
ovale closure in 3 others. The distribution of graft sizes chosen is illustrated in Figure 1. 
 
 
 
 
 
 
Echocardiography 
 
Intraoperative transesophageal echocardiogram (TEE) was performed in all patients to 
assess the degree of AI preoperatively and post reimplantation. Transthoracic 
echocardiogram (TTE) was used in follow-up evaluation of AI. AI was scored as none, 
trivial, mild, moderate, or severe (0 to 4+). 
 
 
Statistical Analysis 
 
All data are reported as the mean ± SD unless otherwise specified. Actuarial freedom 
from adverse late events was plotted using the Kaplan-Meier method. 
 
 
 
Figure 1: Graft size 
distribution. Numbers 
over the column 
indicate the number of 
patients for each group. 
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Results 
 
Patient Demographics 
 
Preoperative demographic data are listed in Table 1.  
 
Table 1: Preoperative Patient Characteristics 
Characteristica No. Patients (%) 
                                                         (n = 35) 
Age (years)                                                                   36 ±13 
Sex (male) 23 (66) 
NYHA functional class 
• I 
• II 
• III 
• IV 
 
21 (60) 
7 (20) 
7 (20) 
− 
Left ventricular ejection fraction 
• >0.60 
• 0.40–0.59 
• <0.39 
 
24 (69) 
10 (28) 
1 (3) 
Aortic incompetence 
• None/trivial (0 to 1+) 
• Mild (2+) 
• Moderate (3+) 
• Severe (4+) 
 
11 (31) 
9 (26) 
8 (23) 
7 (20) 
Bicuspid aortic valve 3 (9) 
Acute A dissection 2 (6) 
Mitral regurgitation 3 (9) 
Diameter of aneurysm (mm) 
• Annulus 
• Aortic root 
• Ascending aorta 
 
27.5 ±2.8 
52.4±5.7 
49.1 ±11.4 
a Continuous variables are presented as mean _ 1 standard deviation; categoric variables are presented as n (%). 
NYHA = New York Heart Association. 
 
Patients were predominantly male, and the mean age was 36.5 ± 12.6 years (range, 14 to 
62 years). Most patients had normal left ventricular function. Preoperatively, absent-to-
mild AI was seen in 20 of the 35 patients, and moderate-to-severe AI was present in 15. 
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A bicuspid aortic valve was present in 2 patients. Elective reimplantation was performed 
in 33 patients, and 2 underwent emergent operation for acute type A dissections. Aortic 
valve cusp repair was performed in 2 patients. The mean follow-up was 19 months 
(range, 1 to 60 months) and was 100% complete. 
 
 
Operative Outcome 
 
The mean CPB time was 186 ± 72 minutes, with a mean aortic cross-clamp time of 157 ± 
64 minutes. Elective hemiarch reconstruction using hypothermic circulatory arrest was 
required in 11 patients, with a mean circulatory arrest time of 19 ± 4 minutes. There 
were no operative or hospital deaths, and no patients died during follow-up. 
Four patients required early reoperation (<24 hours) for bleeding. None had evidence of 
acute aortic dissection at reoperation. Temporary right ventricle dysfunction with 
tricuspid regurgitation developed postoperatively in 1 patient. Right ventricular 
function fully recovered with perioperative medical management, and echocardiography 
at the time of discharge from the hospital demonstrated no further evidence of tricuspid 
regurgitation. A late pericardial effusion occurred in 1 patient, and a pleuropericardial 
window was required. 
 
 
Aortic Valve Function 
 
No patient left the operating room with greater than mild AI. Significant AI (>2+) 
developed in 3 patients during follow-up, and they required aortic valve replacement 
with mechanical prosthesis. In the first patient, postoperative TEE at the completion of 
surgery demonstrated mild AI. At the time of discharge from the hospital, the AI had 
progressed to moderate (3+). This patient required a reoperation 1 month after the first 
procedure because of rapid increase in left ventricle volumes.  
In the second patient, the underlying cause was bacterial endocarditis. Discharged home 
after the first operation with trivial AI, the patient was readmitted 6 months later with 
complains of high fever and general fatigue. Echocardiography demonstrated severe AI 
and leaflet vegetations. Methicillin resistant Staphylococcus aureus was isolated from 
blood cultures. At reoperation, the valve was completely detached from the Dacron 
prosthesis, and friable vegetations were attached to the three leaflets. 
  84 
The third patient requiring a reoperation was a 14-year-old boy who had an extreme 
growth spurt within a 22-month period. The discharge echocardiogram after 
reimplantation had demonstrated trivial AI. The follow-up echocardiogram at 22 
months demonstrated severe AI. At the time of reoperation, all three leaflets were found 
to have extremely elongated free margins (>45 mm). 
The overall 5-year freedom from reoperation and significant AI (>2+) was 83.5% ± 8.6% 
(Fig 2). The 5-year freedom from reoperation owing to structural valve deterioration 
and significant AI (2+) (thus excluding the patient with endocarditis) was 88.9% ± 8.1%. 
At the close of the study, the severity and number of patients with AI were 13 with 0 AI, 
15 with 1+ AI, 4 with 2+ AI, and 0 with >2+ AI (Fig 3). There were no episodes of 
clinically significant thromboembolism. 
 
 
 
 
 
Fig 2. Overall freedom from 
reoperation and aortic 
insufficiency (AI) exceeding 2+. 
Fig 3. Comparison between aortic 
insufficiency (AI) at time of discharge 
(solid columns) and last follow-up AI 
(gray columns). Numbers over the 
columns indicate the number of patients 
for each 
group. 
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Comment 
 
Since its first description in the early 1990s, valve-sparing aortic root replacement has 
gained acceptance, particularly in Marfan patients who have isolated root pathology 
with functionally normal valve leaflets. The native valves are preserved, and the 
disadvantages of a mechanical prosthesis and the complication of life-long 
anticoagulation are avoided. 
The two basic techniques are reimplantation (David) and remodelling (Yacoub). The 
principal advantage of the reimplantation technique [6], compared with the remodelling 
technique [5], is the stabilization of the annulus. This is particularly important for 
patients with connective tissue disorders such as Marfan syndrome, where the annulus 
may dilate over time. The advantage of the remodelling technique, in contrast with the 
original reimplantation technique, is the creation of sinuses of Valsalva and thus an 
anatomic reconstruction of the aortic root and normal leaflet motion and stresses. 
However, recent reports have suggested higher incidence of late AI compared with the 
reimplantation technique, most likely secondary to the lack of annular fixation [10, 12]. 
The higher incidence of late AI in the remodelling group has convinced most surgeons to 
choose the reimplantation technique as the preferred technique. However, the major 
criticism of the standard reimplantation technique has been the absence of sinuses of 
Valsalva. Several studies [17–21], including finite element analysis [22] and a 
threedimensional phase-contrast magnetic resonance imaging study [23], have 
demonstrated the anatomic importance of the sinuses. These findings have led to 
modifications to the reimplantation technique [10–12, 24]. 
Short-term data on the modification of the reimplantation technique using the Valsalva 
conduit have previously been reported with satisfactory results [25]. This current 
multicenter study has examined the mid-term results of the reimplantation technique 
using the Valsalva conduit in Marfan patients. 
Three patients required aortic valve replacement during follow-up secondary to the 
development of significant AI. Postoperative TEE at the completion of the operation 
demonstrated mild AI in the first patient; but at the time of discharge, AI had progressed 
significantly (3+). This was the first valve-sparing aortic root replacement performed at 
the institution. An incorrectly undersized prosthesis was the most likely cause of the 
early failure. Although it is difficult to draw definitive conclusions from a single patient’s 
experience, we would not recommend leaving the operating room if the postoperative 
TEE shows mild or greater AI. 
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Two other patients had rapid development of significant AI, and both demonstrated 
trivial AI on echocardiography at the last follow-up before readmission. Endocarditis 
secondary to methicillin resistant Staphylococcus aureus developed in 1 patient. No 
aortic valve cusp repair was performed during the first operation. Severe AI was found 
to have developed at the 22-month follow-up in the other patient, a 14-year-old boy. 
During reoperation, the free margins of all three leaflets were noted to be in excess of 45 
mm. In retrospect, this patient was probably not a candidate for the reimplantation 
technique owing to his abnormally stretched leaflets. 
According to the guideline of Edmunds and colleagues [26], the 5-year freedom from 
reoperation in our series owing to structural valve deterioration (thus excluding the 
patient with endocarditis) and significant AI (>2+) was 88.9% ± 8.1%. Our data are 
consistent with other reported series [9, 10]. Recently, David and colleagues reported 8-
year freedom from moderate-to-severe AI of 90% ± 6% with the reimplantation 
technique. A modification involving the creation of neo-sinuses was implemented during 
the last 2 years of the David group’s experience. 
In a smaller series from the same center consisting of Marfan syndrome patients 
exclusively, De Oliveira and colleagues [8] reported a 10-year freedom from reoperation 
of 100%. However, the actual freedom from AI exceeding 2+ was 75% ± 13% at 10 
years. Further subgroup analysis demonstrated that freedom from AI exceeding 2+at 8 
years was 71% ± 21% in the remodelling group and 96% ± 4% in the reimplantation 
group [27]. 
Others [12] have echoed our preference for the Valsalva conduit. Clinical analyses have 
suggested that leaflet motion after the reimplantation technique with the Valsalva graft 
is similar to that of normal subjects [25]; however, longer follow-up is needed to draw 
definitive conclusions. The Valsalva conduit combines the advantages of annular 
fixation—a feature of the standard reimplantation—with the creation of sinuses in the 
remodelling technique, without adding to the technical complexity of the operation (ie, 
creating sinuses from a standard graft). Furthermore, using preconstructed sinuses of 
Valsalva potentially allows for more reproducibility and uniformity. 
Criticism of the Valsalva conduit has centered on the predetermined height of the sinus 
segment and the fixed diameters of the conduit [11]. In patients with Marfan syndrome, 
the commissural heights may not match the predetermined dimensions of the sinus 
segment chosen from the corresponding annular diameter. Suboptimal re-creation of 
leaflet coaptation may result in early failure of the repair. We argue that the Valsalva 
conduit can be adjusted to the patient’s specific dimensions because the collar and the 
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skirt can be fashioned to adapt to the patient’s anatomy. Moreover, techniques to adjust 
and reposition the height of the new sinotubular junction when the commissural heights 
are shorter than the height of the skirt have been described [28, 29]. 
Our study is limited by its retrospective nature and its size of 35 patients. However, the 
mid-term results in this multicenter study examining reimplantation valvesparing root 
replacement in Marfan patients with the Gelweave Valsalva prosthesis are satisfactory, 
and thus encourage further use of this type of repair. Nevertheless, at mean follow-up of 
19 months, 4 patients had 2+ AI, suggesting that long-term results are needed to further 
define the durability of this technique. 
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Abstract 
 
 
Objectives: Reimplantation valve-sparing aortic root replacement has been increasingly 
performed with improving perioperative and midterm results. However, extending the 
age criterion in patient selection remains a debate. This study reviews the results of 
reimplantation valve-sparing aortic replacement in patients greater than 60 years of 
age. 
 
Methods: During a 51-month period, 63 patients with aortic root aneurysms underwent 
reimplantation valve-sparing aortic root replacement. The Gelweave ValsalvaTM 
prosthesis (TERUMO CardioVascular Systems Corp., Ann Arbor, MI, USA) was used in all 
but one case. The patients were predominantly male, and the mean age was 67 years 
(range, 61–83 years). Four patients had congenital bicuspid aortic valves, and cusp 
repair was required in one patient. The mean follow-up was 25 months (range, 1–51 
months). 
 
Results: There were one hospital and two late deaths. Overall survival at 51 months was 
84 ± 9.9%. During follow-up, one patient developed severe aortic incompetence (AI) 
requiring an aortic valve replacement (AVR). Freedom from reoperation at 51 months 
was 92.8 ± 6.8%. Moderate AI was present at latest echocardiogram in one patient. 
Freedom from moderate or severe AI at 51 months was 90 ± 9.4%. There was no 
episode of endocarditis on follow-up. Univariate analysis demonstrated that no 
preoperative or intraoperative factor was a predictor for late reimplantation failure. 
 
Conclusions: Reimplantation valve-sparing aortic root replacement in patients greater 
than 60 years old can be performed with satisfactory perioperative and midterm results. 
Long-term results are needed to define the durability of this technique and its role in 
this subset of patients. 
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Since its first description by David, the criteria in patient selection for reimplantation 
valve-sparing aortic root replacement have evolved. Initially, the technique was 
reserved for patients with normal, tricuspid aortic valve morphology [1,2]. As clinical 
experience and surgical confidence grew, the indications were extended to patients with 
leaflet abnormality such as cusp prolapse, Marfan’s syndrome, acute aortic dissections, 
and bicuspid aortic valves. Multiple studies have demonstrated satisfactory results in 
these subsets of patients [3-7]. 
However, many surgeons remain reluctant in performing valve-sparing aortic root 
replacement in older patients even if appropriate anatomical criteria are met. Subgroup 
analysis in previous studies has suggested increased morbidity and mortality in older 
patients [8,9]. Furthermore, others argue that in the older patients, bioprosthesis aortic 
root replacement can be performed with less technical demand, presumed lower 
morbidity and mortality, and satisfactory durability. 
Current population study has demonstrated a consistent increase in life expectancy 
compared to previous decades. According to the current U.S. population study, patients 
age 60 and 65 years old have a life expectancy of 22 and 18 years, respectively [10]. 
With this increasing life expectancy in the elderly, reoperation in octogenerians with 
previous aortic root replacement may become more common. Alternatively, mechanical 
prosthesis is not an ideal option, as anticoagulation in this aging population is not 
without complications. Preservation of the native aortic valve remains  the ideal 
solution. The aim of this study was to review the results of reimplantation valve-sparing 
aortic replacement, performed in two different cardiac centers, in patients greater than 
60 years of age. 
 
 
Material and Methods 
 
From January 2003 to April 2007, a total of 127 patients underwent reimplantation 
valve sparing aortic root replacement at the Istituto Clinico Humanitas (Rozzano, Italy) 
and at the University of Pennsylvania Medical Center (Philadelphia, PA, USA). Sixty-three 
(49%) patients were greater than 60 years old. All 63 cases were elective, as no 
reimplantation was performed emergently in this group of patients. A retrospective 
review of this subgroup of patients was performed.  
The operative technique has been previously described [4]. Briefly, median sternotomy 
was performed and cardiopulmonary bypass was instituted with arterial cannulation via 
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the ascending aorta or femoral artery and venous cannulation via bicaval or right atrial 
cannulation. In patients undergoing elective hemiarch reconstruction, deep hypothermic 
circulatory arrest and retrograde cerebral perfusion (DHCA/RCP) were employed 
during the open distal anastomosis. Depending on the surgeon’s preference, myocardial 
protection was achieved by combination of antegrade and retrograde Custodiol ® 
cardioplegic solution (Dr. F. Köhler Chemie, Alsbach, Germany) and topical cooling with 
4 °C saline solution or by intermittent antegrade and retrograde cold blood perfusion. 
All patients underwent the reimplantation valvesparing aortic root replacement 
according to the technique described by David [1]. The Gelweave ValsalvaTM prosthesis 
(TERUMO CardioVascular Systems Corp., Ann Arbor, MI, USA) was used in all cases but 
one. The graft sizes used are summarized in Figure 1. Four patients had bicuspid aortic 
valves. In one patient, the right and left coronary cusps were fused with a median raphe 
that was neither thickened nor fibrosed. The free margin was significantly longer than 
the free margin of the noncoronary cusp, resulting in prolapse of the fused right and left 
coronary cusps. The fused cusp was pliable and simple plication of the free margin with 
6-0 Gore-Tex suture (W.L. Gore & Associates, Flagstaff, AZ, USA) was performed. The 
three other bicuspid aortic valves had nearly symmetrical cuspswith no evidence of 
prolapse; no leaflet repair was required. Hemiarch reconstruction was performed 
utilizing DHCA/RCP in all four patients. Concomitant procedures included mitral valve 
repair in seven patients (11%), coronary artery bypass in 10 patients (16%), atrial 
septal defect repair in one patient (2%), and radiofrequency ablation for atrial 
fibrillation in two patients (3%). 
 
 
 
 
Fig 1. Graft size distribution 
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Echocardiography 
 
Intraoperative transesophageal echocardiogram (TEE) was performed in all cases to 
assess the degree of aortic incompetence (AI) preoperatively and post reimplantation. 
Transthoracic echocardiogram (TTE) was used in follow-up for the evaluation of AI. 
Aortic insufficiency was scored as none, trivial, mild, moderate, or severe. 
 
Statistical analysis 
 
Continuous variables were expressed as the mean ± SD and were analyzed using the 
unpaired 2-tailed t - test. Categorical variables were presented as a percentage and were 
analyzed with the chi-square test or Fischer’s exact test when appropriate. Univariate 
analysis was performed to identify risk factors for late reimplantation failure as 
demonstrated by either the presence of moderate or severe AI or the requirement of 
aortic valve replacement (AVR). Preoperative factors examined were renal failure, New 
York Heart Association (NYHA) class, left ventricular ejection fraction (LVEF), severity of 
preoperative AI, presence of bicuspid aortic valve, diameter of the annulus, sinus 
segment, and ascending aorta. Intraoperative factors examined were cardiopulmonary 
bypass (CPB) and aortic cross clamp time, the graft size used for reconstruction, and 
concomitant cusp repair, mitral valve repair, coronary artery bypass graft, and hemiarch 
reconstruction. Actuarial survival, freedom from reoperation, and freedom from 
moderate or severe AI were plotted using the Kaplan-Meier method. 
 
 
Results 
 
Patient demographics 
 
Preoperative demographic data are listed in Table 1. Patients were predominantly male, 
and the mean age was 67.1 years old (range, 61–83 years old). The majority of patients 
were NYHA class I or II with normal left ventricular ejection fraction. Moderate or severe 
AI was present in 62% of the patients preoperatively. All patients underwent elective 
operation for aortic root aneurysms. 
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Table 1: Clinical Profile of Patients 
Characteristic n = 63 
Age (years) 67.1±5.3 
Sex (male) 45 (71) 
NYHA functional class 
1. I 
2. II 
3. III 
4. IV 
 
19 (30) 
27 (43) 
15 (24) 
2 (3) 
Left ventricular ejection fraction 
1. > 60% 
2. 40–59% 
3. < 39% 
 
44 (70) 
16 (25) 
3 (5) 
Aortic incompetence 
1. None/trivial 
2. Mild 
3. Moderate 
4. Severe 
 
13 (21) 
11 (17) 
23 (37) 
16 (25) 
Bicuspid aortic valve 4 (6) 
Mitral regurgitation grater than mild 7 (11) 
Diameter of aneurysm (mm) 
1. Annulus 
2. Sinus segment 
3. Ascending aorta 
 
25 ± 0.5 
50 ± 0.6 
52 ± 0.7 
Values are mean ± 1 SD.  
Numbers in parenthesis are percent. 
 
 
Operative outcome 
 
The mean CPB time was 134 ± 46 minutes with a mean aortic cross clamp time of 116 ± 
39 minutes. Elective hemiarch reconstruction using hypothermic circulatory arrest was 
required in four patients, with a mean DHCA/RCP time of 18 ± 3 minutes. 
There was one hospital death and two late deaths. The cause of the hospital death was 
sepsis at four months after reimplantation in a patient who had a cardiac arrest on 
postoperative day 4. Resuscitation was successful; however, the patient suffered a 
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devastating neurologic injury due to anoxia. The patient had previously been discharged 
from the intensive care unit on postoperative day 1. Coronary angiography 
demonstrated no evidence of coronary button occlusion, and the cause of the cardiac 
arrest remains unclear. The causes of late death were cardiac (sudden death) in one 
patient at 37 months and noncardiac (hepatocellular carcinoma) in the other patient at 
48 months. At the time of surgery, there was no evidence of hepatic neoplasm. Liver 
function test and hepatitis B and C markers were negative. Both patients had trivial AI at 
latest follow-up. Overall survival at 51 months was 84 ± 9.9% (Figure 2). Eight patients 
required re-exploration (< 24 hours) for bleeding and tamponade. One patient sustained 
a transient stroke but demonstrated complete neurologic recovery on follow-up. No 
thromboembolic events or endocarditis occurred during the follow-up period. Six 
patients (9%) are currently receiving oral anticoagulation therapy for atrial fibrillation.  
At the closure of the study, 48 (80%) of the remaining 60 patients were in NYHA class I, 
nine (15%) in class II, and three (5%) in class III. The mean follow-up was 25 months 
(range, 1–51 months) and was 100% complete. 
 
 
 
 
 
 
 
 
 
Fig 1. Overall survival at 51 months. 
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Aortic valve function 
 
No patient left the operating room with greater than mild AI. One patient developed 
severe AI during followup and required aortic valve replacement with a bioprosthesis 
42 months after the first operation. At the time of discharge from the hospital after the 
initial reimplantation procedure, the patient had no AI on echocardiography. The first 
follow-up echocardiogram at 15 months demonstrated mild AI, with progression to 
severe AI at 42 months follow-up. Due to the presence of symptoms and increasing left 
ventricular dimensions on echocardiography, the patient underwent AVR. 
At reoperation, the Valsalva graft was opened and the native valve inspected. A prolapse 
of the noncoronary cusp was identified as the probable cause of the severe AI. The three 
cusps were removed and a bioprosthetic aortic valve was implanted within the Valsalva 
graft with a standard AVR technique. In retrospect, a shortening or a plication of the free 
margin of noncoronary cusp at the time of the first operation could have avoided the AI 
recurrence. 
Two other patients developed moderate AI during follow-up. The first patient had been 
discharged from the hospital with mild AI. Aortic insufficiency continued to be stable at 
24 and 36 months follow-up. However, at 46 months follow-up, progression to moderate 
AI was demonstrated by echocardiography. The first patient, discharged from the 
hospital with mild AI, was found to have, at 46 months of follow-up, moderate AI. 
Nevertheless, the patient has remained stable in NYHA class I with a left ventricular 
ejection fraction of > 60% and no increase in left ventricle dimensions. The second 
patient also had been discharged from the hospitalwithmild AI. Echocardiography 
performed during the first follow-up at 14 months demonstrated the presence of 
moderate AI. At 26 months follow-up, AI had regressed to mild AI. The two studies had 
been performed by the same echocardiographer. A subsequent third study performed by 
a second echocardiographer confirmed only mild AI. On retrospective review, the two 
echocardiographers agreed that there was an overvaluation of the AI grade at the 
second follow-up echocardiogram. At the closure of the study, the severity and number 
of patients with AI were the following: no AI, n = 14; trivial AI, n = 15; mild AI, n = 29; 
moderate or severe AI, n = 1. Table 2 shows a comparison between preoperative and 
latest follow-up degree of AI. The 51-month freedom from moderate or severe AI was 90 
± 9.4%. The overall 51-month freedom from reoperation was 92.8 ± 6.8% (Figure 3). 
Univariate analysis demonstrated that no preoperative or intraoperative factor was a 
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predictor for late reimplantation failure as demonstrated by moderate or severe AI or 
the requirement of AVR. 
 
Table 2: Preoperative and Latest Follow-Up AI 
 Preoperative AI Latest Follow-Up AI 
None 2 (3) 14 (24) 
Trivial 11 (17) 15 (25) 
Mild 11 (17) 29 (47) 
Moderate 23 (37) 1 (2) 
Severe 16 (26) 1∗(2) 
AI = aortic incompetence. Numbers in parenthesis are 
percent. 
∗The only patient reoperated for severe AI. 
 
 
Conclusions 
 
Age as a selection criterion remains unclear in patients undergoing reimplantation 
valve-sparing aortic root replacement. The operation is technically demanding, and 
concerns regarding increased morbidity and mortality in the elderly patients remain. 
Furthermore, technologic advancement has resulted in the improvement of 
bioprosthesis durability. This leads to the fundamental question of whether there is an 
advantage with valve-sparing aortic root replacement when compared to bioprosthesis 
aortic root reconstruction in older patients. 
Our study demonstrates that reimplantation valve-sparing aortic root replacement can 
be performed with low perioperative morbidity and mortality in patients age greater 
than 60 years. The hospital mortality was 1.5% (1/63 patients) with a late mortality rate 
of 3% (2/63 patients). Although other valve-sparing aortic root replacement series have 
similar outcome, subgroup analysis within these studies has suggested that increasing 
age is associated with poor outcome. David et al. recently reviewed the Toronto 
experience of 220 valve-sparing aortic root replacement and identified age over 65 
years, LVEF < 40%, and advanced NYHA class as predictors of poor outcome [9]. 
Kallenbach et al. recently reported the Hanover experience and identified that age 
greater than 70 years influenced survival negatively [8]. However, both of these studies 
were total reviews of their respective institutional experiences with a heterogeneous 
population of patients. Indications included aneurysms, aortic dissection, and patients 
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with Marfan’s syndrome. Moreover, between 13% and 19% of cases were emergent 
surgical interventions. On the contrary, our series did not include patients with aortic 
dissections or emergent indications. The majority of the patients were in NYHA class I or 
II (73%) with LVEF greater than 60% (70%). The data suggest that in appropriately 
selected patients, age as a sole criterion for patient selection is perhaps less critical. 
In our series, the reoperative rate for bleeding was 13%. Possible explanations may be 
that our series involve an older population (mean age 67 years) and perhaps a high rate 
of concomitant procedures (> 30%). Our midterm results also suggest that the durability 
of reimplantation valve-sparing aortic root replacement is acceptable in patients over 60 
years old. Freedom from reoperation and freedom from moderate or severe AI at 51 
months were 92.8 ± 6.8% and 90 ± 9.4%, respectively. Although the mean follow-up was 
25 months, our data are similar to other early and midterm series [4,11,12]. Follow-up 
was also encouraging with an overall survival of 84 ± 9.9% at 51 months. 
Even though our series have demonstrated low perioperative morbidity and mortality 
with good midterm results, many surgeons may continue to advocate bioprosthesis 
aortic root replacement (because of its presumed lower morbidity and mortality) in 
favor of reimplantation. Careful review demonstrates that our results are comparable to 
other contemporary bioprosthesis aortic root replacement series, and the presumed 
differences in morbidity and mortality is not clear. Gleason et al. recently reported a 
series of 176 patients undergoing aortic root replacement with the St. Jude Medical (St. 
Paul, MN, USA) full porcine root bioprosthesis [13]. The operative mortality was 3.9%. 
The perioperative stroke rate was 1.1% and endocarditis rate was 1.1%. Etz et al. 
recently reviewed the Mount Sinai experience with aortic root reconstruction using a 
bioprosthetic valved conduit in 275 consecutive patients. Hospital mortality was 6.2% 
with four patients (1.5%) having sustained permanent strokes [14]. Earlier in 2001, the 
Mount Sinai group had reported its subgroup analysis of patients greater than 65 years 
undergoing bioprosthesis aortic root replacement with a similar technique. In a series of 
84 patients, the operative mortality was 8.3% with an overall rate of valve-related 
complications (endocarditis or thromboembolism) of 7.1% after discharge. 
Although no randomized study comparing the durability of valve sparing procedures 
and Bentall operation in the elderly has been performed, with the current third 
generation bioprosthesis and their improved durability (10 years freedom from 
reoperation ranging from 87% to 99%), [14,15,16] many question the need to subject 
older patients to a longer and more technically demanding reconstruction with valve-
sparing aortic root replacement. The debate focuses on the expected survival of elderly 
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patients versus the long-term durability of the current bioprosthesis. Current population 
study has demonstrated a consistent increase in life expectancy in recent decades, with 
patients aged 60 and 65 years old having a life expectancy of 22 and 18 years, 
respectively [10]. Although long-term studies of bioprosthesis aortic root replacement 
have been reported, [16,17] series with 20-year follow-up have been limited. 
Furthermore, reoperative aortic root replacement is technically demanding, with 
evidence suggesting that older age is a negative predictor of outcome [18]. Alternatively, 
mechanical prosthesis is not an ideal option, since anticoagulation in this aging 
population is not without complications. 
In addition to age criterion, our study confirms with others that extending the indication 
for valve-sparing aortic root replacement to patients with bicuspid aortic valves is 
appropriate. In our series, four patients with bicuspid aortic valve underwent the valve-
sparing procedure with satisfactory result. Also similar to other studies, preoperative 
severity of AI and aneurysm size were not predictors of late reimplantation failure. 
Sixty-two percent of the patients in our series had moderate or severe AI preoperatively, 
compared to 2% after the reimplantation procedure. No other preoperative or 
intraoperative factor was found to be a predictor of late reimplantation failure. The 
fundamental concept in achieving satisfactory repair is the precise geometric 
reconstruction of the aortic root apparatus and leaflet coaptation. 
We firmly believe that preservation of the native valve is the most ideal option in aortic 
root reconstruction. The performance and the durability of native aortic leaflets are 
unmatched by any valvular prosthesis. Clinical analysis has also demonstrated that 
leaflet motion after reimplantation with the Gelweave ValsalvaTM  prosthesis is similar 
to that of normal patients [19]. Freedom from anticoagulation and the low rate of 
thromboembolic events and endocarditis are extremely appealing for older patients 
[20]. Following the paradigm of mitral valve repair a few decades ago, increase in 
surgical experience has resulted in extending the age criterion for valve-sparing aortic 
procedure. We believe that increasing age is not a contraindication for valve-sparing 
aortic root replacement, and that the procedure does offer an advantage over 
bioprosthesis in properly selected patients greater than 60 years of age. Our experience 
demonstrated that good surgical outcome can be accomplished and should be expected 
in this subset population of patients if appropriately selected. Nonetheless, age should 
never be the sole criterion in patient selection, but must include a comprehensive 
evaluation of the comorbidities of the patient. 
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Limitations of this study are the relatively small sample size and the length of the mean 
follow-up. However, our results demonstrated that reimplantation valve-sparing aortic 
root replacement can be performed successfully in the elderly patients with very low 
hospital mortality. Moreover, our series demonstrated excellent midterm survival and 
freedom from reoperation and freedom from significant AI. 
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Abstract 
 
 
 
Aortic valve reimplantation has been shown to be a safe procedure. However, evidences 
of durability in bicuspid aortic valves (BAVs) are limited in the literature. Between 2002 
and 2011, 132 patients (mean age 61 ± 12 years) underwent aortic valve 
reimplantation. In 24 patients (18%), aortic valve was bicuspid. Mean follow-up was 50 
± 26 months (range 1–102 months) and was 99% complete. In-hospital mortality was 
0.8% (1 patient). Survival at 1 and 5 years was 99 and 94%, respectively. Overall 
freedom from aortic valve reoperation at 1 and 5 years was 96 and 90%, respectively, 
without significant difference between patients with bicuspid and tricuspid aortic valve. 
Freedom from aortic valve regurgitation >2+/4+, excluding patients reoperated, was at 
1 and 5 years of 100 and 99%, respectively. Patients with valve cusp repair showed a 
higher rate of aortic valve reoperation; however, only postoperative aortic regurgitation 
>2+/4+ was significant risk factor for redo procedure at multivariate analysis. Aortic 
valve reimplantation in BAV without cusp repair provides excellent mid-term results. 
Further observations and longer follow-up are necessary to determine if BAV sparing, 
even in the presence of cusps alterations, could allow satisfying durability. 
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Introduction 
Aortic valve-sparing operation with valve reimplantation was introduced to treat 
patients with aortic root aneurysm associated with normal or minimally abnormal aortic 
cusps [1]. Nowadays, this procedure is considered safe and has a proved durability at 
long-term follow-up [2], so that indications were extended to patients with severe aortic 
regurgitation, bicuspid aortic valve (BAV) and aortic cusp prolapse or abnormalities. 
Cusp repair is performed with great variability among published surgical experiences in 
up to 55% of the cases [2–4], on the contrary evidences of durability of BAV 
reimplantation are limited [2, 5, 6]. 
The aim of this study was to examine our experience with reimplantation valve-sparing 
operation focusing on influence of preoperative valve characteristics in determining 
need for reoperation. 
 
 
Material and methods 
 
Between 2002 and 2011, 132 consecutive patients underwent aortic valve-sparing 
operation with valve reimplantation. The indication for operation was the presence of 
aortic root aneurysm. The Ethics Committee approved the study and waived the need 
for patient consent. The patients’ characteristics are shown in Table 1. 
Our surgical technique has been previously described in detail [7]. A Gelweave 
Valsalva™ graft was implanted in all the patients; the graft sizes used were: 26 mm in 2 
patients, 28 mm in 13, 30 mm in 42 and 32 mm in 75. 
In 13 cases, anatomical or cusp motion abnormalities concurred in determining aortic 
regurgitation and needed an adjunctive cusp repair. This finding was more frequent in 
patients with BAV (10/24 patients, 42%) than in tricuspid aortic valve (TAV) (3/108 
patients, 3%). Cusp prolapse was found in seven patients with BAV and was corrected 
with free margin shortening (four patients), central cusp plication along the nodule of 
Arantius (one case) or cusp triangular resection (two patients). In the remaining three 
cases, stress fenestration repair with pericardial patch (one patient) and shaving of a 
calcified raphe (two patients) were performed. Cusp prolapse correction (central 
plication of right coronary cusp in one case, free margin shortening of right coronary 
and non-coronary cusps in one case) was necessary in two patients with TAV; in the 
remaining case, stress fenestration repair with pericardial patch was performed. 
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Table 1: Patient characteristics 
Variable No. of patients (%) or mean ± SD 
Gender 
Male 
Female 
 
96 
36 
Age (years) 61 ± 12 
LVEF > 45% 116 (88%) 
Aortic regurgitation degree >2+/4+ 88 (67%) 
BAV 9/24 (38%) 
TAV 79/108 (73%) 
NYHA class III–IV 25 (19%) 
Emergent operation 2 (1.5%) 
CAD 17 (13%) 
COPD 24 (18%) 
CRF (creatinine > 200 μmol/l) or 
preoperative HD 
6 (4.5%) 
Marfan syndrome 5 (3.8%) 
Bicuspid aortic valve 24 (18%) 
AAD 1 (0.8%) 
Chronic aortic dissection 5 (4%) 
Diameter (mm) 
Aortic root 
Ascending aorta 
 
48 ± 9 
51 ± 9 
AAD: acute aortic dissection; BAV: bicuspid aortic valve; CAD: coronary artery disease; COPD: chronic obstructive pulmonary 
disease; CRF: chronic renal failure; HD: haemodialysis; LVEF: left ventricular ejection fraction; TAV: tricuspid aortic valve. 
 
 
Concomitant procedures were mitral valve repair (10 patients, 7.5%), scheduled 
coronary artery bypass (12 patients, 9%), atrial septal defect repair (3 patients, 2%) and 
radio frequency ablation for atrial fibrillation (2 patients, 1.5%). 
Mean cardiopulmonary bypass time was 134 ± 30 min (range 90–279 min) and the 
mean duration of aortic cross-clamping time was 114 ± 23 min (range 67–204 min). 
Aortic regurgitation was graded as none, trace (1+/4+), mild (2+/4+), moderate (3+/4+) 
or severe (4+/4+). A transoesophageal echocardiogram (TEE) was carried out 
intraoperatively in all the patients after weaning from cardiopulmonary bypass in order 
to evaluate residual aortic valve regurgitation and to characterize cusps’ level of 
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coaptation. Transthoracic echocardiography was performed before discharge and at 6 
and 12 months and every year thereafter. 
Follow-up ranged from 1 to 102 months (mean 50 ± 26 months) and was available in 
130 of 131 patients (99% complete). 
 
 
Statistical analysis 
 
Continuous variables were expressed as the mean ± SD. Categorical variables were 
compared with the Chi-square or Fisher exact test when appropriate. Six variables 
(Marfan syndrome, BAV, preoperative cusp prolapse, valve cusp repair, preoperative 
aortic regurgitation degree>2+/4+, postoperative residual aortic regurgitation 
degree>2+/4+) were entered into a univariate analysis to determine whether any single 
variable influenced the risk for reoperation and into a model of Cox regression analysis 
to study its independent predictability. 
Survival rates and freedom from reoperation were calculated using the Kaplan–Meyer 
method. Univariate comparisons for failure time data were performed using the 
Wilcoxon test. Statistical analyses were performed using the Stat-View Statistical 
Software Package 5.0 (SAS Institute, Inc., Cary, NC, USA), NCSS 2001 (Number Chruncher 
Statistical System, Kaysville, UT, USA). 
 
 
Results 
 
In-hospital outcome 
 
There were no intra-operative deaths. The mortality predischarge was 0.8% (one 
patient). Early reoperation for excessive bleeding or tamponade was necessary in 15 
patients (11%) and in 3 cases (2.2%) for sternal dehiscence/mediastinitis. Perioperative 
myocardial infarction occurred in two patients (1.6%). Cerebrovascular accidents were 
registered in three patients (2.2%); stroke in one and transient ischaemic attack in two. 
A permanent pacemaker implantation was necessary in three patients (2.2%) for 
complete AV block.  
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Seven patients were discharged with a residual aortic regurgitation degree >2+/4+; 
nevertheless in last 4 years, all patients were discharged with residual aortic 
regurgitation degree <2+/4+. 
 
Survival 
 
There were eight late deaths during follow-up; in three cases because of cancer, one had 
acute bowel ischaemia after descending thoracic aorta endovascular procedure, two 
patients had worsening heart failure and in two cases sudden death occurred. The 
cumulative 1-year and 5-year survival rates (excluding hospital mortality) were 99 and 
94%, respectively. 
Freedom from aortic valve endocarditis was 100 and 99% at 1 and 5 years. 
Thromboembolic events occurred in two patients during follow-up with a rate of 
freedom from cerebrovascular ischaemic events at 1 and 5 years of 99 and 97%, 
respectively. 
 
Reoperation 
 
Eleven patients underwent aortic valve reoperation during follow-up for recurrent 
aortic insufficiency, in one case because of aortic valve endocarditis. All the patients 
underwent successful aortic valve replacement and the survival rate was 100% at 38 ± 
27 months. Table 2 reports data about reoperation. At univariate analysis, preoperative 
cusp prolapse (P = 0.013), valve cusp repair (P = 0.023) and postoperative aortic 
regurgitation >2+/4+ (P < 0.001) were significant risk factors for aortic valve 
reoperation. Preoperative aortic regurgitation degree >2+/4+ (P = 0.08), Marfan 
syndrome (P = 0.06) and bicuspidy (P = 0.32) showed no significance. At the 
multivariate analysis, postoperative aortic regurgitation degree >2+/4+ (P = 0.032) was 
the only significant independent risk factor for aortic valve reoperation. 
Overall freedom from reoperation for aortic valve regurgitation was 96% at 1 year and 
90% at 5 years. 
Cumulative freedom from aortic valve reoperation and from residual aortic 
regurgitation degree >2+/4+ was 96 and 89% at 1- and 5-year follow-up, respectively. 
Patients with preoperative none or trace aortic regurgitation (AR) had a freedom from 
reoperation at 1 and 5 years of 98%; in patients with AR degree >2+/4+, freedom from 
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aortic valve redo was at 1 and 5 years of 95 and 87%, respectively (AR ≤ 2+/4+ vs. AR > 
2: P = 0.11). 
 
 
Table 2: Aortic valve characteristics and mechanisms of recurrent aortic regurgitation 
in patients who underwent aortic valve reoperation 
 
Patient AV Preop AVR AV repair Reason for 
recurrent AVR 
Interval time 
(months) 
1 TAV Trivial  Three cusps 
prolapse, technical 
problem 
1 
4 TAV Severe  RC and LC 
retraction, normal 
annulus 
79 
7 BAV Severe Free margin 
shortening NC-RC 
cusp 
NC-RC cusp 
retraction 
7 
23 TAV Severe  NC cusp prolapse, 
no cusps 
abnormalities 
34 
30 TAV Severe  NC cusp prolapse, 
no cusps 
abnormalities 
15 
45 TAV Moderate  Not well defined 34 
54 TAV Severe  LC cusp prolapse, 
no cusps 
abnormalities 
31 
67 TAV Moderate  Endocarditis 48 
72 BAV Severe NC cusp triangular 
resection and central 
plication 
NC cusp prolapse 9 
91 TAV Moderate Fenestration repair Not well defined 4 
105 BAV Moderate NC cusp triangular 
resection and central 
plication 
NC cusp tear 
(suture 
dehiscence?) 
6 
BAV: bicuspid aortic valve; LC: left coronary; NC: non-coronary; RC: right coronary; TAV: tricuspid aortic valve. 
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Patients with BAV showed freedom from aortic valve reoperation of 86% after 1 year 
with stable results in the first 5 years. There was no difference comparing the durability 
between TAV (freedom from reoperation of 98 and 92% at 1 and 5 years, respectively) 
and BAV (P = 0.26) (Fig. 1). 
 
 
Overall freedom from reoperation in patients with preoperative normal or minimally 
abnormal aortic valve cusps was 99 and 93% at 1 and 5 years, respectively (Fig. 2). 
Patients needing cusp repair showed freedom from aortic valve redo of 69% at 5 years 
(P < 0.001). No difference between BAV and TAV was found in durability after 
stratification for adjunctive cusp repair (Fig. 3). 
 
 
 
 
 
Fig 1. Freedom from aortic valve 
reoperation in patients with tricuspid and 
BAV (P = 0.26). 
 
Fig 2. Freedom from aortic valve 
reoperation according to the 
adjunct of cusp repair (P <0.001). 
 
Fig 3. Freedom from aortic valve 
reoperation in patients with 
tricuspid or BAV associated or 
not with valve cusp repair. 
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BAV and TAV reimplantation without cusp repair provided a freedom from aortic valve 
reoperation at 1 year of 100 and 99%, respectively, at 5 years of 100 and 93%, 
respectively. Freedom from reoperation at 5 years in patients who underwent 
associated cusps repair was 72% in TAV and 67% in BAV. 
 
 
Discussion 
 
The BAV annular asymmetry is considered to be better preserved with root remodelling  
[6, 8]. Previous experiences [3, 8] showed no differences in durability between 
preserved BAV and TAV. These results were supported by a recent work by Schäfers et 
al. [9] with excellent results and freedom from aortic valve reoperation of 97% at 10 
years. 
Annular dilatation, together with cusp injuries or retraction, stress tears and 
fenestration, developing fibrosis and, of course, failure of suboptimal surgical correction 
[8, 10–12], are possible mechanisms leading to aortic regurgitation recurrence [10, 13, 
14]. Valve-sparing reimplantation is the only operative approach able to stabilize the 
size of a dilated aortoventricular junction thus preventing future dilatation [2, 14]. This 
characteristic could be more effective in preventing recurrence of valve regurgitation in 
BAV. However, despite the widespread of this technique, few reports focused on BAV [5, 
12]; even in experiences with large population, the number of BAV patients is limited [2, 
4, 15] or the results not discussed [13]. 
In our experience, a favourable anatomical and functional cusp condition allowed 
satisfying mid-term durability with a global freedom from reoperation of 94% at 5 
years; in particular, excellent results were registered in the BAV subgroup. However, 
especially in BAV, cusp abnormalities are not uncommonly associated [12]. We were led 
to add valve cusp repair in only 10% of the cases, but this rate is lower than in several 
other experiences reporting cusp repair incidences ranging from 20 to 60% [2, 3, 10, 12, 
15]. Even if bicuspidy did not emerge as a risk factor for aortic valve reoperation [2–6, 
12, 15], there is no general agreement about the durability of BAV sparing with 
adjunctive cusp repair [2, 3, 10, 12] and our data are supportive for a less satisfying 
durability in this subgroup of patients. However, a very recent paper from de Kerchove 
et al. [14], focusing on patients with BAV reimplantation with adjunctive cusp repair in 
93% of the cases, has reported a superb freedom from reoperation: 100% at 6 years. 
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We found a tendency in early failure (less than 1 year from valve-sparing procedure) in 
patients with BAV who needed valve cusp repair (Figs 2 and 3). Interestingly, similar 
results were reported in literatures with most of the reoperations (up to 80%) 
performed during the first year of the follow-up [3, 8, 11, 12, 15]. Cusp lesions and 
technical failure were reported as the main cause for reoperation in these cases. 
Furthermore, many of these patients were discharged with a residual mild insufficiency 
degree that abruptly hesitated in moderate or severe regurgitation. Postoperative 
degree of aortic regurgitation is recognized to be an independent risk factor for 
recurrent aortic regurgitation [3] and our data confirm this finding. In the early phase of 
our experience, seven patients were discharged with a suboptimal result and four of 
these underwent aortic valve reoperation during the first year after the valve-sparing 
repair. Concerning intraoperative TEE, a residual aortic regurgitation ≥2+/4+ and a level 
of coaptation> 2 mm below the lower border of the Dacron graft is considered 
inacceptable nowadays. Our policy allowed us to register no early failure in last 3 years 
and will probably provide an even better mid- and long-term outcome in the future. 
 
 
Limitations 
 
The main limitation of the study was the small number of patients with BAV; however, 
the presented subgroup is one of the most representative single-centre series in the 
literature. This is a retrospective analysis even if performed on a prospectively collected 
database. Data about residual aortic regurgitation or development of significant aortic 
insufficiency were extrapolated in up to 20% of the cases from echocardiography 
evaluation performed in peripheral centres. 
 
 
Conclusion 
 
If a BAV does not present cusp calcification or some stenosis degree, for which the 
indication for valve replacement is clear, a valve-sparing procedure should be 
considered as a primary approach. We are familiar with the reimplantation technique 
since 2002 and we agree with the potential role in annular stabilization provided by 
valve reimplantation.  
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Preoperative aortic regurgitation degree is not an independent risk factor for recurrent 
aortic insufficiency in BAV sparing. 
Although bicuspidy could present as a complex disease causing aortic regurgitation, it 
did not emerge as a risk factor for reoperation after valve-sparing procedures. Several 
pathogenetic mechanisms could lead to recurrent aortic regurgitation along annular or 
root dilatation and therefore to the need for further procedures. BAV preservation is 
particularly interesting in patients developing aortic regurgitation or undergoing aortic 
root surgery who deny mechanical prostheses and could suffer from suboptimal 
durability of biologic prostheses. Sparing BAVs with minimal cusp alterations provide 
excellent mid-term results. A proper intraoperative assessment, a close postoperative 
follow-up and the limited risk during redo procedure in these young patients could 
allow experienced surgeons to make efforts in sparing BAV even in the presence of cusp 
abnormalities. However, further evidences and longer follow-up are required to state if 
this particular subgroup of patients could benefit from a satisfying durability.  
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Abstract 
 
 
 
Aim.  Aortic valve-sparing operations are nowadays considered safe and reliable 
procedures in terms of mid-term and long-term results. Although surgical techniques 
regarding the modality of grafts’ implantation have been properly addressed, the 
modality of cusp repair, when needed, is still open to debate. We sought to review the 
literature to try to shed light on when the cusp repair is required and how it should be 
performed. 
 
Methods. We searched the PubMed database using the keywords aortic valve-sparing 
operation, aortic valve-sparing reimplantation, valve-sparing aortic root replacement, 
aortic valve repair, and aortic cusp repair. Only studies that included and described in 
detail the technique of cusp repairs in adjunct to aortic valve-sparing operation were 
considered. 
 
Results. Bicuspid aortic valve more often requires correction when compared with 
tricuspid valve. The range of the techniques varies from the ‘simple’ free margin 
plication to the more complex triangular resection with patch repair. Results in the 
literature seem to be encouraging, showing that, in most of the cases, cusp repair does 
not affect valve competence in the mid-term and long-term. 
 
Conclusion.  Correction of the cusp is a delicate balance between undercorrection that 
could lead to residual prolapse and overcorrection that could lead to cusp restriction. 
Although complex repair of the aortic valve in addition to root replacement provided 
satisfactory results, it should be reserved for experienced centers with a large volume of 
patients. 
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Introduction 
 
Since their introduction between the late 1980s and the early 1990s, valve-sparing 
operations have progressively spread. Basically, there are two main types of aortic 
valve-sparing operations: reimplantation of the aortic valve and remodeling of the aortic 
root [1,2]. More recently, a third technique, the so-called ‘Florida sleeve’, has been 
proposed [3]. Although these procedures were initially reserved for younger patients 
with normal or nearly normal aortic valve, the encouraging mid-term and long-term 
results in terms of mortality, morbidity, and valve durability [4–7] have convinced many 
surgeons to expand the indication to older individuals with more compromised aortic 
valve [8–10]. This evolution has resulted in the need to develop a technique that, in 
addition to the root graft implantation, could correct residual aortic insufficiency due to 
abnormalities of the aortic valve. These abnormalities may be either a consequence of 
the increased mechanical stress and strain on the aortic cusps generated by the root 
aneurysm itself or intrinsic alterations of the valve [11]. If at the beginning of the 
experience, the cusp repair was limited to tricuspid aortic valves, over time even the 
most challenging bicuspid valves have begun to be treated [12,13]. Nowadays, surgeons 
have a wide range of techniques to reduce the cusps’ prolapse, restore the cusps’ motion, 
and to increase the coaptation surface of the free margin [14–16]. Our aim is to review 
the literature to clarify when cusp repair is required and how it should be performed. 
 
 
 
Methods 
 
For this review, we searched the PubMed database using the keywords aortic valve-
sparing operation, aortic valvesparing reimplantation, valve-sparing aortic root 
replacement, aortic valve repair, and aortic cusp repair. Only studies that included and 
described in detail the technique of cusp repairs in adjunct to aortic valve-sparing 
operation were considered. 
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Results 
 
Mechanisms of aortic regurgitation in root dilatation and anatomical bases of residual 
aortic insufficiency 
 
Enlargement of the aortic root may functionally cause aortic regurgitation even in the 
presence of normal aortic valve cusps (type I lesion according to the functional 
classification of the aortic valve regurgitation) [17]. Moreover, dilatation of the aortic 
root may increase the stress on specific areas of the cusps. By means of a finite element 
model, Grande et al. [11] demonstrated that when the aortic root dilatation exceeds 
50%, an increase of strain on the cusps occurs (ranging from 39 to 189%) and it is 
disproportionately higher at the attachment edge and coaptation area. This can lead to 
the elongation of the free margin of the cusp and to fenestration at the commissure sites, 
creating the bases of residual aortic regurgitation after a valve-sparing procedure. In 
this setting, repair of the prolapsed cusp (type II lesion, most commonly due to cusp free 
margin elongation) is required. Furthermore, primary cusp abnormalities, such as the 
presence of a fibrotic/calcified cusp raphe, can lead to limited cusp motion (type III 
lesion), affecting early results and durability of the valve-sparing procedure. 
As the aortic valve becomes fully assessable only after restoring the aortic sinuses’ 
three-dimensional geometry altered by the dilatation of the aortic root, aortic cusp 
repair should be performed (in the case of tricuspid aortic valve), or at least thoroughly 
checked [in the case of bicuspid aortic valve (BAV)], after the reconstruction of the aortic 
root by means of the graft [18]. It is of crucial importance to make sure that the cusps 
are coapting at the same level and well above the nadir of the aortic annulus (8–11mm) 
and the cusps have no ‘restricted’ motion. It has been demonstrated that, although 
suboptimal cusp coaptation can exist without aortic incompetence in the short-term, 
normal coaptation is associated with optimal long-term function of the valve [19]. 
The most frequently used cups repair techniques are reported in Table 1. 
In an attempt to evaluate the stress to which the cusps are exposed after surgical repair, 
Labrosse et al. [20],  in a finite element study simulating leaflet correction, demonstrated 
that different techniques have different impacts. In particular, free margin shortening 
did not induce significant increase in cusp stress with respect to the reference value. On 
the contrary, the central cusp plication and the commissural plication did, with increases 
in excess of 36 and 45%, respectively. 
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Table 1. Most frequent cusp repair techniques 
Valve Cusp repair techniques 
TAV/BAV Free margin shortening/resuspension 
TAV/BAV Nodule of Arantius plication 
TAV/BAV Triangular resection 
BAV Raphe shaving 
BAV Raphe resection and closure 
BAV Raphe resection and patch repair 
BAV, bicuspid aortic valve; TAV, tricuspid aortic valve. 
 
 
Cusp repair during valve-sparing operation in tricuspid aortic valve 
 
In a recent publication, David and Armstrong [16] presented their long-term results 
with valve repair during valve-sparing operations, when alterations secondary to aortic 
root aneurysm occur.  It is emphasized that if the free margin of a cusp is elongated, it 
will prolapse after correction of the dilatation of the sinotubular junction and, in 
addition, cusps with stress fenestration, usually located at the commissures that are 
considered the ‘hinge point’, may rupture after reconstruction of the aortic root. They 
suggest correcting the cusp prolapse by plication of its central portion along the nodule 
of Arantius (Fig. 1b) or by weaving a double layer of a fine polytetrafluoroethylene 
(PTFE) suture (Gore-Tex) along the free margin and shortening the free margin; the 
suture has to be secured outside the graft used for the reconstruction of the aortic root 
(Fig. 1a). They recommend, furthermore, using the two techniques in combination when 
cusp prolapse is associated with stress fenestration in the commissural area. In their 
large series including 267 patients treated with aortic-valve-sparing operations, cusp 
repair was performed with these techniques in 24% of the cases (58 patients during 
aortic valve reimplantation and six during aortic root remodeling). The results are 
outstanding: only one patient underwent reoperation for severe aortic incompetence 12 
years after the procedure. They concluded that cusp repair by plication of the central 
portion alone, PTFE suture alone, or a combination of the two techniques had no 
negative effect on the durability of aortic valve-sparing operations. 
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Figure 1. (a) Correction of the cusp prolapse by weaving a double layer of a fine polytetrafluoroethylene suture 
(Gore-Tex) along the free margin and shortening the free margin; the suture has to be secured outside the graft 
used for the reconstruction of the aortic root. (b) Correction of the cusp prolapse by plication of its central portion 
along the nodule of Arantius. (c) Correction of the cusp prolapse by triangular resection and reconstruction with 
autologous pericardium patch. 
 
 
A very similar approach is reported by El Khoury et al. [18]. The residual or new aortic 
valve prolapse is corrected, after having fixed the root by means of the graft, by free 
edge plication with one or two simple sutures placed from one side of the nodule of 
Arantius to the other side and tied, or by shortening the free margin with a running 
Gore-Tex suture to adjust the coaptation height (they define the latter technique ‘free 
margin resuspension’). In a series including 376 patients with tricuspid aortic valve who 
underwent cusp repair with these techniques, 39 had contextually a root replacement 
(36 reimplantation and three remodeling) [14]. Among them, the residual or new 
prolapse was corrected with free margin resuspension in 14 cases, free edge plication in 
18, and plication along with resuspension in six. Reoperation for significant aortic 
insufficiency was necessary in two patients. In one, recurrent aortic insufficiency 3+ 
developed 29 months after root remodeling with resuspension of the three cusps. At 
reoperation, valve analysis detected a slightly restrictive left coronary cusp and 
recurrent prolapse of the two other cusps. The other patient, who initially had root 
reimplantation with cusps thinning and plication along with resuspension on two cusps, 
developed 30 months later aortic insufficiency 3+ and aortic valve stenosis. At 
reoperation, low coaptation and cusp calcification were found. As the median follow-up 
of this series is about 4 years, no long-term conclusion can be drawn. According to the 
authors, free margin plication is their technique of choice to treat residual tricuspid 
valve prolapse, whereas they use the resuspension technique to close stress 
fenestration. 
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Aicher et al. [21] described a more ‘aggressive’ approach for correction of residual 
prolapse. Although they perform, as the preferred technique, plication of the central 
portion of the cusp (one to five plication 5–0 or 6–0 polypropylene stitches placed in a 
stepwise fashion), in the presence of marked tissue redundancy (> 10mm), a triangular 
resection is carried out. If the gap between the two portions of the cusp is limited, it is 
reconstructed by interrupted stitches (6–0 polypropylene); otherwise, a patch of fixed 
autologous pericardium is inserted (Fig. 1c). Autologous pericardium is also used in the 
presence of cusp fenestration. Regardless of the type of repair performed, their aim is to 
achieve an identical height of the free margin and an effective height of 7–8mm (the 
height difference between aortic insertion and free margin of the cusps). In their large 
series of 274 patients who underwent aortic root remodeling, 193 had a tricuspid aortic 
valve. In this subgroup, the cusp prolapse correction was necessary in 103 patients 
involving one cusp in 53 cases, two cusps in 29 cases, and three cusps in 21 cases. The 
prolapse correction consisted of plication of the central portion of the cusp (n= 102), 
triangular resection (n= 2), and pericardial patch repair (n=4). Reoperation for 
significant aortic regurgitation was required in seven (out of 193) patients and 
symmetric cusp prolapse was found in the majority of the patients, but no indication 
whether they underwent cusp repair during the first procedure is provided. 
Oka et al. [22] reported 101 cases of patients with aortic valve reimplantation. Among 
them, 51 had adjunctive cusp repair. The majority of the patients (88%) had a tricuspid 
aortic valve. Various cusp repair techniques were attempted, including central plication 
at the nodules of Arantius by means of 5–0 or 6–0 polypropylene (32 patients), 
reinforcement of the free margin using Gore-Tex CV7 sutures (15 patients), cusp 
perforation closure using autologous pericardial patches (eight patients), and plication 
of the free margin at the commissures (two patients). In this subgroup of 51 patients, 
four had early failure (one had BAV) and six late failure (including two BAV). Two out of 
four patients with early failure received free margin cusp plication at the commissures. 
According to the authors, the latter technique has been abandoned because of 
disappointing results in the short-term. Considering that about one-fifth of patients who 
underwent cusp repair had a failure, it is no wonder that repaired ‘thin’ cusps turned out 
to be an independent risk factor for recurrent aortic insufficiency. Characteristics and 
results of cusp repair during valvesparing operation in tricuspid aortic valve are 
summarized in Table 2. 
 
 
  128 
Table 2. Characteristics and results of cusp repair during valve-sparing operation in 
tricuspid aortic valve. 
 David and 
Armstrong 
[16] 
de 
Kerchove 
et al. [14] 
Aicher et 
al. [21] 
Oka et al. 
[22] 
Sparing operation 267 39 193 101 
Tricuspid aortic valve/bicuspid 
aortic valve 
TAV TAV TAV TAV/BAV 
Valve repair 
Reimplantation 
Remodeling 
64 (24%) 
58 (90.7%) 
6 (9.3) 
39 
(100%) 
36 
(92.3%) 
3 (7.6%) 
103 (53%) 
0 
103(100%) 
51 (50%) 
51 (100%) 
0 
Free margin 
shortening/resuspension 
4 (6.25%) 14 
(35.8%) 
0 15 (29.4%) 
Plication of Arantius nodule 0 18 
(46.1%) 
102 (99%) 32 (62.7%) 
Plication at the commissures 0 0 0 2 (2.9%) 
Free margin 
shortening/resuspension+plication 
of Arantius nodule 
60 (93.7%) 6 (15.3%) 0 0 
Triangular resection 0 0 2 (1.9%) 0 
Pericardial patch 0 0 4 (3.8%) 8 (15.6%) 
Reoperation for valve failure 1/64 
(1.5%) 
2/39 
(5.1%) 
n.a. 7/51(13.7%) 
(5 TAV+2 
BAV) 
BAV, bicuspid aortic valve; TAV, tricuspid aortic valve. 
 
 
Cusp repair during valve-sparing operation in bicuspid aortic valve 
 
A few considerations must be taken into account when the decision to spare a BAV is to 
be made in the setting of an aortic root replacement. 
The morphology of the BAV is variable. The cusps may be nearly equal in size 
(symmetric bicuspid valve), or more often, one cusp may be larger than the other 
(asymmetric bicuspid valve). The larger cusp very frequently has a raphe in the middle, 
marking the place where the leaflet should have divided during development. It must be 
noted that the triangle lying beneath the raphe is reduced in height considerably, 
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contributing to restricting cusp mobility [23,24]. Orientation of the cusps is also 
variable: antero-posterior is more common, occurring in almost 80% of the cases, and 
both coronary arteries take origin from the anterior sinus. Usually, the raphe is located 
in the anterior cusp. In the left–right arrangement, a coronary ostium can be found in 
each sinus with the raphe invariably in the right cusp. 
The BAV requires compensatory mechanisms to be able to function appropriately [25]. 
The anatomical length of the cusp free margin is constant, but their ‘functional’ length 
must change. To compensate for free margin discrepancy, in order to match the 
geometry of full closure and opening, the cusps’ gradual folding and unfolding seems to 
be necessary. An alternative way to compensate is to extend the coaptation area and this 
is achieved by an increased bulge (doming) of the ‘cusp bellies’, which allows the cusp 
free margin to either fold or travel in upward convex arch, or both. 
Patients with BAV undergoing valve-sparing operations more often require additional 
correction of cusp pathologic conditions when compared with patients with tricuspid 
aortic valve [21]. 
 In the setting of valve-sparing operations, prolapse is the most frequent mechanism of 
bicuspid valve leading to residual incompetence after valve reimplantation within the 
graft. It more commonly involves the congenitally fused cusp, but may also be present in 
the normal non-fused cusp [26]. 
As described by the Homburg group in 2000, the geometry of the BAV needs to be 
inspected once the sinuses of Valsalva have been excised (and before reconstruction of 
the aortic root) by applying radial tension on the two commissures. This maneuver 
allows comparing the length of the two cusps [27]. In 2007, Schäfers et al. [13] reported 
the results of a series of 173 patients with repaired incompetent BAV. Among them, 78 
patients, because of root dilatation, underwent root remodeling. In this subgroup, the 
aortic valve was repaired by means of plication of the free margin in 56 cases, triangular 
resection in 33, and cusp replacement with pericardium reconstruction in one. The 
choice of repair technique was based on the cusp’s aspect: if limited tissue redundancy 
was noted, central plication sutures were placed on the free margin until both free 
margins were at identical height. If extensive tissue redundancy or limited fibrosis was 
encountered, triangular excision of cusp tissue with direct approximation of cusp tissue 
was chosen. In the presence of more extensive disorder (i.e., calcification in the raphe), 
the pathological tissue was excised and the cusp was reconstructed by implantation of 
an autologous pericardial patch (preserved in 1.5% glutaraldehyde for 3 min and rinsed 
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for 2 min). Freedom from aortic regurgitation II or greater at 5 years was 95.5% and 
freedom from reoperation at 5 years was 97%. 
In a series of 161 consecutive patients who underwent BAV repair, de Kerchove et al. 
[28] created two matched subgroups of 53 patients each. One, consisting of patients in 
whom the root was not treated (this subgroup analysis is outside the purpose of this 
review) and the other consisting of patients who underwent aortic valve reimplantation. 
In this latter subgroup, aortic cusp repair was needed in the majority of patients (93%, 
n.=49). Several different techniques were used: raphe shaving (23%), raphe resection 
and primary closure (38%), raphe resection and patch repair (11%), cusp prolapse 
repair (77%), patch repair for cusp perforation (6%), and any patch repair (17%). 
Excellent results were obtained at a 52-month follow-up: none of the patients were 
reoperated on for severe aortic incompetence and all of the patients had residual aortic 
incompetence grade of 2 or less. 
Kari et al. [29] from Stanford University reported mid-term results in 75 patients with 
BAV who underwent aortic valve reimplantation. In 50 cases, cusp free margin repair (≥ 
one cusp free margin shortening stitch) was added and it was associated to triangular 
raphe resection in seven patients and commissural suspensory neochord creation in 
three cases. This latter technique was associated to significant aortic regurgitation 
progression and was abandoned. At the mean follow-up of 2.8 years, overall freedom 
from reoperation was 90%, a log-rank test did not show difference in terms of durability 
between patients who had free margin shortening with those who did not (P=0.8), and 
similarly no difference was found according to BAV configuration type. At the time of 
latest transthoracic echocardiogram assessment (median follow-up time of 2.4 years), 
the median aortic regurgitation degree was 0 (interquartile range 0–1) and unchanged 
when compared with the early postoperative echocardiography examination. Again cusp 
repair, number of free margin sutures placed, and BAV type did not have a significant 
impact on aortic regurgitation progression over time. 
Characteristics and results of cusp repair during valvesparing operation in BAV are 
summarized in Table 3. 
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Table 3. Characteristics and results of cusp repair during valve-sparing operation in 
bicuspid aortic valve. 
 de Kerchove et al. 
[28] 
Schäfers et al. 
[13] 
Kari et al. 
[29] 
Sparing operation 58 78 75 
Valve repair 
Reimplantation 
Remodeling 
49 (93%) 
49 (100%) 
0 
78 (100%) 
0 
78 (100%) 
50 (67%) 
50 (100%) 
0 
Plication free margin 0 56 (71%) 0 
Triangular resection 0 33 (42%) 7 (9%) 
Free margin shortening 0 0 50 (67%) 
Commissural neochord 0 0 3 (4%) 
Raphe shaving    
Raphe resection and closure 12 (23%) 0 0 
Raphe resection and patch 
repair 
20 (38%) 0 0 
Cusp prolapse repair 41 (77%) 0 0 
Pericardial patch repair for 
perforation 
3 (6%) 0 0 
Patch repair 9 (17%) 1 (1.2%) 0 
Reoperation for valve failure 0 n.a. 1/50 (2%) 
 
 
Cusp repair during valve-sparing operation in children 
 
Valve-sparing root replacement is an attractive option for children with aortic root 
aneurysms when the aortic valve is functionally normal or repairable. The two most 
common scenarios for this procedure are connective tissue disorders and BAV. The 
approach of the Johns Hopkins Hospital group to correct a possible leaflet prolapse does 
not differ substantially from that used in adults and consists of midleaflet plication or 
free edge suspension with a fine Gore-Tex suture. The former is preferred in young 
patients with connective tissue disorders [30]. In a series of 56 children who underwent 
valve-sparing root replacement (78% reimplantation and 22% remodeling, 
respectively), only two (3.6%) had concomitant aortic valve repair. Regarding a possible 
cusp repair, it must be underlined that their relative contraindications for valve-sparing 
operation include marked leaflet fenestration and asymmetry; giant root with marked 
leaflet irregularities; or bicuspid valves with extensive calcification, severe prolapse 
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and/or marked fenestrations. Four patients were reoperated during follow-up for 
recurrent aortic insufficiency (all from the remodeling group), but unfortunately no 
indication whether they had concomitant valve repair during the first operation is given 
[31]. To our knowledge, no other experiences of aortic valve-sparing procedures and 
concomitant cusp repair in children have, so far, been published. 
 
 
Discussion 
 
The expanding indications of aortic valve-sparing operations to more complicated cases 
have recently generated a growing interest in cusp repair. Repairing the valve is not only 
needed when clear alterations of the cusp are detected, but also in apparently ‘normal 
valve’ to increase the coaptation length to ensure long-term durability. The techniques 
described in the literature are basically intended to correct the possible residual 
incompetence and achieve adequate coaptation height. 
 
 
Correction of the possible residual incompetence 
 
TRICUSPID AORTIC VALVE 
The main techniques to achieve the correction of residual aortic incompetence are as 
follows: 
 
(1) Central cusp plication along the nodule of Arantius. 
(2) Shortening of the free margin. 
(3) Combination of the two techniques. 
 
It makes intuitive sense that central plication is easy and fast, the nodules of Arantius 
are thick enough to hold a 6–0 suture, and reduction of the free margin length can be 
obtained millimeter by millimeter. Nevertheless, according to Labrosse et al. [20], it 
considerably increases the stress and strain on the cusp and larger stresses are 
expected, in theory, to promote tears and local calcification. In addition, central plication 
restores smaller coaptation areas than leaflet resuspension. It, therefore, stands to 
reason that free margin shortening would be the best technique for individual cusp 
correction, although it is more technically demanding and more ‘invasive’, considering 
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that the cusp free margin, except for its central portion, is usually thin. According to this, 
central plication should play a role mainly in the presence of very limited tissue 
redundancy conditioning mild prolapse. It should be emphasized that the results 
obtained by David and Armstrong [16] with these two techniques are outstanding: 
among 64 patients treated, only one needed reoperation in the long-term. Nevertheless, 
as the three-dimensional geometry of tricuspid aortic valve is complex, they recommend 
using caution when more than one cusp needs repair. According to this, it should be 
noted that in the Brussels’ series, both patients who needed reoperation for severe 
aortic insufficiency had, during the first procedure, more than one cusp repaired [18]. 
We do believe that in presence of more than one cusp requiring complex repair, the 
Bentall procedure, which has been demonstrated to be safe and durable, should be 
seriously considered even in young patients. 
Triangular resection in tricuspid valve is a more ‘invasive’ and technically demanding 
technique. According to the recommendation by Schäfers et al., it is indicated only in the 
presence of marked tissue redundancy (> 10 mm), which is an unusual presentation. 
However, cusps with strongly elongated free margin are frequently thin and the risk of 
distortion and/or tear during or after the reconstruction (either with direct suture or 
with patch insertion) should not be underestimated. A second consideration regards the 
durability of the pericardial patch in the mid-term and long-term. As calcification is 
known to develop more frequently in xenograft patches, immunological factors are 
considered to be important items. Fixation of autologous pericardium in glutaraldehyde 
solution reduces tissue retraction and promises good long-term results. Chauvaud et al. 
[32] reported that 15 min fixation in 0.625% glutaraldehyde solution reduces the 
immunologic reaction because of the stabilizing effect induced by the cross-linkage of 
collagen materials. According to this, the use of fixed autologous pericardium should be 
considered superior to that of bovine pericardium, although good preliminary results 
were reported with photo-oxidized bovine pericadium [33]  and, in limited series, with 
decellularized porcine intestinal submucosal extracellular matrix [34]. PTFE has also 
been proposed for cusp extension during aortic valve repair and initial experience in 
limited series showed promising results [35]. PTFE has been quite commonly used for 
leaflet repair in atrioventricular valves or as a leaflet or chordate substitute and has 
shown the ability to withstand prolonged mechanical stress [36]. However, long-term 
function of PTFE as a valve patch is still unclear. On the contrary, the use of PTFE suture 
along the free margin of the aortic cusp has shown excellent long-term results [16]. 
However, it must be highlighted that, in the large Homburg series, the majority of 
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patients underwent, to get a proper coaptation, a ‘simple’ plication of the central portion 
of the cusp, whereas triangular resection and pericardial patch repair were rarely used 
[21]. These data suggest that, to achieve satisfactory cusp coaptation in tricuspid aortic 
valve, in most cases, only the central plication (that is considered the less technically 
demanding and time-consuming technique) is needed. 
Commissural free margin plication is a much less used technique and the lack of data 
does not permit one to draw any definitive conclusion, although a recent finite element 
study has shown an increase in the cusp stress associated with the use of the latter 
technique [20]. Very limited clinical data also seem to lean toward a greater incidence of 
early failure [22].  
Considering the technical difficulty of the tricuspid valve complex repair, in relation 
particularly to the threedimensional geometry of the valve and to the ‘fragility’ of the 
free margin of the cusps, we recommend using the central plication whenever possible, 
as it is the easier and most reproducible technique. It must be also stressed that if the 
immediate result is not satisfactory, the plication can be easily removed or slightly 
addressed. When more than one cusp need to be repaired, the safe and durable 
alternative offered by a valve conduit, although less appealing, should not be forgotten. 
 
BICUSPID AORTIC VALVE 
Apart from the free margin plication, techniques are mainly aimed at the raphe 
assessment and precisely at the following assessments: 
 
(1) Raphe shaving. 
(2) Raphe resection and primary closure. 
(3) Raphe resection and patch repair. 
 
Observations by Robicsek et al. [25] indicate that the fused cusp is exposed to 
abnormally high stress in both diastole and systole. This could be the pathogenetic 
mechanism underlying the unfavorable evolution of this cusp toward the free margin 
elongation or calcification conditioning restricted motion. This finding suggests to shave 
or to remove the raphe if it causes an alteration of the normal opening and closing 
mechanism of the cusp. According to Schäfers et al . [13], who described precisely the 
indications to use one or the other technique, the choice of repair type is based on cusp’s 
aspect; they suggested central plication for limited tissue redundancy, triangular 
excision of cusp tissue with direct approximation for extensive tissue redundancy or 
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limited fibrosis, pathological tissue excision and cusp reconstruction bymeans of 
autologous pericardial patch for calcification in the raphe. Following this systematic 
approach, they obtained excellent freedom from reoperation at follow-up [27]. de 
Kerchove et al. [28] showed excellent results with several different techniques including 
raphe shaving, raphe resection and primary closure, raphe resection and patch repair, 
cusp prolapse repair, patch repair for cusp perforation, and any patch repair. The 
analysis of the data coming from the two more experienced centers in BAV repair 
[13,28] indicates that, to achieve durable competence of BAV, in a large number of cases, 
raphe resection is required. Among the patients who needed cusp repair in the Homburg 
series, about one-half were treated with triangular resection as well as in the Brussels’ 
series, raphe resection was utilized in a little more than half of the cases. Although the 
excellent results of these two series could lead to a broad use of these techniques, we 
strongly believe that BAV reconstruction by means of raphe resection with or without 
patch should be reserved for centers with extensive experience in valvesparing surgery 
and valve repair. 
 
 
Achieving an identical height of cusp free margin and an effective height of 7–8mm 
 
That suboptimal cusps’ coaptation is a risk factor for recurrent aortic insufficiency is 
nowadays a well established concept. The height of coaptation seems to be crucial in 
maintaining valve stability during the first year of follow-up. The functional aortic valve 
failure following valve-sparing operations, was first described by Bassano et al. [37].  
Similarly, Pethig et al. [38] in a series of 75 patients with aortic valve reimplantation and 
echocardiography follow-up identified coaptation cusp level below the inferior rim of 
the prosthesis as an independent risk factor for early procedure failure. It seems, 
therefore, crucial to recreate an anatomical aspect of the valve within the prosthesis as 
similar as possible to healthy individual’s aortic root, in which the height difference 
between aortic insertion and free margin of the cusps (effective height) ranges between 
8 and 11mm [39]. In our opinion, this concept involves the absolute need for an 
exhaustive and thorough intraoperative transesophageal echocardiogram, aimed not 
only at evaluating the valve competence, but also its three-dimensional morphology 
within the root graft. The surgeon must be aware that inadequate coaptation reserve 
increases, even in the presence of perfect competence, the risk of procedure failure. 
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In conclusion, it seems that BAV more often requires correction when compared with 
tricuspid valve. Range of the techniques varies from the ‘simple’ free margin plication 
(used in most of tricuspid aortic valve) to the more complex triangular resection with 
patch repair. Results in the literature seem to be encouraging showing that, in most 
cases, cusp repair does not affect valve competence in the mid-term and long-term. 
However, we should not forget that correction of the cusp is a delicate balance between 
undercorrection that could lead to residual prolapse and overcorrection that could lead 
to cusp restriction. Complex repair of the aortic valve in addition to root replacement 
should be reserved for experienced centers with a large volume of patients. 
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Abstract 
 
 
 
Background. We assessed whether additional cusp repair during valve-sparing aortic 
root replacement affects the echocardiographic mid-term results; a subgroup analysis 
among patients with bicuspid aortic valve (BAV) and tricuspid aortic valve (TAV) was 
performed. 
 
Methods. Between June 2002 and May 2015, 157 consecutive patients underwent 
valve-sparing aortic root replacement with the David technique. Thirty patients (19%) 
had BAV. In 19 patients (12%), cusp motion or anatomic abnormalities contributed in 
determining aortic regurgitation requiring an additional cusp repair. Mean follow-up 
was 7 ± 3.4 years. 
 
Results. The cumulative 1-, 5-, and 12-year survival rates were 98%, 94%, and 90%, 
respectively. Fourteen patients (9%) required aortic valve replacement during follow-
up. In 2 patients the underlying cause was bacterial endocarditis. Freedom from aortic 
valve reoperation was 96% at 1 year, 92% at 5 years, and 89% at 12 years. Reoperation 
rate was significantly higher (p < 0.001) in patients who received leaflet repair 
compared with patients who did not, with a freedom from reoperation at 8 years of 58% 
versus 94%. Among patients with BAV, those who did not require cusp repair had a 
freedom from reoperation at 8 years of 94%, with a significant difference compared 
with patients who received cusp repair (p = 0.04). Cusp repair did not affect reoperation 
risk in patients with tricuspid aortic valve. 
 
Conclusions. Adjunctive cusp repair seems to affect the mid-term reoperation risk in 
patients with BAV and not in patients with tricuspid aortic valve. We recommend 
caution in using this technique in case of asymmetric BAV requiring cusp repair. 
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The valve-sparing aortic root replacement (V-SARR) is currently considered a safe and 
reliable procedure with encouraging mid-term and long-term results [1, 2]. Initially 
designed for a valve with preserved cusp morphology, over the years the technique has 
been extended also to valves with anatomic abnormalities requiring an additional cusp 
repair [3, 4]. However, evidence of durability after correcting cusp abnormalities is 
limited in literature. 
 
 
Materials and Methods 
 
A total of 157 patients underwent V-SARR with the David technique at the Humanitas 
Research Hospital from June 2002 to May 2015. The local ethics committee approved 
the study and waived the need for patient consent. 
 
 
Indication for Surgery 
 
Indication for surgery was proximal aortic dilatation with or without aortic 
incompetence (AI) and lack of significant aortic cusp calcification. Age older than 60 
years [5], BAV [6], cusp prolapse, high grade of AI (≥3+), large-sized aortic root 
aneurysm (≥60 mm), and left ventricular ejection fraction of 0.40 or less were not 
considered contraindications. The procedure was performed in the setting of acute 
aortic dissection in only 1 patient. 
The operative technique has been previously reported in detail [7]. Based on surgeon 
preference, the technique proposed by Cameron and Vricella in 2005 [8], consisting 
of anchoring the polyethylene terephthalate fiber (Dacron) graft (CarboMedics, Austin, 
TX) by means of a single horizontal mattress suture at the nadir of each cusp, was used 
in 18 patients (11%). In all the other patients, the graft was anchored by means of a 
continuous horizontal row of mattress sutures at the level of the ventriculoaortic 
junction. The Gelwave Valsalva graft was invariably used. 
Additional cusp repair was required in 19 patients (7 with TAV and 12 with BAV; p < 
0.01), of whom 12 underwent single cusp repair and 7 had multiple cusp repairs. 
Preoperative and intraoperative data, according to the need for cusp repair, are listed in 
Tables 1 and 2, respectively. Cusp repair procedures were performed according to 
standard techniques [9] either after reconstruction of the aortic root (when the three-
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dimensional geometry was restored), in case of TAV, or before root reconstruction (soon 
after excision of the sinuses of Valsalva) in case of BAV. Details of cusp repair, according 
to the valve anatomy, are reported in Table 3. There were no intraoperative conversions 
to Bentall procedure. None of the patients required a second cardiopulmonary bypass 
run to revise the valve after intraoperative evaluation by transesophageal 
echocardiography. 
 
Table 1. Preoperative Dataa 
Variables All (n = 157) Cusp Repair (n = 19) No Cusp Repair(n = 138) 
Age, y 61 ± 12 52 ± 14 62 ± 11 
Sex, male 118 (75%) 17 (90%)  101 (73%) 
Hypertension 99 (63%) 9 (47%) 90 (65%) 
Diabetes 9 (6%) 1 (5%) 8 (6%) 
Smoke 64 (41%) 7 (37%) 57 (41%) 
COPD 27 (17%) 2 (10%) 25 (18%) 
Renal failure 8 (5%) − 8 (6%) 
NYHA class 
I 
II 
III 
IV 
 
79 (51%) 
47 (29%) 
29 (18%) 
2 (1%) 
 
15 (79%) 
1 (5%) 
3 (16%) 
− 
 
64 (46%) 
46 (33%) 
26 (20%) 
2 (1%) 
Marfan syndrome 6 (4%) 1 (5%) 5 (4%) 
LVEF 
≤0.40 
0.41–0.49 
≥0.50 
 
12 (8%) 
9 (6%) 
136 (86%) 
 
1 (5%) 
− 
18 (95%) 
 
11 (8%) 
9 (7%) 
118 (85%) 
Preoperative AI grade 
None/Trace 
Mild 
Moderate 
Severe 
 
35 (22%) 
25 (16%) 
50 (32%) 
47 (30%) 
 
2 (10%) 
3 (16%) 
5 (26%) 
9 (48%) 
 
33 (24%) 
22 (16%) 
45 (33%) 
38 (27%) 
Aortic valve anatomy 
Tricuspid 
Bicuspid 
 
127 (81%) 
30 (19%) 
 
7 (37%) 
12 (63%) 
 
120 (87%) 
18 (13%) 
Aortic root diameter 
<60 mm 
≥60 mm 
 
141 (90%) 
16 (10%) 
 
17 (90%) 
2 (10%) 
 
124 (90%) 
14 (10%) 
Elective surgery 156 (99%) 19 (100%) 137 (99%) 
Type A aortic dissection 
Acute 
Chronic 
 
1 (0.6%) 
5 (3%) 
 
− 
− 
 
1 (0.7%) 
5 (4%) 
Mitral incompetence (>2+) 31 (20%) 4 (21%) 27 (19%) 
Coronary artery disease 19 (12%) 1 (5%) 18 (13%) 
a Results are expressed as number (%) or mean±SD. AI = aortic incompetence; COPD = chronic obstructive pulmonary disease; LVEF 
= left ventricular ejection fraction; NYHA.=New York Heart Association. 
 
 
 
 
 
  145 
Table 2. Intraoperative Dataa 
Variables All (n= 157) Cusp Repair (n = 19) No Cusp Repair (n = 
138) 
CPB time (min) 138 ± 32 152 ± 32 136 ± 31 
Aortic cross-clamp time (min) 118 ± 25 125 ± 23 117 ± 25 
Graft size (mm) 
26 
28 
30 
32 
 
2 (1%) 
20 (13%) 
52 (33%) 
83 (53%) 
 
− 
5 (26%) 
7 (37%) 
7 (37%) 
 
2 (1%) 
15 (11%) 
45 (33%) 
76 (55%) 
Aortic arch replacement 1 (0.6%) − 1 (0.7%) 
Mitral valve repair 11 (7%) − 11 (8%) 
Coronary artery bypass graft 17 (11%) − 17 (12%) 
Radiofrequency ablation for atrial 
fibrillation 
2 (1%) 1 1 (0.7%) 
Atrial septal defect closure 3 (2%) − 3 (2%) 
a Results are expressed as number (%) or mean ±SD.  CPB = cardiopulmonary bypass. 
 
 
 
Table 3. Cusp Repair Techniques in Tricuspid and Bicuspid Aortic Valves 
Technique BAV TAV 
Free-margin shortening with running suture − 1 
Nodule of Arantius plication 4 5 
Debridement of cusp calcification 1 − 
Repair of stress fenestration 2 1 
Raphe resection and primary closure N/A 5 
Raphe shaving N/A 5 
BAV= bicuspid aortic valve; N/A= not applicable; TAV= tricuspid aortic valve. 
 
 
Echocardiographic and Clinical Follow-Up 
 
Intraoperative transesophageal echocardiography was performed after weaning from 
cardiopulmonary bypass and achieving hemodynamic stability to evaluate the dynamic 
motion and residual AI grade of the reimplanted valve. None of the patients left the 
operating room with an AI grade greater than mild. Postoperatively, transthoracic 
echocardiography was performed at 1 week, 6 and 12 months, and every year 
thereafter. 
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Patients were treated with warfarin sodium for anticoagulation only if a concomitant 
procedure required it; otherwise they were prescribed only aspirin. 
Clinical follow-up, performed by means of office visit or phone call, ranged from 1 to 12 
years (mean, 7 ± 3.4 years) and was 99% complete with a total of 2 patients lost to 
follow-up. 
 
 
Statistical Analysis 
 
Continuous variables were expressed as the mean ± SD and were analyzed by using the 
unpaired two-tailed Student’s t test. Categorical variables were presented as percentage 
and were analyzed with the X2 test or Fisher’s exact test when appropriate. Estimates for 
longterm survival and freedom from morbid events were made by the Kaplan-Meier 
method. Differences between survival curves were evaluated with the log-rank statistic. 
 
 
Results 
 
Early Results 
 
There were no intraoperative deaths. Hospital mortality was 1.2% (2 patients). In one 
case hospital death was attributable to sepsis at 4 months after reimplantation in a 
patient who had a cardiac arrest on postoperative day 4. Although resuscitation was 
successful, the patient had a devastating neurologic injury as a result of anoxia. Coronary 
angiography demonstrated no evidence of coronary button occlusion, and the cause of 
the cardiac arrest remains unclear. Another patient died of sudden cardiac arrest on 
postoperative day 6 during the rehabilitation program; post-mortem examination failed 
to identify the cause of death. 
Permanent neurologic deficit was observed in 2 patients. 
Another 2 patients had transient neurologic deficit. Four patients had a perioperative 
myocardial infarction, 3 patients had implantation of permanent transvenous 
pacemaker, and 4 patients experienced renal failure. Reexploration for bleeding was 
necessary in 16 patients. Sternal dehiscence or mediastinitis was observed in 3 patients. 
Assisted ventilation for more than 48 hours was needed in 5 patients. 
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Late Results 
 
The cumulative 1-, 5-, and 12-year survival rates were 98%, 94%, and 90%, respectively 
(Fig 1A). The 10-year survival rate of patients who underwent cusp repair and patients 
with no need of cusp repair was 95% and 89%, respectively, with no significant 
difference (p = 0.8; Fig 1B). Eight patients died during follow-up. Causes of deaths were 
cardiac related in 4 patients (2 sudden deaths and 2 heart failures). Two patients 
experienced stroke during follow-up, 4 months and 2 years after the operation. Aortic 
valve infective endocarditis developed in 2 patients, 2 and 4 years after the operation. 
 
 
 
Reoperation 
 
OVERALL. Thirteen patients experienced significant (>2+) AI and 1 patient had severe 
aortic stenosis (AS) during follow-up and required aortic valve replacement. The overall 
freedom from reoperation as a result of significant AI or severe AS was 96% at 1 year, 
92% at 5 years, and 89% at 12 years (Fig 2). The overall freedom from aortic valve 
reoperation and moderate or severe residual AI was 96% at 1 year, 92% at 5 years, and 
78% at 12 years (Fig 3). Aortic valve characteristics and mechanisms of recurrent AI or 
AS in patients who underwent aortic valve replacement are reported in Table 4. In 2 
patients, the underlying cause was bacterial endocarditis; the infection affected 1 patient 
with BAV and 1 with TAV. Neither of the valves in these 2 patients required an 
Figure 1: (A) Overall cumulative survival. (B) Cumulative survival according to need for cusp 
repair (green line) or not (blue line). 
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adjunctive cusp repair during the first procedure; at latest follow-up before the event, 1 
patient had no residual AI and the other had mild residual AI. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Overall freedom 
from aortic valve 
reoperation. 
Figure 3: Freedom from 
aortic valve reoperation and 
moderate or severe aortic 
incompetence (AI). 
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Table 4. Aortic Valve Characteristics and Mechanisms of Recurrent Aortic Incompetence 
in Patients Who Underwent Aortic Valve Replacement 
Patient Age 
(y) 
Valve 
Anatomy 
Grade of 
Preoperative 
AI 
Cusp Repair 
Technique 
AI at 
Discharge 
Cause of 
Recurrent AI 
Interval 
Time 
(mo) 
1 28 TAV None None Modearte Three cusps 
prolapse, 
technical 
problem 
1 
4 65 TAV Severe None Mild NC cusp 
prolapse 
80 
7 33 BAV Severe NC-RC cusp free-
margin 
shortening (running 
suture) 
Moderate NC-RC cusp 
retraction 
7 
8 65 TAV Severe None None NC cusp 
prolapse 
42 
23 51 TAV Severe None Mild NC cusp 
prolapse 
33 
30 45 TAV Severe None Mild NC cusp 
prolapse 
14 
45 67 TAV Moderate None Mild Unknown 33 
54 33 TAV Severe None Mild LC cusp 
prolapse 
30 
67 71 TAV Moderate None Mild Endocarditis 48 
72 36 BAV Severe NC cusp triangular 
resection 
Moderate NC cusp 
prolapse 
8 
76 33 BAV Moderate LC-RC cusp raphe 
shaving and 
nodule of Arantius 
plication 
None Aortic stenosis 
owing to cusps 
fibrosis and 
posterior 
commissure 
calcification 
96 
91 37 TAV Moderate LC cusp 
fenestration repair 
with 
pericardial patch 
Moderate Three cusp 
prolapse 
4 
105 63 BAV Moderate LC-RC cusp raphe 
resection and 
primary closure and 
NC cusp 
nodule of Arantius 
plication 
Trivial Commissure 
detachment 
(suture 
dehiscence) 
5 
166 52 TAV Trivial None None Endocarditis 29 
AI = aortic incompetence; BAV=. bicuspid aortic valve; LC = left coronary cusp; NC = noncoronary cusp; RC = right coronary cusp; 
TAV = tricuspid aortic valve. 
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A 33-year-old patient with BAV exhibited AS and underwent valve replacement at 8 
years; during the first procedure, a valve repair consisting of left coronaryright coronary 
cusp raphe shaving and nodule of Arantius plication was performed. Predischarge and 3 
and 36 months’ echocardiography showed no residual AI and no transaortic pressure 
gradient. At 70 months, moderate AI and mild-to moderate AS was documented. Two 
years later, despite a stable moderate AI, severe AS was diagnosed. On reoperation, 
strongly fibrotic cusps and calcification of the posterior commissure were found. 
 
IMPACT OF THE LEARNING CURVE AND SURGICAL TECHNIQUE. To evaluate the impact 
of the learning curve on the reoperation rate we compared the results of the patients 
who had undergone surgery in the first 3 years of experience with those treated in the 
subsequent years. Freedom from reoperation at 8 years was 85% versus 91% (p= 0.17), 
respectively. 
We also compared the freedom from reoperation of patients in whom the Valsalva graft 
was anchored to the ventriculoaortic junction by means of a single suture (Cameron-
Vricella technique) with those treated with the standard technique. Freedom from 
reoperation at 5 years was 90% versus 92% (p= 0.89), respectively. 
 
SUBGROUP ANALYSIS. Freedom from reoperation was 93% at 5 years and 91% at 10 
years for TAV and 86% at 5 years and 78% at 10 years for BAV (p= 0.07; Fig 4A). 
Freedom from aortic valve reoperation and moderate or severe residual AI was 93% at 
5 years and 89% at 10 years for TAV and 86% at 5 years and 78% at 10 years for BAV 
(p= 0.1; Fig 4B). The rate of aortic valve reoperation was significantly higher (p < 0.001) 
in patients who received cusp repair compared with patients who did not, with a 
freedom from reoperation of 78% versus 98% at 1 year and of 58% versus 92% at 8 
years, respectively (Fig 5). 
Among patients with TAV, the additional cusp repair did not significantly affect the 
freedom from reoperation (83% versus 92% at 8 years; p= 0.26; Fig 6A). Conversely, 
among patients with BAV, those who required an additional cusp repair had a 
significantly lower freedom from reoperation (50% versus 94% at 8 years; p= 0.04; Fig 
6B). Excluding the two cases of endocarditis, the results did not change significantly (p= 
0.2 for TAV and p= 0.01 for BAV), but of note, the freedom from reoperation for BAV 
with no need for cusp repair was 100% at 10 years. 
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Figure 4: (A) Freedom from aortic valve reoperation according to the valve anatomy. 
Bicuspid aortic valve (BAV; green lines) and tricuspid aortic valve (TAV; blue lines) are 
shown. (B) Freedom from aortic valve reoperation and moderate or severe aortic 
incompetence (AI) according to the valve anatomy. Bicuspid aortic valve (BAV; green lines) 
and tricuspid aortic valve (TAV; blue lines) are shown. 
Figure 5: Freedom from aortic valve reoperation according to the need for cusp 
repair (red line) or not (blue line). 
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Comment 
 
We started our experience with the V-SARR in October 2002; since then we have not 
applied any restrictions in surgical indication in terms of patient age, valve anatomy, 
grade of AI, aortic root aneurysm size, and left ventricle function. Instead, despite the 
encouraging results reported in the literature, we are reluctant to use this technique in 
urgent or emergency cases. Indeed the large majority of our patients were operated on 
electively [10, 11]. 
In our series, we have invariably used the Valsalva graft, which, once pressurized, 
generates bulging pseudosinuses without the need for any substantial variation in the 
original reimplantation technique [12]. The particular design of the graft makes it 
possible to adapt to each individual anatomy, re-creating the original root geometry 
even in the most challenging asymmetric BAV. We previously demonstrated that the 
compliance of pseudosinuses of the Valsalva graft is maintained over the years [13]. 
To evaluate the impact of the learning curve on the reoperation rate, we compared the 
results of patients who had undergone surgery in the first 3 years of experience with 
those treated in the following years. The freedom from reoperation at 8 years was not 
significantly different in the two subgroups (85% versus 91%; p = 0.17); apparently, the 
first years of our experience did not affect the overall reoperation rate. 
Figure 6: (A) Freedom from aortic valve reoperation in tricuspid aortic valve (TAV) according 
to the need of cusp repair (green line) or not (blue line). (B) Freedom from aortic valve 
reoperation in bicuspid aortic valve (BAV) according to the need of cusp repair (red line) or not 
(black line). 
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In considering the prospect of an aortic valve-sparing procedure, a deep knowledge of 
the surgical anatomy of the aortic root is mandatory. The aortic valve needs to be 
considered a functional unit composed of three structures: (1) the functional aortic 
annulus, comprising the ventriculoaortic junction and the sinotubular junction, (2) the 
aortic cusps, and (3) the three sinuses of Valsalva. Although the anatomic 
ventriculoaortic junction seems to be placed at approximately one third of the height of 
the aortic root, the surgical intraluminal ventriculoaortic junction is a virtual ring 
formed by joining the basal attachment of the aortic cusps [14, 15]. On the extraluminal 
side of the aortic root, the limit of the surgical dissection during V-SARR corresponds to 
the roof of the left atrium on the side of the noncoronary and left coronary sinus and to 
the myocardium coming from the ventricular septum and continuing laterally to the 
right ventricular outflow tract on the side of right coronary sinus [16]. Since 2008, based 
on surgeon preference, the Cameron-Vricella technique [8], consisting of placing a single 
mattress suture at the level of each cusp nadir, was used in a minority of cases (11%), 
apparently with no impact on results at 5 years (p = 0.89). We believe that what matters 
is not the number of mattress sutures that are placed to anchor the Dacron graft, but 
rather how deep into the ventriculoaortic junction the graft is lowered. To achieve a 
proper positioning of the graft, the dissection outside the aorta must be to the level 
described above, so that the prosthesis can incorporate the entire functional aortic 
annulus, thus preventing the aortic root from further dilatation. 
Valve-related complications such as thromboembolism and infective endocarditis were 
relatively rare in our series (1.2% in both cases); if the rate of thromboembolic event in 
the literature is certainly lower after V-SARR than after the Bentall procedure, the 
incidence of endocarditis seems to be comparable, at least in the younger population 
[17, 18]. In this sense, the lack of a prosthetic valve does not seem to protect patients 
from bacterial infection. However, because endocarditis is an unpredictable event that is 
probably not related to the surgical technique, we thought it best in our analysis to 
perform the survival curves also excluding the patients who had endocarditis to assess 
the freedom from reoperation without this potential bias; nevertheless, the outcomes 
did not change significantly. 
In our experience, valve anatomy per se (BAV or TAV) had no significant impact on the 
freedom from reoperation, and these data are consistent with the literature [3, 19]. 
Going deeper into the analysis, we found that the additional cusp repair significantly 
affected the reoperation risk. This finding does not appear to be in line with the largest 
published series [4, 9]. The relatively small number of patients who underwent cusp 
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repair may have affected the outcome. However, we find it necessary to make the 
following observations: first, the term “additional cusp repair” is too generic as it 
includes a wide variety of techniques ranging from a “simple” freemargin plication 
(mostly used in TAV) to the more complex triangular resection with patch repair; and 
second, the BAV more frequently requires cusp correction in comparison with TAV, and 
the type of repair needed is usually more complex. In this sense, a subgroup analysis of 
patients with the two types of valve seems to be necessary. With regard to patients with 
BAV, based on the analysis of our results, since 2011 we began to be more careful to 
treat the asymmetric valves requiring complex adjunctive cusp repair by means of  
V-SARR [6]. However, at that time the mean follow-up of approximately 4 years was not 
long enough to draw conclusions. The current investigation, with a longer follow-up 
time, shows more clearly that BAV requiring cusp repair (12 of 30 patients; 40%) is 
affected by a significantly higher reoperation rate. Conversely, BAV with minimal cusp 
abnormalities and no need for cusp repair provided excellent 10-year results. This latter 
type of BAV (type 0, according to the classification by Sievers and Schmidtke [20]) has 
usually symmetric cusps with the two commissures facing each other at 180 degrees 
and a lack of raphe or minimally represented raphe. As the V-SARR basically consists of 
a three-dimensional reconstruction of the aortic valve within a Dacron neoroot, in our 
opinion this configuration is even easier to treat than TAV, with only two reference 
points to realign symmetrically at the level of the sinotubular junction of the neoroot. 
Recently, Bavaria and colleagues [21] showed an interesting approach to V-SARR in 
asymmetric raphed BAV (type 1 Sievers). They advocate, during root reconstruction, 
respect for the native commissures orientation, and discourage the forcing of a 150- to 
210-degree geometry into a 180- to180-degree configuration. However, it must be noted 
that in this scenario, frequently a complex cusp repair including free-margin 
equalization, optimization of coaptation zone, raphe release or resection, and 
debridement of any cusp calcification is required. This means that several variables are 
added to the procedure, potentially affecting the result in terms of valve durability. 
Midterm and long-term outcomes of this subset of patients will need to be analyzed to 
validate this approach. In our series, the number of patients with BAV with cusp repair is 
not large enough to allow a further analysis of the result based on the type of repair 
performed in this subset of patients. Conversely, among patients with TAV, the cusp 
repair did not seem to affect the freedom from reoperation, even at 8 years. In this 
regard, we note that among the patients with TAV treated with additional cusp repair, 
only 1 underwent reoperation. We believe that the less technically demanding type of 
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valve repair needed in case of TAV could explain this finding. On the contrary, among 
patients with TAV who underwent reoperation, 8 of 9 did not undergo cusp repair 
during the first procedure and the large majority of them had cusp prolapse on 
reoperation. These data suggest a more aggressive approach to the TAV during 
reimplantation, in terms of cusp repair, to reduce even the smallest differences in length 
of the free margins to achieve the maximal coaptation depth. 
Finally, in a young patient with raphed BAV, the cause of valve replacement was a severe 
AS that occurred at 96 months. The “natural history” of the reimplanted BAV (which is 
not supposed to be stenotic at the time of surgery) after V-SARR is mostly unknown; 
however, its evolution toward stenosis seems to be extremely rare [22]. A possible 
explanation of this low incidence can be provided by recent studies that show that BAV 
stenosis with aortic dilatation and BAV insufficiency with root dilatation represent two 
different phenotypes [23, 24]. In conclusion, our 12 years’ experience with V-SARR 
provided satisfactory results in terms of survival and aortic valve function. The anatomy 
of the valve per se had no impact on the outcomes. Additional cusp repair seems to affect 
the mid-term reoperation risk in patients with BAV and not in patients with TAV. 
Probably the complexity of cusp repair required by the BAV with cusp abnormality 
could have had a significant impact on valve function during follow-up. Correction of 
even minimal and apparently irrelevant cusp prolapse in TAV could possibly reduce the 
reoperation risk in this subset of patients. We recommend caution in performing V-
SARR in patients with asymmetric BAV requiring a complex cusp repair. 
 
The major limitation of the current investigation is the retrospective approach of the 
analysis. Another limitation is the small number of patients who underwent additional 
cusp repair, particularly in the BAV subgroup, and this may have affected the outcomes. 
Finally, not all of the follow-up echocardiographic studies were performed at our 
institution, so that some important quantitative and qualitative factors were, in some 
cases, missing. 
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Abstract 
 
 
This retrospective analysis of a selected series of Bentall-De Bono procedures was 
carried out in order to evaluate the performance of the Carboseal composite valve graft 
(Sulzer Carbomedics Inc, Austin, TX, USA). Between October 1997 and April 2004, 120 
patients underwent aortic root replacement with the Carboseal Composite Valve Graft. 
The mean age of patients was 59.7±13.4 years (range, 21– 83 years); 96 patients (80%) 
were male. Eighty- nine patients (74.2%) had annulaortic ectasia, 10 patients (8.3%) 
post-stenotic dilatation, 3 (2.5%) post dissection aneurysm, 2 (1.7%) acute type A 
dissection and 1 (0.8%) endocarditis. The average follow-up duration was 29.2 months 
(range 2–82 months). Hospital mortality was 1.7% (2 of 120 patients). The actuarial 
survival rate (including hospital mortality) was 97.2±1.5% at 1 year, 91.6±3.5% at 3 
years and 84.0±8.0% at 5 years. Chronic renal failure was an independent risk factor for 
late mortality (P=0.02). The actuarial freedom from pseudoaneurysms at 3 years was 
higher among patients without Marfan syndrome (94.7±3.2% vs. 75.0±21.6% at 3 years, 
P<0.003). In our recent series, the Bentall-De Bono operation provided good results with 
low incidence of prosthetic related complications. Pseudoaneurysms requiring re-
operation have a higher incidence among patients with Marfan syndrome. 
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1. Introduction 
 
In order to assess the performance of the Carboseal composite valve graft (Sulzer 
Carbomedics Inc, Austin, TX, USA) we retrospectively analysed a selected series of 
Bentall-De Bono procedures. 
 
 
2. Materials and methods 
 
2.1. Patients 
 
Between October 1997 and April 2004, 120 patients underwent aortic root replacement 
with the Carboseal composite valve graft. Until November 2003 we have exclusively 
used this conduit regardless of patient’s age. After this date we also started implanting 
‘home made’ biological conduits (pericardial valve, Mosaic® Medtronic Inc., Minneapolis, 
MN, USA and a tubular graft, Sulzer Vascutek, Renfrewshire, Scotland, UK) in patients 
aged >65 years. So far our experience with biological conduits is limited to 12 cases. 
Patients preoperative characteristics are listed in Table 1. 
 
 
2.2. Operative technique 
 
A median sternotomy was performed and hypothermic cardiopulmonary bypass (32 °C) 
was instituted with cannulation of the ascending aorta, aortic arch or femoral artery and 
right atrium. Myocardial protection was achieved with a combination of antegrade and 
retrograde cardioplegic solution and topical cooling with 4 °C saline solution. The 
‘button technique’ [1] was used in all cases and all patients received the Carboseal 
composite valve graft. If aortic dissection was present, continuity between the separated 
layers of the aorta was restored using gelatin-resorcinol formaldehyde biologic glue 
(GFR; F.I.I, Saint-Just Malmont, France) [2] and the distal anastomosis was further 
reinforced with an inner and outer Teflon felt strip. Concomitant procedures included 
planned coronary artery bypass grafting in 18 patients (15%), coronary artery bypass 
grafting due to perioperative technical problems in 4 patients (3%), mitral valve 
replacement in 4 patients (3%), mitral valve repair in 3 patients (2%) and left atrial 
ablation for atrial fibrillation in 3 patients (2%). The mean cardiopulmonary bypass 
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time was 99±30 min (range 61–213 min) and the mean aortic cross-clamp time was 
82±21 min (range 52–159 min). 
 
 
Table 1. Preoperative patients characteristics 
Characteristic N=120 
Age (years) 59.7±13.4 
Sex (male) 96 (80) 
NYHA functional class 
I 
II 
III 
IV 
 
24 (20) 
57 (48) 
39 (32) 
− 
Left ventricular ejection fraction 
>60% 
40–59% 
<39 
 
66 (55) 
44 (37) 
10 (8) 
Marfan syndrome 4 (3) 
Indications for operation  
Primary operation 
Anuloaortic ectasia 
Poststenotic dilatation 
Acute aortic dissection 
Chronic aortic dissection 
Endocarditis 
105 (87) 
89 
10 
2 
3 
1 
Reoperation 
Aortic valve prosthesis 
Valsalva sinus aneurysm after AVR or AAR 
Valsalva sinus aneurysm after CABG 
15 (13) 
1 
11 
3 
Values are mean±1 SD. Numbers in parentheses are percent. NYHA=New York Heart Association. AAR=ascending aorta replacement. 
AVR=aortic valve replacement. 
 
 
2.3. Follow-up 
 
Follow up was conducted between March and April 2004 and was 96% complete. The 5 
patients, whose follow-up was incomplete, were censored at the time of their last follow-
up. The average follow-up duration was 29.2 months (range 2–82 months). 
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2.4. Statistical analysis 
 
Univariate and multivariate analysis to determine whether any single factor influenced 
hospital mortality was not carried out due to the low incidence (2 cases). Preoperative, 
intraoperative and postoperative variables were analysed for their influence on 
mortality during follow-up. Variables considered were: sex, age, NYHA class, chronic 
renal insufficiency (creatinine levels greater than or less than 1.9 mg/dl), left ventricle 
ejection fraction (<40% or >40%), coronary artery disease, Marfan syndrome, bicuspid 
aortic valve, indication for operation (anuloaortic ectasia, post-stenotic dilatation, 
dissection, endocarditis) previous aortic valve or aortic operation, cross clamping time, 
cardiopumonary bypass time, concomitant procedures and postoperative complications 
(myocardial infarction, respiratory insufficiency, bleeding, neurologic deficit, 
hemodialysis). Variables achieving a P-value of less than 0.2 in the univariate analysis 
were examined using Cox proportional hazard regression. Estimates for long term 
survival and freedom from morbid events were made with the Kaplan– Meier method. 
Differences between survival curves were evaluated with the log-rank statistic. 
 
 
3. Results 
 
3.1. Early mortality 
 
Hospital mortality rate, defined as all patients who died within 30 days after the 
operation or during initial hospitalisation was 1.7% (2 of 120 patients). Cause of death 
was acute prosthetic endocarditis complicated by acute myocardial infarction and sepsis 
in one patient and multiple organ failure (MOF) in the other patient. Because of the small 
number of the events (2 cases), unvariate and multivariate analysis was not carried out. 
 
3.2. Early morbidity 
 
Early (<24 h) re-intervention for excessive bleeding was necessary in 11 patients 
(9.2%). Perioperative myocardial damage (serum creatinine kinase level 300 IU/l, with 
a creatinine kinase MB isoenzyme fraction 3%) occurred in 4 patients (3.3%). 
Haemodialysis for renal insufficiency was necessary in 3 patients (2.5%). Permanent 
neurological deficits developed in 2 patients (1.7%). Transient neurological deficits 
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involving left or right side weakness were observed in 2 patients (1.7%) and in both 
cases the deficit was fully recovered. One patient (0.8%) developed prosthetic 
endocarditis and died from sepsis 15 days after the operation. 
 
 
3.3. Late mortality 
 
There were 7 (6.4%) late deaths. Causes of death were cerebral haemorrage in 3 
patients, ischemic heart disease in 1 patient, uncontrollable bleeding during reoperation 
in 2 patients and cholecystic cancer in 1 patient. Overall actuarial survival is shown in 
Fig. 1. The survival rate was 97.2±1.5% at 1 year, 91.6±3.5% at 3 years and 84.0±8.0% at 
5 years. The difference in survival between Marfan and non-Marfan patients was not 
significant (P=0.584). Univariate analysis showed a significant association between late 
death chronic renal insufficiency (P<0.001), left ventricle ejection fraction (LVEF) <40% 
(P=0.04) and re-operation on the aortic root (P=0.04). In the Cox multivariate analysis 
chronic renal insufficiency (creatinine levels greater than 1.9 mg/dl) was found to be the 
only independent risk factor for late mortality (P=0.02; OR=11.5). The results of 
univariate and multivariate analysis are reported in Table 2. 
 
 
 
 
 
 
 
 
 
 Figure 1: Overall actuarial survival. 
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Table 2. Univariate and multivariate analysis of late mortality 
Variable Univariate P value Odds ratio              Multivariate 
95% Confidence 
           interval 
 
P value 
Chronic renal 
insufficiency 
<0.001 11.5 1.29–103.70 0.02 
LVEF <40% 0.04    
Redo on the aortic root 0.04    
LVEF=left ventricle ejection fraction. 
 
 
3.4. Re-operations 
 
Re-operation as a result of complications in the composite valve graft procedure was 
necessary in 6 (5.5%) patients, 3 to 65 months after primary operation.  
Pseudoaneurysm at the aortic or coronary ostial suture lines occurred in 4 (3.5%) 
patients, 2 of which had Marfan syndrome. All patients with pseudoaneurysm except 
one were re-operated at our institute and survived the operation. The other patient 
underwent re-operation in another hospital and died from uncontrollable bleeding 
during the procedure. 
Two more patients required re-operation for prosthetic valve endocarditis, where the 
composite valve graft was replaced with an aortic homograft root. One of them died 
during the operation from uncontrollable bleeding. Freedom from re-operation due to 
complications of the composite valve graft procedure was 97.9±1.4% at 1 year, 
93.8±3.2% at 3 years and 78.1±10.4% at 5 years (Fig. 2). The rate of freedom from re-
operation for patients with Marfan syndrome was lower than that of the remaining 
patients (75.0±21.6% vs. 94.7±3.2% at 3 years), and the difference was significant 
(P=0.003). 
 
 
3.5. Operations on the remaining aorta 
 
Three patients (2.7%) underwent subsequent operations for aneurismal disease of the 
abdominal aorta respectively 3, 7 and 15 months after the initial operations. None of 
them had Marfan syndrome. The freedom from operation on the remaining aorta was 
98.5±1.4% at 2 years, 95.9±2.9% at 3 years and 91.5±5.1% at 5 years. 
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3.6. Prosthetic endocarditis 
 
Two patients (1.8%) developed prosthetic valve endocarditis respectively 3 and 19 
months after the operation. The infected valve conduit was replaced in both cases by a 
homograft aortic root. The first patient, as previously mentioned, died during the re-
operation from uncontrollable bleeding; the second made a complete recovery and, at 
the time of the last follow-up, was in NYHA class I. The freedom from prosthetic 
endocarditis was 99.1±0.8% at 1 year, and 90±7.9% at 5 years. 
 
3.7. Thromboembolism 
 
Thromboembolic events occurred in 2 patients (1.8%). Both of them had a stroke and 
survived the event, but with a permanent neurological deficit. The freedom from 
thromboembolism at 5 years was 98±1.4%. 
 
 
 
 
 Figure 2: Freedom from re-operation due to complications of the 
composite valve graft procedure. 
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3.8. Anticoagulant-related complications 
 
Three patients (2.7%) suffered cerebral haemorrhage respectively 31, 35 and 37 months 
after the initial operation. All of them died. The freedom from anticoagulantrelated 
complications was 97±2.0% after 2 years, and 94.4±3.2% after 5 years. 
When including death, re-operation, endocarditis, thromboembolism and anticoagulant-
related complications as events, the event free survival was 95.3±2.0% at 1 year, 
79.5±5.5% at 3 years and 61.8±10.3% at 5 years (Fig. 3). 
 
 
 
 
 
4. Discussion 
 
Composite valve graft replacement is the most radical mode of treating the combined 
disease of the aortic valve and aortic root. Although our experience began in 1997, from 
October 2002 onwards we have only used this approach in cases of gross structural 
defects of the aortic valve, preferring the aortic valve sparing operations [3] when the 
anatomy is suitable for repair.  
Four patients underwent unscheduled bypass grafting because of electrocardiogram’s 
ischemia soon after the weaning from CPB. Intra-operative transesophageal 
echocardiogram documented a hypokinetic left ventricular anterior wall in two cases 
and hypokinetic left ventricular posterior wall in the other two. The treatment consisted 
 Figure 3: Event free survival.
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of safenous vein grafting of either left anterior descending artery or right coronary 
artery, depending on the area involved. A kinking at the coronary ostium site was 
supposed to be the cause in all four cases. 
Two patients (1.8%) experienced an early stroke. Both of them had risk factors for 
adverse cerebral outcome. The first was an 80-year-old patient with previous cerebral 
events; the second, because of ischemia after the weaning from the cardiopulmonary 
bypass (CPB) requiring a venous graft on the right coronary, had a long cross-clamping 
time (158 min) and CPB time (187 min). 
The most frightening late complication within our group of patients was the 
anticoagulant-related cerebral haemorrhage that occurred in 3 cases and caused death 
in all of them. The reasons were patient related: the uncontrolled usage of 
anticoagulation and postponement of routine controls. It is well known that 
antithrombotic therapy with coumarin derivates carries a substantial risk of bleeding 
that varies with the drug used, the intensity of the anticoagulant effect and the clinical 
circumstances of individual patients. Abe and associates [6] showed, in patients with a 
CarboMedics biliflet valve in the aortic position, approximately 1.1%/yr thromboemboli 
or thrombosis with an international normalised ratio (INR) of 2.0 to 3.5. Wang and 
associates [7] with the same valves, used a target INR of 1.5 and observed 
thromboemboli in 2.7%/yr. For this reason, we recommend to our patients a target INR 
of 2.5 (range 2–3) [8]. 
Although our cut-off for the use of biological prosthesis is aged >65 years, 35% of our 
patients, though ‘elderly’, received a mechanical conduit. At the beginning of our 
experience we considered not reliable ‘home made’ biological conduits and we used to 
perform the Bentall-De Bono operation exclusively with mechanical conduits. More 
recently, on the basis of other authors experience [15] we started using, in patients aged 
>65 years, a ‘home made’ conduit. This consisted of a pericardial valve (Mosaic® 
Medtronic Inc., Minneapolis, MN, USA) and a tubular graft (Sulzer Vascutek, 
Renfrewshire, Scotland, UK), preserving mechanical prosthesis only to patients having 
thromboembolic problems. 
Pseudoaneurysms occurred in 4 patients; the leak was localised at the proximal suture 
line in 2 cases and at the coronary ostial suture line in the other 2 cases. Hilgenberg and 
associates [9] reported no re-operation for coronary ostial pseudoaneurysm. However, 
the incidence of this complication with the button technique in other series varies from 
3.1% to 9% [1,4,10]. Miller and Mitchell [11] describe the use of a ‘life saver’ or 
doughnut of Teflon felt or autologus pericardium (tanned in 0.625% glutaraldehyde 
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solution for 10 to 15 min) placed around the coronary ostium on the adventitional 
aspect to prevent tearing of tissues. We did not use any reinforcement of the coronary 
ostial suture lines in any of the patients. It must be said that both patients with 
pseudoaneurysms at the coronary ostial suture line had Marfan syndrome, which is well 
known to be associated with severe medial cystic necrosis of the ascending aorta (grade 
4). In consistence with other experiences [4,5], our study suggests that suture line 
reinforcement in patients with connective disorders must probably be taken into 
consideration. 
The GFR glue was used in case of acute aortic dissection (2 patients) to obliterate the 
false lumen and reinforce the aortic layers. The use of tissue glue in the treatment of this 
pathology has been reported to reduce significantly the mortality [12]. Nevertheless, 
recent reports [13,14] have documented the necrosis of the arterial wall after 
application of glue and this is supposed to be one of the causes of subsequent formation 
of pseudoaneurysms. Considering that we still do not have a perfect glue, we think we 
may pay the small price of occasional pseudoaneurysm formation for the greater benefit 
of improving survival in acute type A dissection. 
In conclusion we assume that composite graft aortic root replacement is the treatment 
of choice in many pathologic conditions affecting the aortic root and the aortic valve. In 
our recent series (mean follow-up time is 29.2 months), the Bentall-De Bono operation 
provided good results with low incidence of prosthetic related complications. Given that 
longer follow up is needed to draw definitive conclutions, we thus believe that 
aggressive use of the Bentall- De Bono operation is appropriate if aortic valve surgery is 
necessary in patients with even moderate ascending aorta dilatation. 
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Abstract 
 
 
Background. Composite valve graft replacement is currently the treatment of choice for 
a wide variety of lesions of the aortic root and the ascending aorta. In this study we 
report our experience with aortic root replacement using a composite graft. 
 
Methods. Between October 1978 and May 2001, 274 patients (79.6% male and 20.4% 
female) with a mean age of 53.5 years underwent composite graft replacement of the 
aortic root. One hundred sixty-one patients (70.8%) had annuloaortic ectasia and 46 
(16.8%) aortic dissection. The classic Bentall technique was used in 94 patients (34.3%), 
the “button technique” in 172 patients (62.8%), and the Cabrol technique in 8 patients 
(2.9%). 
 
Results. The early mortality rate was 6.9% (19 of 274 patients). Cardiopulmonary 
bypass time longer than 180 minutes and associated coronary artery bypass grafting 
were found to be independent risk factors of early mortality. The actuarial survival rate 
was 77.7% at 5 years and 63% at 10 years. The independent risk factors for late 
mortality were coronary artery disease, chronic renal failure, and postoperative dialysis. 
The actuarial freedom from reoperation on the remaining aorta was higher among 
patients without Marfan syndrome (94.6% versus 79.6% at 10 years, p = 0.008). 
 
Conclusions. Composite valve graft replacement can be performed with low hospital 
mortality and morbidity. The button technique offers some advantages and should be 
used whenever possible. In case of acute aortic dissection root replacement is usually 
not necessary. Marfan patients should be treated with early root replacement before 
dissection occurs. 
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Composite valve graft implantation described first in 1968 by Bentall and De Bono [1] is 
a well-documented technique of aortic root replacement used for a large spectrum of 
pathologic conditions involving the aortic valve and the ascending aorta [2– 4]. In the 
present study we have evaluated the results of our 23-year experience with aortic root 
replacement (ARR) using a composite valve graft in 274 patients. 
 
 
Material and Methods 
 
Patients 
 
From October 1978 to May 2001, 274 patients underwent ARR using composite valve 
graft. Two hundred eighteen patients (79.6%) were male and 56 were female (20.4%). 
The mean age (± one standard deviation) was 53.5 ± 14.5 years (range, 13 to 80). Thirty-
five patients (12.8%) had Marfan syndrome, 2 had Behçet’s disease, and 1 had Turner 
syndrome. Twenty patients (7.3%) were in New York Heart Association (NYHA) 
functional class I, 84 (30.7%) in functional class II, 113 (41.2%) in functional class III, 
and 57 (20.8%) in functional class IV. 
The most common indication for operation was annuloaortic ectasia (161 patients, 
58.8%). Thirty-nine patients (14.2%) had previously undergone surgical intervention on 
the aortic valve or ascending aorta or both. They required reoperation because of 
progressive dilatation of the Valsalva sinuses in 34, prosthetic aortic valve endocarditis 
in 4, and acute aortic dissection in 1. The patients’ profiles are reported in Table 1. 
 
 
Operative Techniques 
 
A standard median sternotomy was performed. Cardiopulmonary bypass (CPB) was 
instituted by cannulation of the ascending aorta, aortic arch, or femoral artery 
(depending on the extension of the aneurysm and the presence of dissection) and the 
right atrium or the superior and inferior vena cavae. Myocardial protection was 
obtained by antegrade administration of cold hyperkalemic crystalloid cardioplegia and 
topical cooling with 4°C saline solution. 
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Table 1.  Patient Characteristics 
Characteristic No. (%) 
Number of patients 274 
Sex 
Male 
Female 
 
218 (79.6) 
56 (20.4) 
Age (years) 
Mean ± SD 
Range 
 
53.5 ± 14.5 
13-80 
NYHA class 
I 
II 
III 
IV 
 
20 (7.3) 
84 (30.7) 
113 (41.2) 
57 (20.8) 
Marfan syndrome 35 (12.8) 
Behçet disease 2 (0.7) 
Indications for operation 
Primary operation 
Anuloaortic ectasia 
Aortic dissection 
Acute 
Chronic 
Poststenotic dilatation 
Endocarditis 
Reoperation 
Aortic valve prosthesis 
endocarditis 
Valsalva sinus aneurysm after 
AVR or AAR 
Acute aortic dissection 
 
235 (85.8) 
161 (68.5) 
46 (19.6) 
18 
28 
25 (10.6) 
3 (1.3) 
39 (14.2) 
 
4 (10.3) 
 
34 (87.1) 
1 (2.6) 
AAR = ascending aorta replacement or repair; AVR = aortic valvevreplacement; NYHA = New York Heart Association. 
 
 
For the first 94 patients (34.3%) the classic Bentall operation [1] with inclusion and 
wrapping technique was used. In 1994 the Bentall procedure was abandoned in favor of 
the “button technique” [2– 4]. Since then it has been used in 172 patients (62.8%). The 
coronary reimplantation suture lines were rarely reinforced externally with a Teflon 
strip. The Cabrol technique [5, 6] was used in 8 patients (2.9%). This method of 
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coronary reimplantation was utilized only in case of extreme aortic dilatation or 
reoperation because of difficult mobilization and approximation of coronary arteries to 
the aortic graft. 
In case of acute aortic dissection a hemiarch replacement was usually performed using 
the open technique. Nevertheless 3 patients required a total arch replacement. In 4 
patients the dissection was limitated to the ascending aorta and a closed distal 
anastomosis was performed. The continuity between the separated layers of the aorta 
was restored using gelatin-resorcineformaldehyde glue (GRF) and the distal 
anastomosis was furtherly reinforced with an inner and outer felt strip of Teflon. 
Concomitant procedures included coronary artery bypass grafting in 23 patients (8.4%), 
mitral valve replacement in 5 (1.8%), extra-anatomic aorto-aortic bypass in 2, and atrial 
septal defect repair in 1. Thirty-one patients (11.3%) had associated aortic arch 
replacement. 
Cerebral protection was obtained with deep hypothermia with circulatory arrest 
(DHCA) in 15 patients, DHCA and retrograde cerebral perfusion in 1, and antegrade 
selective cerebral perfusion with moderate systemic hypothermia in 26 [7]. Mean 
duration of cardiopulmonary bypass (CPB) was 153 ± 49.1 minutes (range, 92 to 425), 
and mean aortic cross-clamp time was 106.6 ± 32.4 minutes (range, 55 to 305). 
A Björk-Shiley composite graft prosthesis (Shiley Inc., Irvine, CA) was used in 80 
patients (29.2%); a Sorin composite graft (Sorin Biomedica S.P.A., Saluggia, Italy) in 56 
(20.4%); a St. Jude composite graft (St. Jude Medical Inc., St. Paul, MN) in 35 (12.8%); a 
Carbomedics composite graft (Carbomedics Inc., Austin, TX) in 70 (25.6%); and an ATS 
(ATS Medical Inc., Minneapolis, MN) in 33 (12%). 
 
 
Follow-Up 
Of all hospital survivors, 239 (93.7%) were available for follow-up in intervals ranging 
from 3 months to 265 months (mean, 62.7) with a total of 1,431 patients-years. Follow-
up information was obtained by our direct examination or by correspondence with the 
patient. The date of last inquiry was between May and October 2001. Postoperative 
complications were analyzed according to the “Guidelines for reporting morbidity and 
mortality after cardiac valvular operations” [8]. 
 
 
 
  180 
Statistical Analysis 
 
Statistical analysis was performed with SPSS 8.0 Statistical software (SPSS, Chicago, IL). 
Continuous variables were expressed as the mean ± SD and were compared with 
unpaired two-tailed t test. Categorical variables were analyzed with a Χ2 test or Fisher’s 
exact test where appropriate. All variables that achieved p less than 0.2 in the univariate 
analysis were included in a multivariate model and examined by stepwise logistic 
regression for early mortality, and Cox multivariate analysis for late mortality. All 
variables analyzed are shown in Table 2. Survival and event-free data were analyzed 
with Kaplan- Meier actuarial techniques for estimation of survival probabilities and 
compared with log-rank tests. 
 
 
Table 2. All Variables Analyzed by Univariate Analysis With Respect to Early and Late 
Mortality 
Sex 
Age (13–40; 41–60; 61–70; 71–80 years) 
New York Heart Association class (I, II, III, IV) 
Marfan syndrome 
Annuloaortic ectasia 
Aortic dissection (acute, chronic) 
Aortic dissection (acute, chronic) 
Associated coronary artery disease 
Chronic renal failure 
Reoperation 
Cardiopulmonary bypass time (≤180, >181 minutes) 
Clamping time (≤120, >121 minutes) 
Emergency operation 
Aortic arch replacement 
Coronary artery bypass grafting 
Postoperative dialysis 
Cardiac complications 
Postoperative pulmonary insufficiency 
Postoperative sepsis 
Postoperative bleeding 
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Results 
 
Early Mortality 
 
The overall early mortality rate (defined as death within 30 days or during initial 
hospitalization) was 6.9% (19 of 274 patients). Cause of death was operative myocardial 
infarction in 5 patients, cardiac arrest in 4, uncontrollable bleeding in 3, multiple organ 
failure in 2, myocardial failure with impossible weaning from CPB in 2, severe 
neurologic damage in 1, respiratory insufficiency in 1, and pulmonary 
thromboembolism in 1. In the univariate analysis (Table 3), coronary artery disease (p = 
0.009), CPB time (p < 0.001), aortic cross-clamp time (p = 0.025), associated coronary 
artery bypass graft surgery ([CABG] p = 0.013), cardiac complications (p = 0.003), 
postoperative dialysis (p = 0.002), and sepsis (p = 0.014) were risk factors for early 
death. Multivariate analysis indicated CPB time longer than 180 minutes (p < 0.001; 
odds ratio [OR] = 12.5) and CABG (p = 0.025; OR = 4.6) as independent risk factors for 
early mortality (Table 3). 
 
 
Early Morbidity 
 
Cardiac complications occurred in 33 patients (12%) and were associated with an 
increased risk of early death on univariate analysis. The patients operated on using the 
Cabrol technique had an high incidence of these complications (3 of 8 [37.5%] versus 30 
of 266 [11.3%]). All 3 patients sustained myocardial infarction and 2 of them died. 
Thirteen patients had persistent or recurrent atrial fibrillation, 8 from complete heart 
block requiring pacemaker implantation, 3 from ventricular tachycardia/ fibrillation; 1 
from myocardial infarction, 1 from endocarditis, 1 from cardiac tamponade, and 1 from 
left ventricular failure. 
Fifteen patients (5.5%) sustained respiratory insufficiency requiring prolonged 
mechanical ventilation (more than 48 hours). Sepsis occurred in 15 patients (5.5%) and 
was associated with an increased risk of early mortality (p = 0.014). Renal insufficiency 
requiring dialysis observed in 9 patients (3.3%) was associated with a higher mortality 
rate (44.4% compared with 5,7%; p = 0.002). Nine patients (3.3%) required 
rethoracotomy for bleeding: 6 (5.9%) underwent the classic Bentall or Cabrol procedure 
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and 3 (1.7%), the button technique. Permanent neurologic deficits developed in 4 
patients (1.5%). 
 
 
Table 3. Univariate and Multivariate Analysis for Early Mortality 
       Multivariate  
Variables Patients 
No. 
Patients  
% 
Death  
No. 
Death 
% 
Univariate 
p Value 
Odds 
Ratio 
95% 
Confidence 
Interval 
p Value 
Endocarditis 
No 
Yes 
 
267 
7 
 
97.4 
2.6 
 
17 
2 
 
6.4 
28.6 
 
0.078 
 
   
Associated CAD 
No 
Yes 
 
 
245 
29 
 
 
89.4 
10.6 
 
 
13 
6 
 
 
5.3 
20.7 
 
 
0.009 
   
Chronic renal failure 
No 
Yes 
 
 
267 
7 
 
 
97.4 
2.6 
 
 
17 
2 
 
 
6.4 
28.6 
 
 
0.078 
   
CPB time (minutes) 
≤180 
>181 
 
 
224 
50 
 
 
81.8 
18.2 
 
 
8 
11 
 
 
3.6 
22 
 
 
<0.0001 
 
 
12.5 
 
 
3.9–40.3 
 
 
<0.001 
Clamping time 
(minutes) 
≤120 
>121 
 
 
207 
67 
 
 
75.5 
24.5 
 
 
10 
9 
 
 
4.8 
13.4 
 
 
0.025 
   
Emergency 
operation 
No 
Yes 
 
 
249 
25 
 
 
90.9 
9.1 
 
 
15 
4 
 
 
6.0 
16.0 
 
 
0.061 
   
CABG 
No 
Yes 
 
242 
23 
 
91.6 
8.4 
 
14 
5 
 
6.6 
14.3 
 
0.013 
 
4.6 
 
1.2–17.7 
 
0.025 
Postoperative 
dialysis 
No 
Yes 
 
 
265 
9 
 
 
96.7 
3.3 
 
 
15 
4 
 
 
5.7 
44.4 
 
 
0.002 
   
Cardiac complication 
No 
Yes 
 
 
241 
33 
 
 
88 
12 
 
 
12 
7 
 
 
5.0 
21.2 
 
 
0.003 
   
Pulmonary 
insufficiency 
No 
Yes 
 
 
259 
15 
 
 
94.5 
5.5 
 
 
16 
3 
 
 
6.2 
20 
 
 
0.076 
   
Sepsis 
No 
Yes 
 
259 
15 
 
94.5 
5.5 
 
15 
4 
 
5.8 
26.7 
 
0.014 
   
CABG = coronary artery bypass grafting; CAD = coronary artery disease; CPB = cardiopulmonary bypass 
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Late Mortality 
 
There have been 57 late deaths (22.3%). The main cause of death was chronic heart 
failure. The other causes of late death are listed in Table 4. Overall actuarial survival of 
the 274 patients is shown in Figure 1. The survival rate was 77.7% at 5 years, 63% at 10 
years, and 33.4% at 20 years. The survival rate of the patients with Marfan syndrome 
was lower than that for the remaining patients (61.9% versus 58.8% and 57.7% versus 
29.4% at 10 and 15 years respectively) but the difference was not significant (p = 0.785; 
Fig 2A). Moreover Marfan patients with dissection demonstrated a 10-year survival of 
only 42.2% ± 13.4% whereas no-dissection Marfan patients demonstrated a long-term 
survival of 64% ± 26.3%.  
Patients operated on for aortic dissection had a lower long-term survival rate compared 
with the remaining patients (65% and 58.7% versus 53.6% and 38.1% at 10 and 15 
years respectively; Fig 2B). 
Univariate analysis (Table 5) showed a significant association between late death and 
NYHA III-IV (p = 0.004) associated coronary artery disease (p = 0.05), endocarditis (p = 
0.031), chronic renal insufficiency (p = 0.032), and postoperative dialysis (p = 0.028). 
In the Cox multivariate analysis, associated CAD (p = 0.028; OR = 2.3), chronic renal 
failure (p = 0.012, OR = 4.0), and postoperative dialysis (p = 0.039; OR = 2.9) were 
independent risk factors for late mortality (Table 5). 
 
Table 4. Causes of Late Deaths 
Cause Number 
Congestive heart failure 13 
Stroke 6 
Prosthetic endocarditis 4 
Myocardial infarction 5 
Sudden death 11 
Rupture of thoracic aorta 4 
Cardiac arresta 1 
Suicide 1 
Unknown 12 
Total 57 
a The patient died during operation for abdominal aortic aneurysms. 
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 Figure 1: Actuarial survival rates 
(including hospital mortality) of 
the 274 patients. Percent survival 
± SE is 88.6 ± 1.9 at 1 year, 77.7 ± 
2.9 at 5 years, 63.0 ± 4.3 at 10 
years, 54.7 ± 5.1 at 15 years, and 
33.4 ± 8.2 at 20 years. Number of 
patients at risk at yearly intervals 
for years 0 through 20, 
respectively, is 274, 228, 184, 149, 
127, 106, 92, 73, 65, 57, 53, 40, 34, 
26, 18, 16, 15, 13, 9, 2, and 2.  Figure 2: (A) Actuarial survival rates of 
the patients with Marfan 
syndrome(dashed lines) and without 
Marfan syndrome (solid lines); the 
difference between the two groups was 
not significant (p = 0.785). Percent 
survival ± SE for patients with Marfan 
syndrome is 94.3 ± 3.9 at 1 year, 80.6 ± 
8.3 at 5 years, 70.6 ± 11.9 at 10 years, 
29.4 ± 16.4 at 15 years, and 0 at 20 
years; number of patients at risk yearly 
for years 0 through 16, respectively, is 
35, 30, 26, 22, 17, 13, 12, 9, 9, 8, 6, 3, 3, 
2, 1, 1, and 1. Percent survival for no 
Marfan syndrome is 87.8 ± 2.1 at 1 year, 
77.3 ± 3.1 at 5 years, 62.0 ± 4.6 at 10 
years, 57.7 ± 5.2 at 15 years, and 37.6 ± 
8.9 at 20 years; number of patients at 
risk yearly for years 0 through 20, 
respectively, is 239, 198, 156, 126, 110, 
92, 79, 64, 56, 49, 47, 37, 30, 24, 17, 15, 
14, 14, 9, 2, and 2. 
  
(B) Comparison of actuarial survival of 
patients with aortic dissection (dashed 
lines) and without aortic dissection 
(solid lines;  p = 0.106). Percent survival 
with aortic dissection is 91.3 ± 4.2 at 1 
year, 63.0 ± 8.5 at 5 years, 53.6 ± 9.5 at 
10 years, 38.1 ± 11.8 at 15 years, and 
25.4 ± 13.0 at 20 years; number of 
patients at risk yearly for years 0 
through 20, respectively, is 46, 40, 32, 
24, 21, 16, 15, 14, 12, 12, 10, 6, 5, 4, 3, 3, 
2, 2, 2, 1, and 1. Percent survival for all 
other patients is  88.1 ± 2.2 at 1 year, 
80.1 ± 3.0 at 5 years, 65.0 ± 4.8 at 15 
years, 58.7 ± 5.6 at 15 years, and  33.8 ± 
10.1 at 20 years; number of patients at 
risk yearly for years 0 through 20, 
respectively, is 288, 188, 150, 124, 106, 
88, 76, 59, 52, 45, 43, 33, 28, 22, 15, 13, 
12, 12, 7, 1, and 1 
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Table 5. Univariate and Multivariate Analysis of Late Mortality 
   Multivariate  
Variables Univariate 
p Value 
Odds 
Ratio 
95% 
Confidence 
Interval 
p Value 
Preoperative NYHA 
III/IV 
 
0.004 
   
Associated CAD 0.055 2.3 1.08–4.78 0.028 
Aortic dissection 0.067    
Endocarditis 0.031    
Chronic renal failure 0.032 4.0 1.35–12.01 0.012 
Postoperative dialysis  
0.028 
 
2.9 
 
1.05–8.28 
 
0.039 
CAD = coronary artery disease; NYHA = New York Heart Association. 
 
 
Late Morbidity 
 
Thromboembolic events (TE) occurred in 9 patients (3.3%) and all of them had a stroke. 
Two patients died. The linearized rate of TE was 0.63/100 patient-years. Figure 3A 
shows the actuarial freedom from TE. At 15 years the actuarial freedom from TE was 
90.9% ± 3.1%. 
Thirteen patients (4.7%) had anticoagulant-related bleeding events necessitating 
hospital admission or blood transfusion or resulting in death. Five patients had cerebral 
hemorrhage and 4 of them died. Eight patients had gastrointestinal bleeding or 
retroperitoneal hematoma or both. The linearized risk of anticoagulant-related 
hemorrhage was 0.91/100 patient-years. Estimates for freedom from bleeding 
complications are shown in Figure 3B. 
In 5 patients (1.8%) prosthetic valve endocarditis developed (1 early and 4 late). Two 
patients underwent reoperation (1 died) and 3 were treated with medical therapy (1 
survivor). The linearized risk per 100 patient-years of prosthetic valve endocarditis 
(early and late) was 0.35. The actuarial freedom from endocarditis is shown in Figure 
4A. 
Four patients underwent reoperation for pseudoaneurysm of the coronary ostial suture 
line. In 2 of them the classic Bentall operation was used (2.1%) and in the other 2 (1 
with Behçet’s disease) the button technique was used (1.2%). The linearized rate of 
reoperation for pseudoaneurysm was 0.28/100 patient-years. Freedom from 
reoperation due to pseudoaneurysm for the classic Bentall and for the button technique 
was, respectively, 98.8% and 98.8% at 5 years, 98.8% and 95.5% at 10 years (Fig 4B). 
The difference between the two groups was not significant (p = 0.776). 
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Thromboemboic events, anticoagulant-related hemorrhage, prosthetic valve 
endocarditis, and reoperations for pseudoaneurysms were reviewed to evaluate overall 
valve graft-related morbidity. The actuarial estimate of percentage of patients free of 
any valve graft-related complications is shown in Figure 5. 
 
 Figure 3: (A) Actuarial freedom 
from thromboembolism. 
Percent of patients free of 
thromboembolism ± SE is 99.6 ± 
0.4 at 1 year, 98.2 ± 1.1 at 5 
years, 90.9 ± 3.1 at 10 years, 
90.0 ± 3.1 at 15 years, and 90.0 
± 3.1 at 20 years. Number of 
patients at risk yearly for years 
0 through 20, respectively, is 
274, 228, 182, 147, 126, 103, 89, 
73, 65, 57, 52, 39, 32, 25, 17, 15, 
14, 13, 8, 1, and 1.  
 
(B) Actuarial freedom from 
anticoagulant-related 
hemorrhage. Percent of patients 
free of hemorrhage is 100 at 1 
year, 99.6 ± 0.5 at 5 years, 87.4 ± 
3.7 at 10 years, 81.9 ± 6.3 at 15 
years, and 73.7 ± 9.6 at 20 years. 
Number of patients at risk 
yearly for years 0 through 20, 
respectively, is 274, 228, 183, 
148, 127, 105, 91, 72, 63, 55, 51, 
40, 33, 26, 18, 15, 14, 13, 8, 2, 
and 2. 
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 Figure 4:  (A) Actuarial freedom from 
prosthetic endocarditis. Percent of 
patients free of prosthetic endocarditis ± 
SE is 98.8 ± 0.7 at 1 year, 98.2 ± 0.9 at 5 
years, 96.4 ± 2.0 at 10 years, 96.8 ± 2.0 
at 15 years, and 96.8 ± 2.0 at 20 years. 
Number of patients at risk yearly for 
years 0 through 20, respectively, is 274, 
225, 181, 146, 125, 102, 88, 71, 62, 53, 
42, 39, 32, 25, 17, 14, 13, 12, 7, 1, and 1.  
 
(B) Actuarial freedom from reoperation 
for pseudoaneurysms according to the 
operative technique: classic Bentall 
technique (dashed lines) and “button” 
technique (solid lines; p = 0.776). 
Percent of Bentall patients free of 
pseudoaneurysms is 98.8 ± 1.2 at 1 year, 
98.8 ± 1.2 at 5 years, 98.8 ± 1.2 at 10 
years, 93.9 ± 4.9 at 15 years, and 93.9 ± 
4.9 at 20 years; number of patients at 
risk yearly for years 0 through 20, 
respectively, is 94, 83, 77, 75, 73, 70, 68, 
68, 63, 56, 53, 40, 33, 26, 18, 16, 15, 14, 
9, 2, and 2. Percent of button technique 
patients free of pseudoaneurysms is 100 
at 1 year, 98.8 ± 1.2 at 5 years, and 95.5 
± 3.5 at 10 years; number of patients at 
risk at yearly intervals for years 0 
through 8, respectively, is 172, 140, 101, 
70, 51, 31, 21, 4, and 1. 
 Figure 5: Actuarial freedom from 
valve graft related complications. 
Percent of patients free of 
complications ± SE is  97.9 ± 0.9 at 1 
year, 96.0 ± 1.5 at 5 years, 81.0 ± 4.3 
at 10 years, 71.6 ± 7.3 at 15 years, 
and 63.6 ± 10.0 at 20 years. Number 
of patients at risk yearly for years 0 
through 20, respectively, is 274, 226, 
182, 147, 126, 103, 89, 72, 63, 54, 49, 
39, 32, 25, 17, 14, 13, 12, 7, 1, and 1. 
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Eleven patients have required one or more subsequent interventions for aneurysm or 
dissection of the remaining aorta; 4 were Marfan patients and all of them had aortic 
dissection. The rate of freedom from aortic reoperation of the patients with Marfan 
syndrome was lower than that for the remaining patients at 10 years (79.6% ± 13.6% 
versus 94.6% ± 2.6%) and the difference was significant (p = 0.008; Fig 6). 
 
 
 
 
 
 
 
Comment 
 
Since its introduction in 1968 by Bentall and De Bono [1] the aortic valve and ascending 
aorta replacement with composite graft has led to a significant prolongation of life 
expectancy for patients affected by a variety of pathologic conditions involving the 
ascending aorta and aortic valve such as annuloaortic ectasia, cystic medial necrosis 
with or without Marfan syndrome, and type A aortic dissection [3, 4, 9–17]. 
Our retrospective analysis confirms, in agreement with other recent reports [14–17], 
that this surgical procedure presents a low operative risk. We found CPB time longer 
than 180 minutes and associated CABG to be independent risk factors of early mortality. 
In 1994 we abandoned the original Bentall operation with the inclusion technique and 
introduced the button technique [2–4] with several features that may reduce the 
incidence of early and late complications. Hemostasis may be improved by avoiding 
aortic wall wrapping. Since this modification repeat thoracotomy for bleeding has been 
reduced from 5.9% to 1.7%. Other factors such as the use of preclotting woven aortic 
 Figure 6 : Actuarial freedom from 
reoperation on the thoracic or 
abdominal aorta or both in patients 
with Marfan syndrome (dashed 
lines) and without Marfan 
syndrome (solid lines); the 
difference between the two groups 
was statistically significant (p = 
0.008). Percent of Marfan patients 
free of reoperation ± SE is 100 at 1 
year, 92.9 ± 6.9 at 5 years, 79.6 ± 
13.6 at 10 years, 53.1 ± 23.5 at 15 
years, and 0 at 20 years; number of 
patients at risk yearly for years 0 
through 16, respectively, is 35, 30, 
26, 22, 17, 13, 12, 9, 9, 7, 6, 3, 3, 2, 
1, 1, and 1. Percent of non-Marfan 
patients free of reoperation is 99.5 
± 0.4 at 1 year, 98.8 ± 0.9 at 5 
years, 94.6 ± 2.6 at 10 years, 87.6 ± 
5.7 at 15 years, and 87.6 ± 5.7 at 20 
years; number of patients at risk 
yearly for years 0 through 20, 
respectively, is 239, 198, 157, 126, 
110, 92, 79, 64, 56, 49, 46, 37, 30, 
24, 17, 15, 14, 14, 8, 2, and 2. 
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graft, improved surgeon experience, and more accurate use of eparine and protamine 
may have contributed to the reduction of intraoperative bleeding. 
The button technique without complete aortic wall wrapping may prevent late 
pseudoaneurysm formation [2–4] secondary to dehiscence of the suture line of the 
aortic annulus, distal graft anastomosis, or mainly at the coronary ostial anastomosis 
particularly at the left coronary ostium in patients with Marfan syndrome or with aortic 
dissection [12, 18]. Kouchoucos and associates [3] have suggested that blood 
accumulation within the wrapped perigraft space results in increased tension on the 
anastomosis when the inclusion and wrap technique is used. We also believe that the 
circumferential resection of the distal part of the ascending aorta reinforced with two 
Teflon strips can reduce the stress along the suture line between composite prosthesis 
and aorta. 
We rarely performed coronary reimplantation according to the Cabrol technique [5, 6]; 
it was used for patients who had undergone reoperation or for cases of extreme aortic 
dilatation because of difficult mobilization and approximation of the coronary arteries to 
the aortic graft. One of the greatest technical difficulties with this technique is the sizing 
and orienting of the graft between the right and left main coronary arteries to prevent 
kinking and subsequent myocardial ischemia or infarction. In our experience it was 
associated with a high early mortality rate (3 of 8, 37.5%) and a high incidence of 
perioperative myocardial infarction. Therefore since 1994 we have not used the Cabrol 
technique, and detachment and mobilization of the coronary arteries could be easily 
performed using the button technique. 
As cardiovascular manifestations are the most important causes of death among Marfan 
patients, the survival of these patients depends on the prevention and control of these 
complications. A recent study [19] showed life expectancy improvement among patients 
with Marfan syndrome who had undergone surgical repair for aortic aneurysms. Now 
the median cumulative probability of survival is 61 years whereas 30 years ago, it was 
47 years. 
In our series the survival rate including 30-day mortality of the Marfan patients was 
slightly lower than that of the remaining patients (at 10 years 58.8% ± 14.6% versus 
61.9% ± 4.6%) without statistical difference (p = 0.785). A factor that influenced the late 
survival of the Marfan patients was the presence of aortic dissection: at 10 years the 
survival rate of the Marfan patients with aortic dissection was 42.2% whereas that for 
the Marfan patients without dissection was 64%. Late mortality was associated with 
associated CAD, chronic renal failure, and postoperative dialysis. 
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Although some researchers have found long-term survival to be statistically less 
favorable among patients with aortic dissection at the time of root replacement [16] it 
was not a predictor of late mortality in our series. That may be due to a low rate of 
patients with Marfan syndrome in our series (12.8%) compared with that reported in 
the literature (69.3%) [16]. Crawford [2] underlined in a large series of patients with 
dissection or aneurysm of the ascending aorta or aortic arch that diseases of the aorta 
are often part of a more diffuse degenerative process. The same author [20] reported an 
elevated incidence of operation on the remaining aorta among patients with Marfan 
syndrome who underwent composite graft or aortic valve replacement. A recent paper 
[21] confirmed a significant progression of the disease in the remaining aorta in Marfan 
patients who had previously undergone composite graft replacement. Seventeen of the 
48 patients studied by magnetic resonance imaging had a significant increase in 
diameter of the aorta with a mean rate of dilation of 2.3 ± 3.3 mm per year. Surgical 
intervention was necessary in 14 of them. 
In our study the rate of freedom from reoperation on the remaining aorta of the patients 
with Marfan syndrome was lower than of the other patients at 10 years (79.6% ± 13.6% 
versus 94.6% ± 2.6%) and the difference was significant (p = 0.008). Moreover all 
Marfan patients reoperated on during follow-up had aortic dissection. According to this, 
all patients who have undergone aortic root replacement should be periodically 
evaluated by computed tomography scan, magnetic resonance imaging, or 
transesophageal echocardiography to detect the development of false aneurysms or the 
progression of the disease in the remaining aorta, particularly in patients with Marfan 
syndrome or with aortic dissection.  
Despite refinements in the design of cardiac prostheses and in anticoagulation 
management, mechanical valve replacement is still associated with a variety of valve-
related complications often leading to serious disability or death. In our series the rate 
of valve-related complications was low. Anticoagulant-related hemorrhage was the most 
common late complication with a rate of 0.91 events per 100 patient-years, followed by 
thromboembolisms (0.63/100 patient-years). Endocarditis was a serious complication 
with a high mortality rate (60%). It is our standard policy to replace the infected 
composite graft or prosthesis with a cryopreserved homograft root. Conservative 
treatment failed to eradicate infection in all patients treated except for 1 patient. 
Appropriate antibiotic prophylaxis remains the main preventative measure. 
To avoid the disadvantages of prosthetic heart valves the valve-sparing procedure has 
been introduced [22]. Patients with aortic root aneurysm often have normal or 
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minimally diseased aortic cusps that can be preserved. Actually the valve-sparing 
operation has become our treatment of choice for aortic root aneurysm with normal 
aortic valve and in the past 24 months we have performed 24 procedures. However the 
current series does not include these patients and it reports only our experience with 
composite valve graft replacement. 
Four patients (1.5%) required reoperation for pseudoaneurysm formation at the 
coronary suture lines: in 2 patients the original Bentall operation was used (2.1%) and 
in the other 2—1 of them with Behçet’s disease—the button technique was used (1.2%). 
All patients underwent successful reoperation. Techniques used for reattachment of 
coronary arteries did not influence the incidence of reoperation for pseudoaneurysm 
during follow-up. Because not all patients were evaluated by diagnostic imaging studies 
such as magnetic resonance, computed tomography, or angiography the real incidence 
of pseudoaneurysm formation is unknown and may be higher. 
When a pseudoaneurysm is detected it should be repaired before progressive dilation, 
adherence to the sternum, or rupture because all these situations, which require urgent 
or emergent operation, are associated with high operative risk [3]. Hahn and associates 
[23] reported no early deaths in a limited series of patients who had undergone aortic 
root reoperation for pseudoaneurysm or endocarditis but no operations were done 
emergently. In a study of 81 patients who had undergone reoperation on the aortic root 
or ascending aorta Kouchoukos and colleagues [24] presented an early mortality rate of 
12.5% in 16 patients reoperated on for false aneurysm. In the same report reoperation 
for false aneurysm was a significant predictor of late mortality. 
Eighteen of the 274 patients (66%) who underwent aortic root replacement had acute 
type A dissection. This number represents fewer than 10% of all patients operated on 
for acute type A dissection during the same period. We believe along with Elefteriades 
[25] that the vast majority of aortic dissections can be treated appropriately with a 
simple supracoronary hemiarch replacement and the aortic valve can be left alone or the 
commissures can be resuspended. Long-term survival after root replacement for acute 
aortic dissection was found to be statistically less favorable [10]. Composite graft 
replacement should be limitated to cases of frank annuloaortic ectasia, Marfan 
syndrome, and severe destruction of the proximal aorta. 
Finally we should mention some limitations of the current investigation. First, this is a 
retrospective study over a long period of time in which many factors changed and could 
not be accounted for with the multivariate statistical techniques. Second, owing to 
incomplete data collection during the earlier years some important variables such as left 
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ventricular function and intraoperative myocardial protection were not included in the 
analysis. Therefore the influence of these variables on early and late mortality could not 
be studied.  
In summary composite valve graft replacement can be performed with low rates of 
hospital mortality and morbidity. The button technique offers some advantages and 
should be used whenever possible. In case of acute aortic dissection root replacement is 
usually not necessary. Patients with Marfan syndrome should undergo early root 
replacement before aortic dissection occurs. Valve-related complications have a low 
incidence but often lead to disability or death. A careful follow-up is extremely 
important for evaluating the prosthetic aortic segment, the proximal and distal 
anastomosis, the morphology, and the diameter of the reimplantated coronary arteries 
and the remaining segments of the aorta. 
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Abstract 
 
 
Background. Pulmonary autograft aortic root replacement was used in adults. Risk 
factors for aortic valve incompetence (AI) and pulmonary homograft valve stenosis are 
identified. 
 
Methods. From February 1991 through May 2003, 103 patients, with a mean age of 35.2 
± 9.5 years, underwent aortic root replacement with the pulmonary autograft. Annulus 
reinforcement (reduction annuloplasty or use of root ring) was carried out in 45 
patients. In all but 1 patient, the right ventricular outflow tract was reconstructed with a 
cryopreserved pulmonary homograft. Mean follow-up duration was 6.0 ± 2.8 years 
(range 0.3 to 11 years). 
 
Results. There were no hospital deaths. Overall patient survival was 98.9 ± 1.0% at 1 
year and 97.3 ± 1.9% at 10 years. Autograft function follow-up resulted in 5 patients 
requiring reoperation for aortic incompetence. The univariate risk factors for aortic 
incompetence at discharge and during follow-up were respectively annulus 
reinforcement (p = 0.05) and bicuspic aortic valve (p = 0.05). Reoperation for homograft 
failure occurred in 1 patient. During follow-up, 24 patients (25.5%) developed 
homograft stenosis (gradient > 20 mm Hg). Univariate analysis indicated the diameter of 
the homograft (p = 0.001) as factor associated with stenosis during followup. Cox 
regression identified smaller diameter of the homograft (p = 0.001) and older age of 
donor (p = 0.002) as independent risk factor for the development of homograft stenosis. 
 
Conclusions. The Ross operation can be performed with few complications. Although 
both the aortic autograft and the pulmonary homograft have limited durability, this has 
not yet resulted in considerable reoperation rates and associated morbidity and 
mortality. 
 
 
 
 
 
 
  201 
Ross introduced the replacement of a diseased aortic valve by means of a pulmonary 
autograft in 1967 [1]. Ross’ group identified the advantages of the autograft valve as 
excellent hemodynamic performance, freedom from anticoagulation and, for children, 
the potential for growth. Relatively high mortality, early failure rates reported, and the 
complexity of the procedure have deterred many surgeons from embracing this 
procedure in the past [2, 3]. Recent experience, on the contrary, indicates that this 
operation can be performed with acceptable risk [4, 5]. This can be explained by 
increasing experience and modification of the surgical technique from an original 
subcoronary technique toward a full root replacement technique [6]. This article 
describes our medium-term experience with the Ross operation in 103 adult patients 
(with aortic valve disease) and presents the result of serial echocardiographic study 
assessing the function of the autograft and the pulmonary homograft. 
 
 
Patients and Methods  
 
From February 1991 through May 2003, 103 selected adult patients with a mean age of 
35.2 ± 9.5 years (range 17 to 65 years old) underwent root replacement with the 
pulmonary autograft. The characteristics of the patients are reported in Table 1. 
Our operative techniques for the Ross operation and autograft annulus reinforcement 
and reduction have been previously described [7]. Briefly, all operations were 
performed with the use of mild systemic hypothermia; myocardial protection was 
provided by low sodium normopotassic cardioplegic solution and topical cooling. In all 
the patients, the autograft was implanted as a free standing root. The diameter of the 
aortic annulus and pulmonary autograft was assessed by intraoperative measurement 
with cylindrical sizers. In 39 patients (37.8%) the proximal autograft suture line was 
reinforced by a 5-mm large strip of fresh autologous pericardium or prosthetic material 
(Teflon felt [Impra Inc, subsidiary of C.R. Brand, Temple, AZ], or a woven Dacron ring 
[C.R. Brand, Haverhill, PA]). In 12 patients (11.6%), significant dilatation of the aortic 
annulus (diameter exceeding the Z +2 value for the body surface area), required aortic 
annulus reduction. It was carried out by placing two 2-0 polypropylene sutures as a 
purse-string in a single horizontal plane just below the aortic annulus [8].  Homograft 
reconstruction of the right ventricular outflow tract (RVOT) was accomplished with a 
cryopreserved pulmonary homograft in 102 patients and with a bovine pericardium 
mounted xenograft in 1 patient. All cryopreserved pulmonary homografts were 
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provided by Bio Implant Service Foundation (BIS; Leiden, The Netherlands). The donors 
had a mean age of 45.2 ± 12.9 years (range 9 to 66 years old). Concomitant procedures 
included mitral valve plasty in 1 patient and open mitral commissurotomy in 1 patient. 
Mean cardiopulmonary bypass time was 187.8 ± 35.8 minutes (range 133 to 287 
minutes) and mean aortic cross-clamp time was 137.6 ± 26.5 minutes (range 98 to 232 
minutes). 
 
 
Table 1. Preoperative Patient Characteristics 
Characteristic Number = 103 
Age (years) 35.2 ± 9.5 
Sex (male) 71 
NYHA functional class 
I 
II 
III 
IV 
 
59 (57.3) 
27 (26.2) 
17 (16.5) 
− 
Left ventricular ejection fraction 
> 50% 
30-50% 
< 30% 
 
68 (66.0) 
31 (30.1) 
4 (3.9) 
Predominant lesion 
Aortic stenosis 
Aortic incompetence 
Mixed aortic disease 
 
20 (19.4) 
51 (49.5) 
32 (31.1) 
Aortic valve morphology 
Bicuspid (congenital) 
Tricuspid 
 
44 (42.7) 
59 (57.3) 
Previous aortic valve surgery 
Valve replacement 
Valvulotomy 
Valvuloplasty 
Enucleation of subvalvular membrane 
 
2 (1.9) 
5 (4.8) 
1 (0.9) 
2 (1.9) 
Values are mean ± 1 standard deviation. Numbers in parenthesis are percent. 
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Postoperative Follow-Up 
 
Follow-up was conducted between June and July 2003 by two investigators and was 
97% complete. The 3 patients, whose follow-up was incomplete, were censored at the 
time of their last follow-up.  
Assessment included New York Heart Association (NYHA) functional class, drug therapy, 
electrocardiogram, chest radiogram and transthoracic M-mode, two-dimensional and 
color-flow Doppler echocardiograms. The echocardiographic examinations were 
performed at discharge, 3 to 6 months postoperation, 1 year after the operation, and on 
a regular base thereafter. The mean transvalvular pressure gradient of the aortic and 
pulmonary valves was calculated [9]. Color-flow Doppler was used to detect aortic and 
pulmonary valvular incompetence, and severity was subjectively graded as trivial (1+), 
mild (2+), moderate (3+) and severe (4+). 
 
 
Statistical Analysis 
 
All analyses were performed using SPSS 8.0 for Windows (SPSS Inc, Chicago, IL). 
Continuous variables were expressed as the mean ± standard deviation (SD) and were 
analyzed by using the unpaired two-tailed t test. Categorical variables were presented as 
percentage and were analyzed with the X2 test or Fisher’s exact test when appropriate. 
Univariate and multivariate analysis was used to study potential determinants of aortic 
valve incompetence (AI) grade 2 or more at discharge. The following categorical 
variables were considered: sex, gender, preoperative AI grade 2 or more, preoperative 
left ventricle function less than 40%, annulus reinforcement (reduction annuloplasty or 
use of root ring), and bicuspid aortic valve. Variables that achieved a p value <0.2 in the 
univariate analysis were examined by using multivariate analysis with forward stepwise 
logistic regression for the developing of AI grade 2 or more. The same variables analyzed 
for AI at discharge were studied for AI grade 2 or more during follow-up. Variables that 
achieved a p value less than 0.2 in the univariate analysis were examined by using Cox 
proportional hazard regression for the developing of AI grade 2 or more. 
The development of 20 mm Hg or greater gradient through the pulmonary homograft 
during follow-up was also investigated. For the univariate analysis the following 
variables were considered: diameters of the pulmonary homograft (continuous 
variable), age of the donor (continuous variable), and donor status (beating heart, non 
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beating heart; categorical variables). Variables that achieved a p value less than 0.2 in 
the univariate analysis were examined by using Cox proportional hazard regression for 
the development of a 20 mm Hg or greater gradient through the homograft during 
follow-up. Estimates for long-term survival and freedom from morbid events were made 
by the Kaplan-Meier method. 
 
 
Results 
 
Mean follow-up was 6.0 ± 2.8 years (range 0.3 to 11 years). 
 
 
Mortality  
  
There were no hospital deaths. There were two late deaths. One patient died from 
bacterial meningitis 1 year postoperatively. The other patient developed pulmonary 
homograft endocarditis (proven by autopsy) 8 years after the operation and died 
acutely. Overall patient survival is shown with the Kaplan-Meier analysis in Figure 1, 
with 98.9 ± 1.0% at 1 year and 97.3 ± 1.9% at 10 years. 
 
 
 
 
 
 Figure 1: Overall patient survival. 
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Morbidity 
 
Eleven patients (10.7%) required early reoperation (< 24 hours) for bleeding. Four 
patients (3.9%) developed myocardial infarction (creatinine phosphokinase > 300 IU/L, 
myocardial band > 5%); 2 of them underwent coronary angiography that revealed a 
stenosis of the reimplanted right coronary ostium; the lesion was treated in both cases 
with a stent implantation. Both interventions were done within the same admission, a 
few days after surgery. The others two patients refused to undergo the coronary 
angiography, and are actually in NYHA class I. Three patients underwent pacemaker 
implantation because of permanent atrioventricular block. Two of these patients had 
extensive annular calcification, and 1 patient was a reoperation. 
 
Reoperations for Autograft Failure 
 
Five patients (4.8%) have required reoperation on the autograft valve for incompetence. 
Two patients developed severe aortic incompetence respectively 6 weeks and 15 
months after the Ross procedure. In the first patient the pulmonary autograft was 
quadricuspid and this congenital anomaly was detected only at the end of the initial 
operation. In the second patient the cause of the autograft failure was unclear. In both 
cases a mechanical prosthesis was implanted within the autograft. Another patient has 
undergone aortic valve replacement 4 years after the operation for progressive 
autograft incompetence due to annular dilatation. The remaining 2 patients were 
reoperated respectively 3 and 8 years after the initial operation for a dilatation of the 
autograft root at the sinotubular level and severe AI detected by echocardiogram; in 
both cases a mechanical composite graft was implanted. Freedom (Kaplan-Meier) from 
reoperation on pulmonary autograft is 98.7% ± 1.2% at 5 years, 96% ± 2.9% at 7 years, 
and 87.4% ± 6.4% at 10 years (Fig 2). 
 
Reoperations for Pulmonary Homograft Failure 
 
Reoperation for homograft failure occurred in 1 patient; he developed stenosis of the 
pulmonary homograft (pulse Doppler gradient of 50 mm Hg) 13 months after the initial 
operation. The patient, initially treated with patch angioplasty of the pulmonary 
homograft, had replacement of the homograft 3 years postoperatively. Freedom from 
reoperation on pulmonary homograft is 98.7% ± 1.2% at 10 years. 
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Valvular Endocarditis 
 
Endocarditis occurred in 2 patients. In the first patient the endocarditis was localized on 
the pulmonary autograft and was successfully treated with antibiotics; a recent 
echocardiogram of the patient depicts a trivial aortic incompetence. In the second 
patient, as already described, the endocarditis was localized on the pulmonary 
homograft and was fatal. Freedom from endocarditis is 98.3% ± 1.6% at 5 years and 
95.7% ± 3% at 10 years. 
 
 
Cerebrovascular Accident 
 
Three patients had a cerebrovascular accident (CVA) 9 months, 4 years, and 5 years 
postoperatively, respectively. There was no documented arrhythmia or clot in the heart 
on echocardiography. Freedom from CVA is 96.7% ± 2.2% at 6 years and 92.5% ± 4.6% 
at 10 years. 
When including death of any cause, reoperation, CVA and endocarditis as events, the 
even- free survival at 1 year is 98.9% ± 1%, 96.3% ± 2% at 5 years, 85.5% ± 5.4% at 8 
years, and 75.4% ± 7.3% at 10 years (Fig 3). 
 
 Figure 2: Actuarial freedom from 
reoperation on pulmonary autograft 
during follow-up. 
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Autograft Valve Function 
 
All the patients underwent two-dimensional echocardiogram at discharge. There was no 
aortic incompetence (AI) in 69 patients (67.0%), 30 patients (29.1%) had a trivial AI; 3 
(2.9%) had a mild AI, and 1 (1.0%) had severe AI requiring reoperation 6 weeks after 
the Ross procedure. The influence of the variables including sex, gender, preoperative AI 
grade 2 or more, preoperative left ventricular function, bicuspid valve, annulus 
reinforcement (reduction annuloplasty or use of root ring) on the incidence of early AI 
grade 2 or more (only 4 patients) was investigated. Regurgitation was central in the 
majority of patients. At the univariate analysis, annulus reinforcement (p = 0.05) was the 
only factor associated with AI grade 2 or more at discharge. Multivariate analysis failed 
to show any significant independent risk factor, but numbers in the subgroups were 
small. Recent echocardiographic assessment (within 1 year of closing date of the follow-
up study) of the pulmonary autograft valve function was available in 73% of patients 
(excluding 2 deaths and 5 reoperations); in 85% of patients, an echo of less than 2 years 
old was available. All patients without recent echocardiographic assessment have stable 
clinical examination. Details are listed in Table 2. None of the patients had aortic valve 
stenosis. The number of patients with AI grade 2 or more was significantly (p = 0.03) 
higher during follow-up compared to discharge (4 of 103 at discharge and 18 of 94 
during follow-up). The same variables analyzed for their influence on AI at discharge 
were studied for their influence of AI grade 2 or more during follow-up. At the 
 Figure 3: Event-free survival. 
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univariate analysis, bicuspid aortic valve (p = 0.05) was the only factor associated with 
AI grade 2 or more during follow-up. Cox proportional hazards regression failed to show 
any significant independent risk factor. Freedom from mild or more AI was 97.8% ± 
1.5% at 1 year, 91.3% ± 3.1% at 5 years, 76.4% ± 6.1% at 8 years, and 62.9% ± 8.7% at 
10 years. 
 
 
Table 2. Aortic Valve Function During Follow-Up in the 94 Patients Who Survived With 
Their Pulmonary Autograft in Place 
Aortic  
Incompetence 
Discharge to 
3 Years 
4 to 6 Years 7 to 9 Years >10 Years 
None 4 13 2 5 
Trivial (grade I) 11 19 12 8 
Mild (grade II) 2 8 2 4 
Moderate (grade III) 1 2 1  
Severe (grade IV) − − − − 
 
 
Homograft Valve Function 
 
None of the patients had pulmonary valve stenosis (gradient > 20 mm Hg, peak velocity 
across the pulmonary homograft > 1.4 m/s) at discharge, 9 patients (8.7%) had trivial 
pulmonary regurgitation. During follow-up, 24 patients (25.5%) developed pulmonary 
homograft stenosis. One patient, as already mentioned, underwent reoperation on the 
homograft for a stenosis of greater than 50 mm Hg. The influence of the variables 
including diameter of the pulmonary homograft, age of the donor, and donor status on 
the development of homograft stenosis was investigated. Univariate analysis indicated 
that the diameter of the pulmonary homograft (p < 0.001) was the only factor associated 
with pulmonary stenosis during follow-up. Cox proportional hazards regression 
identified smaller diameter of the pulmonary homograft and older age of donor as 
independent risk factor for the development of pulmonary homograft stenosis (Table 3). 
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Functional Status 
 
At the closure of the study, 94 patients were alive with  their pulmonary autograft in 
place. Of those, 84 patients (87.2%) had no cardiac symptoms and were in NYHA 
functional class I, 11 (11.7%) were in functional class II, and 1 (1.1%) was in functional 
class III. In this patient, a recent echocardiogram revealed a severe AI and a 
pseudoaneurysm of the autograft at the distal suture line. He is scheduled for 
reoperation. 
 
 
Table 3. Cox Proportional Hazards Regression for the Development of Pulmonary 
Homograft Stenosis 
Characteristic Range Multivariate 
p Valuea 
Multivariate Risk Ratio 
per Unit Increase 
(95% Confidence Limit) 
Homograft diameter 
(increasing) 
20–30 mm 0.001 (−) 0.6 (0.4, 0.8) 
Donor age (increasing) 9–66 years 
old 
0.002 (+) 1.05 (1.02, 1.09) 
a The p value is followed by (−) to indicate increased risk with smaller values or (+) to indicate increased risk with larger values. 
Gradient > 20 mm Hg, peak velocity across the pulmonary homograft > 1.4 m/s. 
 
 
 
 
Comment 
Our 11-year experience with the autograft root replacement confirms that the Ross 
procedure can be performed with low mortality and morbidity. This has only been 
possible by careful selection of the patients: only adults with few comorbiditiy were 
scheduled for the operation. 
Autograft failure necessitating reoperation occurred in only 5 patients. In 1 patient the 
pulmonary homograft was quadricuspid and this congenital malformation was detected 
only at the end of the initial operation. The quadricuspid pulmonary valve is a rare 
congenital heart anomaly; the reported incidence ranges from 1 in 400 to 1 in 1000 
autopsies [10]. The rapid progression of regurgitation of a quadricuspid pulmonary 
valve in aortic position has already been described in literature [11] and this graft must 
be considered, therefore, an inadequate candidate for use as an autograft in the Ross 
procedure. 
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Aortic insufficiency during follow-up was mainly caused by dilatation at the annular 
level (1 patient) or at the sino-tubular level (2 patients). The annular dilatation can 
cause AI because it flattens the scalloped shape of the annulus, preventing coaptation of 
the cusps [12]. Reinforcement of the annulus or adjustment of the diameter to the body 
surface area of the patient has been recommended for prevention of AI [12, 13]. 
Therefore, in all procedures since 1997 we invariably use a reinforcement ring, or a 
reduction annuloplasty if the aortic annular diameter exceeds the Z +2 value. In 2 
patients the cause of the AI was dilatation of the pulmonary arterial wall at the 
sinotubular junction. Dilatation of the sinotubular junction cause AI because it pulls the 
commissures of the aortic valve away from the center of the aortic root, preventing 
coaptation of the cusps [12]. Both patients had an aortic bicuspid valve. The relationship 
between bicuspid aortic valve and aortic wall abnormalities has been widely described 
[14, 15]. Given the common embryogenesis of the aorta and pulmonary artery [16], de 
Sa and colleagues [15] hypothesized that similar histologic lesions could exist also in the 
pulmonary wall of patients with bicuspid aortic valve. They found, in fact, a greater 
prevalence of degenerative changes of the media of the pulmonary artery of patients 
with an aortic bicuspid valve. We do not routinely reinforce the distal suture line, but are 
considering it. 
The results of our study, in terms of autograft competence, are consistent with the 
outcomes of other studies using the autograft as a free standing root [17, 18]. Over the 
last few years, the implantation technique has been addressed; in our opinion the free 
standing root technique is critical to achieve and maintain consistent autograft 
competence. There is some evidence that the long-term results, in term of valve 
competence, are superior after root replacement than after cylindric and subcoronary 
techniques [19]. The advantages of the freestanding aortic root over the other two 
techniques has also been shown by Elkins and associates [13] and is probably due to the 
fact that the geometry of the autograft, and therefore the coaptation of the cusps, is 
better preserved. In contrast with this theory is the study of Sievers and associates [20] 
that shows good mid-term results with subcoronary or root inclusion technique; 
however, long-term results are needed. 
The present series is of particular interest as 79.8% of the patients with a recent 
echocardiogram have an AI less than grade 2, and continue to maintain the benefits of 
their pulmonary autograft. The majority of them are in NYHA class I and conduct a 
normal life without anticoagulation. 
Right ventricular outflow tract reconstruction, in our series, was routinely done with a 
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cryopreserved homograft. We, and others [18, 19], have noticed a significant increase in 
pulmonary flow velocities during followup. Pulse-wave Doppler indicated that the 
gradient was located directly at the homograft leaflets and not at the anastomosis. We 
are inclined to think, therefore, that the increased flow velocities are valve related and 
on the base of the results of the multivariate analysis, we support the current practice of 
oversizing the homograft by at least 2 to 3 mm [21]; usually this results in a pulmonary 
homograft with a minimum internal diameter of 28 mm. 
The influence of immune activation on man valve homograft deterioration remains 
unclear. Nevertheless, Oei and associates [22] reported that in rats, aortic valve 
homografts are able to induce a donor reactive immune response that is related to early 
graft destruction and incompetence. Further studies are needed to fully understand the 
role of immunologic factors in man valve homograft deterioration. 
Older age of donor was identified as independent risk factor for the development of 
pulmonary homograft stenosis (p = 0.002); Lund and coworkers [23] found, in a large 
series of patients, that donor age above 65 years old was a significant risk factor for 
homograft failure. According to previous studies [23, 24], however, we keep the donor-
patient age mismatch within 10 years. 
In conclusion, our long-term experience with the Ross operation has confirmed the 
suitability and safety of this operation for patients with aortic valve disease. Although 
both the aortic autograft and the pulmonary homograft have limited durability, this has 
not yet resulted in considerable reoperation rates and associated morbidity and 
mortality. 
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Since their introduction, the valve-sparing operations were faced with a tough challenge: 
to exceed the excellent results of the Bentall-De Bono procedure in the treatment of the 
aortic root pathology. As already happened many years before for the mitral valve 
repair, many surgeons were sceptical at the beginning, considering the procedure 
technically demanding, difficult to reproduce and possibly burdened with a high risk of 
reoperation. Satisfactory short and mid-term results, however, encouraged several 
aortic surgeons to embrace the technique so that, over the years, the valve-sparing 
operations have steadily expanded their indication to include patients with Marfan’s 
syndrome, bicuspid aortic valve (BAV), acute type A aortic dissection, older age and 
additional cusp pathologies. Our data confirm that this procedure can be applied 
successfully in most of these pathologies without compromising the most important 
end-points such as mortality, freedom from recurrent aortic incompetence (AI) and 
freedom from reoperation.  
 
The role of the sinuses of Valsalva 
Since the beginning of the experience with the reimplantation technique, to reconstruct 
the aortic root we have been invariably using the Gelweave Valsalva graft for two main 
reasons: first, we are convinced that the Valsalva sinuses play an important role in the 
opening and closing mechanism of the aortic cusps during the cardiac cycle and, 
secondly, because there is no need for any substantial variation in the original 
reimplantation technique proposed by David  (1,2).  The role of the Valsalva sinuses has 
been largely investigated in literature. Interest in the aortic root blood flow date back to 
Leonardo da Vinci and was first investigated by Bellhouse and Bellhouse in 1968  (3). 
Modern studies, on the basis of mathematic models, have suggested that the flow 
patterns in the aortic root might affect the aortic valve function by allowing load and 
stress sharing between the valve cusps and the aortic wall  (4). In this sense, each aortic 
cusp and the corresponding Valsalva sinus is to be considered, together with the sino-
tubular junction, a “functional unity” that provides a smooth and rapid aortic valve 
closure minimizing the stress and strain on the valve cusps  (5).   
Chapter 2 presents single center preliminary results with the reimplantation technique 
using the Valsalva graft in a series including 32 patients.  There were no intraoperative 
deaths, indicating that this operation can be performed safely at least in elective cases.  
Two patients developed significant recurrent AI requiring mechanical aortic valve 
replacement 4 and 6 weeks after the procedure, respectively. One was the very first 
case, a young man with the Marfan syndrome, in which was selected the wrong size of 
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the graft, probably too small that resulted in a prolapse of all 3 cusps.  The other was a 
patient with a bicuspid aortic valve that during the first procedure underwent an 
additional cusp repair, consisting in a free margin shortening by running suture. Upon 
reoperation, we found a fibrotic retraction of the repaired cusp with a lack of coaptation.  
By these two cases two important lessons were learned: first, the aggressive downsizing 
of the graft is extremely counterproductive as it determines a distortion of the cusps 
leading to severe prolapse, particularly in patients with anulo-aortic ectasia.  Second, the 
free margin shortening with running suture is probably a too aggressive method to 
reduce the free margin length of a prolapsing cusp, as a reactive fibrosis of the cusp 
needs to be expected. Since then, cusp repair has been abandoned in favour of the less 
invasive plication of the nodule of Arantius. Preliminary results of this study are 
consistent whit the experience of others both in term of mortality and reoperation rate  
(6,7).  
In chapter 3, we show the short-term outcome of the same operation performed in 3 
different Italian centers (Humanitas Research Hospital, Milan, S. Orsola Hospital, 
Bologna, Tor Vergata Hospital, Rome). This series of 151 patients included 7 cases 
(4.6%) operated on emergently for acute type A aortic dissection. In-hospital mortality 
was 3.3%, and it was significantly higher among patients operated on for acute 
dissection (42.9% vs. 1.4%; p=0.001). At 5 years, freedom from aortic valve replacement 
and freedom from AI grade 3 to 4 was 90.8% and 88.7%, respectively. Of note, the 
incidence of reoperation was significantly higher among patients who had undergone 
additional cusp repair when compared with patients who had not (25% vs. 3%; p= 
0.005).  Based on this finding, it was decided to abandon this technique for the 
treatment of acute aortic dissection and to be cautious with additional cusp repair. 
However, the number of cusp repair was not high enough to draw definitive conclusion 
also because the ideal cusp repair technique to use in this setting was not fully 
addressed. It must be emphasized that others reported encouraging results with the 
reimplantation of the aortic valve in acute aortic dissection  (8,9).    
In chapter 4, a single center experience of 100 cases of aortic valve reimplantation is 
described with a mean follow-up of 28 months (range 1 to 60 months). The series 
included 15 patients with bicuspid aortic valve.  Two of them, with an evident 
asymmetry of the valve, required an additional cusp repair (free margin shortening by 
running suture and triangular cusp resection) and due to recurrent AI, underwent aortic 
valve replacement. Conversely, other 3 patients with a symmetric BAV (10) requiring a 
less extensive additional cusp repair, showed a stable function of the valve during 
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follow-up without significant AI. Therefore, in sight of this, the policy to spare the BAV 
only in case of symmetric cusps with no need of extensive additional cusp repair was 
adopted.  
Chapter 5 focuses on the mechanical proprieties of the Valsalva graft, analysed by 
magnetic resonance, at mid-term follow-up. In previous studies, the Valsalva’s graft 
compliance at the level of the Dacron pseudo-sinuses was found similar to that of normal 
sinus, shortly after the operation  (2). By means of a case-control study, it was 
demonstrated that the compliance of the graft is maintained, although halved, during the 
mid-term follow-up.  This finding shows that, over the years, the Valsalva graft continues 
to behave like the native aortic root not only from a static point of view (curvature of the 
sinuses) but also from a dynamic point of view and this is supposed to play an important 
role in the durability of the native valve by reducing the stress on the cups.  To our 
knowledge, this is the first study investigating the mechanical proprieties of the Valsalva 
graft at mid-term follow-up.  Nevertheless, the role of the Dacron neo-sinuses in the 
durability of the valve repair is still open to debate as emphasized by the recent editorial 
commentary published by Tirone David (11).  
 
The valve-sparing aortic root replacement in different settings 
In chapter 6, mid-term results of the aortic valve reimplantation in patients with the 
Marfan’s syndrome were investigated by means of a retrospective multicenter study 
including four different centers (Humanitas Research Hospital, Milan, S. Orsola Hospital, 
Bologna, Tor Vergata Hospital, Rome, Hospital of the University of Pennsylvania, 
Philadelphia, USA). A pathological dilatation of the aortic root exists in about 75-85% of 
the patients with the Marfan’s syndrome  (12). Aortic root replacement using a 
mechanical valve conduit, also known as Bentall-De Bono procedure  (13), has 
dramatically improved the survival of these patients and has long been considered the 
“gold standard” treatment, providing early and late excellent postoperative outcomes  
(14). In these individuals, the implantation of a mechanical valve is associated with low 
linearized rates of valve thrombosis, thromboembolism and haemorrhage  (15). 
However, the majority of them are young and with a relatively high life expectancy that 
will lead to a considerable cumulative risk of valve-related morbidity. Moreover, very 
often, the aortic cusps are “functionally” normal  (16).  For these reasons, in the late ‘90s, 
the valve-sparing operations have emerged as an alternative to composite valve-graft to 
treat the aortic root pathology is this scenario.  
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The principal advantage of the reimplantation technique compared with the 
remodelling, is the stabilization of the annulus, which is of primary importance for 
patients with connective tissue disorders such as Marfan’s syndrome, where the annulus 
may dilate over time. In this series, including 35 Marfan patients, three were reoperated 
for significant AI.  
One patient was the very first case, already discussed in comment to chapter 2.  Acute 
endocarditis was the cause of the reoperation in another patient, who had, at latest 
follow-up before readmission, trivial AI. No additional cusp repair was performed 
during the first procedure, so that we consider the event unpredictable and probably not 
related to the surgical technique.  The third case, requiring reoperation at 22 months, 
was a 14-year-old boy with extremely elongated cusp free margins (>45 mm). In this 
case, we learned that patients with abnormally stretched leaflets are probably not 
suitable candidates for this technique. Five years results, with a survival rate of 100% 
and a freedom from reoperation due to structural valve deterioration and significant AI 
of 89%, are consistent with other reported series  (17,18). 
Although the ideal candidate for a valve sparing operation is a young patient with 
functionally normal or “nearly” normal aortic valve because of the long life expectancy 
and the disadvantages of a mechanical prosthesis in the long-term, in the elderly, the 
aortic valve reimplantation may be the ideal solution for two main reasons. First, with 
the increasing life expectancy in the older patients, reoperations in octogenarians with a 
previous aortic root replacement with a bio-prosthesis will become more common. 
Second, in this subset of patients, the alternative option of a mechanical valve may lead 
to a substantial risk of complications related to the anticoagulant therapy  (19). In 
chapter 7, a series is described of 63 patients greater than 60 years of age, who 
underwent aortic valve reimplantation at two different centers (Humanitas Research 
Hospital, Milan, Italy, Hospital of the University of Pennsylvania, Philadelphia, USA). 
With an overall survival of 84% and a freedom from reoperation of 93% at 51 months it 
was found that in this subset of patients, the operation can be performed with 
encouraging results, both in terms of mortality and morbidity. However, age shouldn’t 
be the sole criteria of patients’ selection but should include an overall assessment of the 
comorbidities. It should be noted that in this study patients with aortic dissection and 
emergent indication were not included and the majority of the patients were in NYHA 
class I or II, with a LVEF grater than 60%. Others reported older age as predictor of poor 
outcome, however, the series of patients were heterogeneous including aneurysms, 
aortic dissection and Marfan’s syndrome  (20,21). Conversely, the study in Chapter 7 
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demonstrated that satisfactory outcome con be expected in this subset population if 
appropriately selected. To our knowledge, this is the first published report focusing 
selectively on the valve-sparing aortic root replacement in the elderly. 
Bicuspid aortic valve is one of the main causes of AI, particularly in young subjects. As 
mentioned before for the Marfan patients, composite replacement with a mechanical 
prosthesis is a safe alternative but there is concern regarding the cumulative risk of the 
anticoagulant therapy. Moreover, anticoagulation may not be desired by young 
individuals who play sports. In chapter 8 we present a single center experience with 
aortic valve reimplantation focusing particularly on the impact of the bicuspid aortic 
valve on the reoperation risk at 5 years. The results showed that BAV, per se, had no 
impact on the reoperation risk. Indeed, overall freedom from aortic valve reoperation 
was 90% without significant difference between patients with bicuspid and tricuspid 
aortic valve. Moreover, no difference between bicuspid and tricuspid aortic valve was 
found in durability after stratification for adjunctive cusp repair. These results are 
consistent with the literature. Aicher et al., in a mid-term retrospective study comparing 
patients who underwent aortic root remodelling for tricuspid and bicuspid aortic valve, 
found no significant difference between the two groups in terms of valve stability  (22). 
A few years later, Schäfers, from the same group, confirmed this result in a long-term 
study  (23). Analysing the issue from a different point of view, de Kerchove et al, found 
that in patients with BAV requiring cusp repair, the aortic valve reimplantation 
stabilizes the functional aortic annulus, improves valve mobility (low gradient) and is 
associated in improved outcomes. Based on these data, aggressive root replacement is 
advocated with reimplantation technique even in patients with mild to moderate root 
dilatation (< 45 mm)  (24). However, it should be noted that this “ extreme” indication is 
not reported in the latest ESC guidelines on the treatment of the aortic disease  (25). 
Given the favourable outcomes, as reported in this chapter and the results of other 
experienced aortic centers, the valve sparing aortic root replacement seems to be a 
reasonable approach in this subset of patients. 
 
The impact of the additional cusp repair 
The mechanisms that determine the AI in the setting of an aortic root aneurysm are 
basically two: the distortion of the root geometry with a lack of central cusp coaptation 
and consequent central regurgitant jet and/or the prolapse of one or more cusp that 
usually lead to an eccentric regurgitant jet. In addition, BAVs may have a restricted cusp 
motion due to presence of a raphe. The 3-D root geometry is restored by reimplantation 
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of the valve within the Dacron graft, while, the cusp prolapse need to be corrected by an 
additional cusp repair. Raphe shaving or resection may be required in BAVs. Nowadays, 
surgeons have a wide range of techniques to reduce the cusps’ prolapse, restore the 
cusps motion and to increase the coaptation surface of the free margin  (26-29). 
Nevertheless, the impact of the additional cusp repair on the valve durability is still open 
to debate, particularly in BAVs requiring complex repair. Chapter 9 is a review article 
entirely focused on this issue. According to the data of the major published series, BAV 
more frequently requires correction when compared with tricuspid aortic valve and, in 
most of the cases additional cusp repair does not affect valve competence in the mid and 
long-term. Nevertheless, we do believe that cusp repair is a too generic definition as it 
includes a wide variety of techniques ranging from a “simple” free margin plication to a 
more complex triangular resection with pericardial patch repair and, as emerged from 
our review, BAVs are more prone to complex repair.  In line with this, a subgroup 
analysis, based on the impact of the cusp repair according to the valve anatomy seems 
necessary. In chapter 10, a single center long-term experience with the reimplantation 
technique is described, in which also a subgroup analysis of the impact of cusp repair on 
reoperation risk in bicuspid and tricuspid aortic valve is provided.  The data confirm 
that even in the long-term the valve anatomy per se, being bicuspid or tricuspid, had not 
impact on the freedom from reoperation, whereas, the additional cusp repair continues 
to be a risk factor. If we look at the combination valve anatomy-cusp repair, BAVs 
requiring cusp repair are affected by a significant higher reoperation rate. Conversely, 
bicuspid with minimal cusp abnormalities and no need for cusp repair provided 
excellent 10-year results. Among patients with tricuspid aortic valve, additional cusp 
repair did not seem to affect the freedom from reoperation; indeed only one patient with 
tricuspid aortic valve and cusp repair was reoperated on. In contrast, 8 out of 9 of the 
patients with tricuspid aortic valve who underwent reoperation did not undergo cusp 
repair during the first procedure.  By this long-term experience two important messages 
were obtained: first, the asymmetrical BAVs (type I Sievers) that frequently require 
complex repair didn’t provide satisfactory results. Second, the cusp repair in tricuspid 
aortic valve, which frequently consists in a “simple” plication of the free margin, 
provided excellent results. The principal limitation of this study is that the number of 
patients with BAV that required additional cusp repair is not large enough to permit a 
further analysis based on the type of repair within this subgroup. Nevertheless, a policy 
that seems justified, is to be more aggressive with tricuspid aortic valves in terms of 
cusp repair, treating even valves with minimal prolapse so that to obtain a satisfactory 
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coaptation height and to be more cautious with Sievers type I BAV requiring extensive 
repair. A greater number of patients is needed to evaluate if BAV requiring simple repair 
(basically free margin plication) will provide favourable outcome.  
 
Alternative techniques for aortic root replacement 
 The composite valve graft procedure, according to the modified Bentall technique is 
currently considered the gold standard for the treatment of the aortic root aneurysm or 
acute DeBakey type I dissection in the presence of an irreparable aortic valve. 
Nevertheless, despite its proven excellent long-term outcome, the procedure is not free 
from complications related to prosthetic valves such as life-long anticoagulation therapy 
for the mechanical prosthesis and structural valve deterioration for the biological 
prosthesis  (19,30). In chapter 11, an analysis of risk factors related to this procedure is 
provided in a series of 120 patients treated exclusively with composite mechanical valve 
graft at Humanitas Research Hospital with a follow-up of 5 years. In-hospital mortality 
was 1.7% and overall survival was 84% at 5 years. Chronic renal failure, turned out to 
be the only independent risk factor for late mortality.  Reoperation as the result of 
complications in the composite valve graft procedure was necessary in 5.5%. 
Endocarditis and anticoagulant- related complications occurred at a rate of 1.8% and 
2.7%, respectively. These data confirm the reliability of this technique in terms of 
mortality.  Although the vast majority of our patients were operated on electively, 
hospital mortality below 2% is to be considered an excellent outcome consistent with 
the largest published series  (19,30). With regard to redo operation, that occurred in 6 
patients, it must be noted that in 4 the cause was a false aneurysm with a leak localized 
at the proximal suture line in 2 cases and at the coronary ostial suture line in the other 
two.  The incidence of coronary button dehiscence following the modified Bentall 
technique has been reported as high as 10% and connective tissue disorders, such as 
Marfan’s syndrome, appear to play a significant role in the development of this 
complication  (31).  Of note, both of our patients that experienced coronary button 
dehiscence had the Marfan’s syndrome, however, we did not use any reinforcement of 
the coronary ostial suture line. The role of Teflon felt or autologous pericardium placed 
around the coronary ostium to prevent tearing of tissue is still open to debate. If from 
one side it may prevent from bleeding and button detachment, from the other side it 
could make, in case of redo, difficult dissection of the ostia  (30,32-38). Our study 
suggests that, suture line reinforcement in patients with connective tissue disorders 
should be taken into consideration.  Regardless of the technique utilized to reinforce the 
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button’s tissue, the reduction of the tension at the level of the anastomosis is of 
paramount importance. A recent fine element study, focusing on this issue, seems to 
indicate that the re-creation of a sinus-like graft expansion in the Bentall procedure 
reduces the stress at the coronary button anastomosis  (39). The most serious late 
complication among our group of patients was the anticoagulant-related cerebral 
haemorrhage that occurred in 3 cases and caused death in all of them. The reasons were 
patients related: the uncontrolled usage of anticoagulant therapy and/or postponement 
of routine controls. Although the risk of complication related to anticoagulation depends 
on several factors including type of drug used, individual response and clinical 
circumstances, it seems that in patients with a CarboMedics bileaflet valve in aortic 
position an INR range between 2 and 3.5 is the ideal balance between the risk of 
thromboembolic events and bleeding  (40,41). Based on this data, we recommend to our 
patients a target INR of 2.5. 
Chapter 12 is, as well, a single center experience (S. Orsola Hospital, Bologna, Italy) 
focusing on aortic root replacement with composite valve graft. This study, with a mean 
follow-up of 62 months, includes patients treated both with mechanical and biological 
valves and emergency cases. The surgical technique has been changed over the years. 
Indeed, among the 274 patients included in the series, the first 94 (34%) underwent the 
classic Bentall operation, with inclusion and wrapping technique  (13). In 1994 the 
classic Bentall technique was abandoned in favour of the “button technique”  (42), so 
that this method has been used in 172 cases (63%). The Cabrol technique, consisting in 
suturing the coronary orifices to the tubular Dacron prosthesis by means of a second 
smaller Dacron tube, has been utilized in a minority of the cases (3%) in which, due to 
the extreme root dilatation or severe adherences, the approximation of the coronary 
arteries to the Dacron graft would have generated excessive tension  (43). The overall 
early mortality rate was 6.9% and multivariate analysis indicated CPB time longer than 
180 minutes and concomitant coronary artery bypass grafting as independent risk 
factors. Regarding the early morbidity, the patients who underwent the Cabrol 
technique had a higher incidence of cardiac complications (37% versus 11%) consisting 
in all of them in acute myocardial infarction. Correlation between the Cabrol method and 
myocardial ischemia, due to the thrombosis of the small Dacron connecting tube, has 
been reported in several series, so that it is nowadays utilized only when the button 
technique is not feasible  (44-46). During follow-up, the incidence of false aneurism 
originating from the coronary ostia suture line was the same among patients treated 
with the classic Bentall technique and with the button technique (2 cases for each 
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group), but It must be noted that both of the two patients of the “button” group had a 
severe aortitis as the result of the Behçet’s disease  (47,48). However, our series failed to 
show the superiority of the button technique in terms of false aneurysm incidence’s 
reduction. Probably, the small number of affected cases could have played an important 
role. Indeed, in a recent publication from the same center, updated with 1045 patients, 
the incidence of false aneurysm was significantly lower among patients treated with the 
button technique when compared with the classic Bentall (0.4% versus 2.1%).  
The Ross operation, first described by Donald Ross in 1967  (49) and consisting of 
transplantation of the autologous pulmonary valve into aortic position, represents an 
alternative in the treatment of the aortic valve disease in selected young adults  (50). 
Mechanical prostheses are durable but confer the risk of thromboembolism and 
bleeding as well as lifelong anticoagulation. Bio-prostheses, as an alternative has a 
considerable rate of failure, which is pronounced in young adults  (51). Concerning the 
root aneurysm, the Ross operation has represented also an alternative treatment to the 
Bentall operation in young adults with aortic incompetence and aortic root aneurysm  
(52) but more recently, due to the spread of the successful valve-sparing operations, this 
indication is no longer considered. There is still a role for it in a subset of young adults 
and precisely those with non-reparable bicuspid aortic valve and aortic root aneurysm  
(53). In chapter 13, a single institution’s evaluation of the Ross operation (St. Antonius 
Hospital, Nieuwegein, the Netherlands) in a population of 103 young adults with a mean 
follow-up 6 years, is provided. Outcome in terms of mortality was excellent: none of the 
patients died in hospital and there were two late deaths, one of which was non-cardiac 
related. This has been possible by careful patients selection: only young adults with few 
comorbidity were scheduled for the operation. The operative mortality associated with 
this procedure is quite variable among reports.  A recent meta-analysis (that includes 
also our series) reported a pooled early mortality for adult series of 3.2% (range 1.4%-
6.5%)  (54). Although the Ross procedure is regarded as a complex procedure, its 
primary indication is the treatment of the aortic valve pathology in young adults so that, 
an early mortality far beyond 2%, is in our opinion not acceptable. Five patients 
required reoperation on the autograft valve for incompetence, with a freedom from 
reoperation on pulmonary autograft of 87.4% at 10 years. Cox regression failed to show 
any risk factor associated to the development of aortic incompetence during follow-up. 
Others, found a dilated aortic annuls (>28 mm) and preoperative aortic incompetence as 
independent predictors of late pulmonary autograft failure  (55). As aortic insufficiency 
during follow-up is mainly caused by dilatation at the annular or sino-tubular level, 
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starting from 1997, we invariably used a reinforcement ring or a reduction annuloplaty 
if the aortic annular diameter exceeded the Z+2 value.  As known, a second Achilles heel 
of the Ross operation is the pulmonary homograft, which may develop dysfunction 
during follow-up. In our series, 25% of the patients developed, at a mean follow-up of 6 
years, pulmonary homograft stenosis and one of them underwent reoperation 1 year 
after the initial procedure. Cox regression identified smaller diameter of the homograft 
and older age of donor as independent risk factors for this complication. The fate of the 
pulmonary homograft varies among reports depending on how dysfunction is defined  
(56,57). David et al. recently reported a freedom form pulmonary reintervention of 
92.7% at 20 years, but echocardiographic data showed a freedom pulmonary valve 
dysfunction, either incompetence or stenosis, of 53.8%.  However, the reoperation rate 
due to this late complication is reasonably low and with the advent of catheter-based 
pulmonary valve implantation, the problem is further mitigated.  
 
Conclusions 
The valve-sparing aortic root replacement is now part of the surgical armamentarium to 
treat patients with aortic insufficiency and root aneurysm. Long-term results show that 
this technique is extremely reliable, at least in presence of normal or nearly normal 
aortic cusps. Concerns regarding the durability of the aortic valve remain for patients 
who require extensive cusp repair, particularly in case of bicuspid aortic valve.  
The composite valve graft procedure, according to the modified Bentall technique, is 
currently considered the gold standard for the treatment of the aortic root aneurysm or 
acute type I dissection in the presence of a irreparable aortic valve. 
The Ross operation represents an alternative treatment in young adults with non-
reparable aortic valve with or without aortic root aneurysm, but due to the complexity 
of the procedure it should be reserved for centers of proven experience and with a high 
volume of patients. 
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 Chapter 2: single institution preliminary clinical and echocardiographic results of 
aortic valve reimplantation in 32 consecutive patients are provided. There were no 
deaths and the freedom form moderate to severe aortic incompetence at discharge was 
94%. 
Chapter 3: results during a 5-year period of valve-sparing reimplantation procedure are 
evaluated by a multicenter Italian study. In-hospital mortality was 3.3% and was 
significantly higher among patients operated on for acute dissection. Eight of 151 
patients required late aortic replacement. Additional cusp repair turn out to be a 
significant risk factor for reoperation. 
Chapter 4: single center experience with aortic valve reimplantation by means of a 
modified Dacron graft that incorporates sinuses of Valsalva, in a series of 100 
consecutive patients.  Overall survival and freedom from re-operation at 60 months 
were 91.7% and 90.9%, respectively. Cox regression identified cusp’s repair as 
independent risk factor for late reimplantation failure.  
Chapter 5: an assessment of the compliance of the Dacron pseudo-sinuses of the 
Valsalva graft at mid term follow-up was performed by means of magnetic resonance. At 
a mean follow-up of 55 months the compliance of the Dacron pseudo-sinuses is still 
appreciable and significantly greater than the tubular portion.  
Chapter 6: a retrospective review was performed of 35 patients with the Marfan’s 
syndrome who, in four different centers, underwent the reimplantation valve-sparing 
aortic root replacement using the Gelwave Valsalva prosthesis. There were no operative 
or hospital deaths and no patient died during follow-up. The 5-year freedom fro 
reoperation owing to structural valve deterioration was 88.9%. 
Chapter 7: the results of reimplantation valve-sparing aortic root replacement, 
performed in two different cardiac centers, in patients grater than 60 years of age were 
evaluated. There were one hospital and two late deaths. Freedom from reoperation and 
freedom from moderate or severe residual aortic incompetence at 51 months were 
92.8% and 90%, respectively. There was no episode of endocarditis on follow-up.  
Chapter 8: a single institution experience with reimplantation valve sparing operation 
focusing on the influence of valve anatomy in determining the need for reoperation is 
provided. Overall freedom from aortic valve reoperation at 5 years was 90% without 
significant difference between patients with bicuspid and tricuspid aortic valve. Aortic 
valve reimplantation in patients with bicuspid aortic valve with no need of additional 
cusp repair provided excellent mid-term results.  
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Chapter 9: review of the literature to try to shed light on when, during aortic-valve 
sparing operation, the additional cusp repair is required and how it should be 
performed. Results in literature showed that, bicuspid aortic valve more often required 
correction in comparison with tricuspid aortic valve.  According to the largest published 
series, cusp repair did not affect the valve competence even in the long-term. 
Chapter 10: single center, retrospective experience with additional cusp repair during 
aortic valve reimplantation with a maximum follow-up of 12 years, is reported. Results 
indicated that adjunctive cusp repair affects the reoperation risk in patients with 
bicuspid aortic valve but not in patients with tricuspid aortic valve. Among patients with 
bicuspid aortic valve, those who did not require cusp repair showed a significantly 
higher freedom from reoperation compared with patients who received cusp repair.  
Chapter 11: a retrospective single institution (Humanitas Research Hospital, Rozzano, 
Milan, Italy) analysis of a selected series of Bentall procedures was carried out in order 
to evaluate the performance of the Carboseal mechanical composite valve graft. The 
actuarial survival rate, including in-hospital mortality, was 84% at 5 years. Chronic renal 
failure was the only independent risk factor for late mortality. False aneurysm requiring 
re-operation had a higher incidence among patients with the Marfan’s syndrome.  
Chapter 12: a single center (S. Orsola-Malpighi Hospital, Bologna, Italy) experience with 
aortic root replacement using a composite graft in reported. The actuarial survival rate 
was 63% at 10 years. Risk factors for late mortality were coronary artery disease, 
chronic renal failure and postoperative dialysis. The freedom from reoperation on the 
remaining aorta was lower among patients with the Marfan’s syndrome.  
Chapter 13: risk factors for aortic valve incompetence and pulmonary homograft valve 
stenosis were identified in a single center series of young adults who underwent the 
Ross operation. There were no hospital deaths. Autograft function follow-up resulted in 
5 of 103 patients requiring reoperation for severe aortic incompetence, whereas 
reoperation for homograft dysfunction occurred in 1 patient. 
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